Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 101
Encontrada(s) 2 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Coverage of overdose prevention programs for opiate users and injectors, A cross-sectional study

  • Arribas-Ibar, Elisabet
  • Sanchez-Niubo, Albert|||0000-0003-0309-181X
  • Majó, Xavier|||0000-0003-4338-6014
  • Domingo Salvany, Antònia|||0000-0003-3302-4538
  • Brugal, María Teresa|||0000-0003-0580-676X
Background: The use of opiates, particularly heroin, remains an important cause of morbidity and mortality. Half of the deaths among heroin consumers are attributed to overdose. In response to this problem, overdose prevention programs (OPPs) were designed. The objective of our study was to assess coverage of OPPs among the target population in a specific Spanish region (Catalonia) and to identify characteristics related to attendance. Methods: A cross-sectional survey recruited individuals from outpatient treatment centers (OTCs), therapeutic communities (ThCs), and harm reduction facilities (HRFs) in Catalonia. From 513 participants, 306 opiate users and/ or injectors were selected for this study. Coverage was calculated as the proportion of subjects who declared having participated in an OPP. A Poisson regression with robust variance was used to assess factors (socio-demographic aspects and psychoactive substance use patterns) associated to OPP participation, taking into account recruitment strategy. Results: Average age of the 306 subjects was 39.7 years (s.d.: 7.7); 79% were male; 79.2% lived in urban areas and 56.3% were unemployed or had never worked. Overall OPP coverage was 43.5% (95% CI: 37%-49%). Training was received mostly in HRF (60%), followed by OTC (24.4%), prison (19%), and ThC (16%). OPP sessions were attended by 41% of Spanish-born study participants and by 63.3% of foreigners; 92.2% of the participants lived in urban areas. The Poisson regression analysis adjusted by age, sex, and type of recruitment center showed that OPP participation rates were higher for individuals with foreign nationality (PR = 1.3; 95% CI: 1.04-1.72), for those living in municipalities with more than 100,000 inhabitants (PR = 2.0; 95% CI: 1.37-2.81) or the Barcelona conurbation (PR = 2.5; 95% CI: 1.68-3.77), and for those having ever been in prison (PR = 1.6; 95% CI: 1.41-1.81) and had first consumption when they were less than 12 years old (PR = 1.2; 95% CI: 1.06-1.45). Conclusion: Coverage as a whole can be considered high. However, in Catalonia, new strategies ought to be developed in order to attract opiate users and injectors not currently participating, by expanding OPP offer to services and regions where coverage is poor.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Principales daños sanitarios y sociales relacionados con el consumo de alcohol, Health and social harm related alcohol

  • Sarasa-Renedo, Ana
  • Sordo, Luis|||0000-0003-1760-9472
  • Molist, Gemma|||0000-0002-0927-1945
  • Hoyos, Juan|||0000-0003-3772-2771
  • Guitart, Anna M.|||0009-0004-7493-4954
  • Barrio, Gregorio
El alcohol afecta al cerebro y a la mayoría de los órganos y sistemas y se relaciona con numerosos problemas sanitarios, incluyendo enfermedades mentales, neurológicas, digestivas, cardiovasculares, endocrinas y metabólicas, perinatales, cáncer, infecciones y lesiones intencionadas y no intencionadas. Los mecanismos fisiopatológicos aún no se comprenden bien, aunque se ha postulado toxicidad directa del etanol y de sus metabolitos, déficits nutricionales y absorción de endotoxinas microbianas intestinales, todo modulado por los patrones de consumo y factores genéticos y ambientales. A nivel individual no puede predecirse con precisión quién tendrá o no problemas. A nivel poblacional para muchos problemas, como varios tipos de cánceres, hepatopatías, lesiones y probablemente conductas de riesgo, como relaciones sexuales sin protección, se suele observar una relación dosis respuesta lineal o exponencial. Para otros, como mortalidad general en mayores de 45 años, enfermedades isquémicas o diabetes mellitus la relación es en forma de J. Su impacto sobre la carga global de enfermedad es enorme, incluso después de descontar los efectos beneficiosos sobre la enfermedad cardiovascular, con diferencias importantes según país, edad, género, posición socioeconómica y otros factores. Buena parte de los daños se relacionan con su capacidad para producir dependencia y con la intoxicación aguda. A menudo genera también consecuencias negativas para otras personas (violencia, incumplimiento de responsabilidades familiares o laborales, molestias) que no suelen considerarse al evaluar la carga de enfermedad. El objetivo de este trabajo es describir los principales daños sociales y sanitarios relacionados con el consumo de alcohol y los mecanismos que los generan a partir de fuentes secundarias., Alcohol affects the brain and most organs and systems, and its use is related to a large number of health problems. These include mental, neurological, digestive, cardiovascular, endocrine, metabolic, perinatal, cancerous, and infectious diseases, as well as intentional and non-intentional injuries. Physiopathological mechanisms still remain unraveled, though direct toxicity of ethanol and its metabolites, nutritional deficit and intestinal microbial endotoxin absorption have been suggested, all of which would be further modulated by use patterns and genetic and environmental factors. Individually it is difficult to precisely predict who will or will not suffer health consequences. At population level several disorders show a linear or exponential dose-response relationship, as is the case with various cancer types, hepatopathies, injuries, and probably risky behaviors such as unsafe sex. Other health problems such as general mortality in people above 45 years of age, ischemic disease or diabetes mellitus show a J-shaped relationship with alcohol use. The overall effect of alcohol on the global burden of disease is highly detrimental, despite the possible beneficial effect on cardiovascular disease. Large differences are found by country, age, gender, socioeconomic and other factors. Disease burden is mostly related with alcohol's capacity to produce dependence and with acute intoxication. Often alcohol also produces negative consequences for other people (violence, unattended family or work duties, etc) which are generally not taken into account when evaluating burden of disease. The aim of this study was to describe the main alcohol-related social andhealthharms, aswell astheirgeneratingmechanisms, usingsecondary data sources.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Tratamiento especializado delabuso o dependencia del alcohol, Specialised treatment for alcohol abuse or dependence

  • Suelves, Josep M.|||0000-0002-7716-6944
  • Villalbí, Joan Ramón|||0000-0001-6915-2545
  • Bosque Prous, Marina|||0000-0002-8830-8880
  • Espelt, Albert|||0000-0002-8625-4356
  • Brugal, María Teresa|||0000-0003-0580-676X
Fundamentos: El Plan Nacional sobre Drogas (PNSD) impulsó la prevención y el tratamiento de los trastornos por uso de drogas ilegales, y ahora abarca los trastornos por uso de alcohol. El objetivo de este trabajo es realizar una estimación de las personas en tratamiento especializado por alcohol en la red pública. Métodos: Se revisan documentos del PNSD, del sistema de información sobre drogodependencias de Cataluña y del de Barcelona. Para Cataluña y Barcelona se presentan datos de 1991 a 2010. Resultados: Para el conjunto de España hay información disponible desde hace pocos años, con exhaustividad y validez variable. En Catalunya, el número de admisiones a tratamiento por alcohol notificadas se incrementó: el alcohol causa anualmente más del 40% del total de admisiones a tratamiento en la red de drogodependencias; la edad media es de 44 años y el 23% son mujeres. En Barcelona las admisiones a tratamiento por alcohol superan las 2.000 al año, suponiendo 217 por 100.000 habitantes mayores de 15 años varones y 67 en mujeres. Conclusiones: Los datos disponibles sugieren que por lo que respecta al alcohol el sistema de información sobre drogas ha de desarrollarse más en España, resolviendo problemas metodológicos. Los datos disponibles para Cataluña sugieren que la red de atención a drogas ha permitido abordar la necesidad asistencial por dependencia al alcohol conjuntamente con la de drogas ilegales. Esta información es relevante, pues apenas existen datos de tratamiento referidos a la población., Background. The National Plan for Drugs in Spain (PNSD) fostered the prevention and treatment of illegal drug use disorders, and now also covers alcohol use disorders. The goal of this paper is to estimate the number of persons in specialized treatment because of alcohol in public services. Methods. Review of the key documents of the PNSD, the drug information system of Catalonia, and the Barcelona drug information system. For Catalonia and Barcelona data from 1991 to 2010 are presented. Results. In recent years, there has been more information available for Spain as a whole, of varying validity and comprehensiveness. In Catalonia, the number of reported admissions to treatment for alcohol use disorders has risen: alcohol causes yearly over 40% of all admissions in the drug addiction treatment network; mean age is 44 years, and 23% are women. In Barcelona, admissions to treatment due to alcohol are more than 2.000 each year, relative frequency is 217 by 100.000 residents over 15 years for men and 67 for women. Conclusions. Available data shows that for alcohol, the drug information system needs further development in Spain, solving methodological issues. Available data for Catalonia suggests that the network of drug treatment centres has improved treatment for alcohol use disorders along with that of illegal drugs. This information is relevant, as there is almost no population based treatment data. This information should be completed for other Regional Administrations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Driving and legal status of Spanish opioid-dependent patients

  • Roncero, Carlos|||0000-0003-1421-7385
  • Álvarez, F.Javier
  • Barral, Carmen|||0000-0001-9963-6153
  • Gómez-Baeza, Susana
  • Gonzalvo, Begoña
  • Rodríguez-Cintas, Laia|||0000-0003-2703-6225
  • Brugal, María Teresa|||0000-0003-0580-676X
  • Jacas, Carlos|||0000-0002-7023-3657
  • Romaguera, Anna
  • Casas Brugué, Miquel|||0000-0003-3496-8522
Background: Opioid dependent patients have legal problems, driving violations and accidents more frequently than the general population. We have hypothesized that those patients currently driving may have better legal outcomes than those who do not possess a valid driving license. With this aim we have analyzed the information gathered in the PROTEUS study regarding the legal and driving statuses and assessed the possible association between them. The PROTEUS study was an observational, cross-sectional, descriptive, multicenter nationwide representative study, conducted in Spanish healthcare centers for opioid dependent patients.Findings: The driving and legal statuses of a population of opioid dependent patients ≥18 years and enrolled in Opioid Agonist Therapy treatment centers in Spain, were assessed using a short specific questionnaire and the EuropASI questionnaire to highlight distinct individual clinical needs. 621 patients were evaluable (84% men, 24.5% active workers). 321 patients (52%) drove on a regular basis. Nineteen percent of patients had some problem with the criminal justice system. There was a significant difference (p = 0.0433) in status, according to the criminal justice system, between patients who drove on a regular basis and those who did not, with a higher percentage of patients with non-pending charges among usual drivers.Conclusions: Regular drivers showed fewer legal problems than non-regular drivers, with the exception of those related to driving (driving violations and drunk driving). Driving is a good prognostic factor for the social integration of the patients and policies should be implemented to enable these patients to drive safely under medical authorization. The legal description will be useful to assess treatment efficacy. © 2013 Roncero et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications, a systematic review and meta-analysis

  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Vázquez, Juan Carlos
  • Ullmo, Johana|||0000-0002-9313-917X
  • Llurba, Elisa|||0000-0003-4048-6407
Background: Evidence on the impact of low-molecular-weight heparin, alone or in combination with low-dose aspirin, for the prevention for preeclampsia in high-risk patients is conflicting. Objective: We conducted a meta-analysis of studies published to assess the effectiveness of low-molecular-weight heparin for the prevention of preeclampsia and other placenta-related complications in high-risk women. Data Sources: A systematic search was performed to identify relevant studies, using the databases PubMed and Cochrane Central Register of Controlled Trials, without publication time restrictions. Study Eligibility Criteria: Randomized controlled trials comparing treatment with low-molecular-weight heparin or unfractionated heparin (with or without low-dose aspirin), in high-risk women, defined as either history of preeclampsia, intrauterine growth restriction, fetal demise, or miscarriage or being at high risk after first-trimester screening of preeclampsia. Study Appraisal and Synthesis Methods: The systematic review was conducted according to the Cochrane Handbook guidelines. The primary outcome was the development of preeclampsia. We performed prespecified subgroup analyses according to combination with low-dose aspirin, low-molecular-weight heparin type, gestational age when treatment was started, and study population (patients with thrombophilia, at high risk of preeclampsia or miscarriage). Secondary outcomes included small for gestational age, perinatal death, miscarriage, and placental abruption. Pooled odds ratios with 95% confidence intervals were calculated using a random-effects model. Quality of evidence was assessed using the grading of recommendations assessment, development, and evaluation methodology. Results: A total of 15 studies (2795 participants) were included. In high-risk women, treatment with low-molecular-weight heparin was associated with a reduction in the development of preeclampsia (odds ratio, 0.62; 95% confidence interval, 0.43-0.90; P=.010); small for gestational age (odds ratio, 0.61; 95% confidence interval, 0.44-0.85; P=.003), and perinatal death (odds ratio, 0.49; 95% confidence interval, 0.25-0.94; P=.030). This reduction was stronger if low-molecular-weight heparin was started before 16 weeks' gestation (13 studies, 2474 participants) for preeclampsia (odds ratio, 0.55; 95% confidence interval, 0.39-0.76; P=.0004). When only studies including low-dose aspirin as an intervention were analyzed (6 randomized controlled trials, 920 participants), a significant reduction was observed in those with combined treatment (low-molecular-weight heparin plus low-dose aspirin) compared with low-dose aspirin alone (odds ratio, 0.62; 95% confidence interval, 0.41-0.95; P=.030). Overall, adverse events were neither serious nor significantly different. Quality of evidence ranged from very low to moderate, mostly because of the lack of blinding, imprecision, and inconsistency. Conclusion: Low-molecular-weight heparin use was associated with a significant reduction in the risk of preeclampsia and other placenta-mediated complications in high-risk women and when treatment was started before 16 weeks' gestation. Combined treatment with low-dose aspirin was associated with a significant reduction in the risk of preeclampsia compared with low-dose aspirin alone. However, there exists important clinical and statistical heterogeneity, and therefore, these results merit confirmation in large well-designed clinical trials.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cardiovascular risk assessment in women at high risk for pre-eclampsia in first half of pregnancy

  • Ullmo, Johana|||0000-0002-9313-917X
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Bos-Real, L.|||0000-0002-6159-0644
  • Padilla-Lopez, Mireia|||0000-0002-4374-3870
  • Coma-Barbarà, Marina
  • Martorell, Silvia
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Ordóñez, J. (Jordi)|||0000-0003-4896-5832
  • Llurba, Elisa|||0000-0003-4048-6407
Background: Women diagnosed with pre-eclampsia (PE), especially those with early-onset and severe forms, are at heightened risk of future cardiovascular disease (CVD). It is uncertain if women at high-risk for PE present cardiovascular impairment at the beginning of pregnancy. The aim of this study was to assess cardiovascular biomarkers and cardiac function in the first half of pregnancy in women at high-risk for PE. Methods: This was a prospective cohort study including women attending first trimester screening for PE. Risk of PE in the first trimester was calculated using a previously validated model, which includes maternal factors and biophysical markers. A cut-off of 1 in 250 was used to classify high-risk for developing PE. Maternal echocardiographic function and morphometry were evaluated, and peripheral blood samples were obtained to assess hematological and biochemical variables, including lipid profile and cardiovascular and angiogenic factors. Results: A total of 349 pregnant individuals were included; 257 at high-risk and 92 at low-risk for PE. Maternal echocardiography was performed at a mean ± SD gestational age of 14.9 ± 1.3 weeks and blood sampling at 16.3 ± 1.9 weeks. The high-risk PE group exhibited a significantly worse lipid profile (lower levels of high-density lipoproteins 69.7 ± 14.2 vs 74.0 ± 14.6 mg/dL, p=0.020), lower placental growth factor (0.89 ± 0.63 vs 1.15 ± 0.58 MoM, p<0.001), and significantly lower levels of N-terminal pro-brain natriuretic peptide (51.0 ± 2.1 vs 52.1 ± 2.0 ng/L, p=0.008). Echocardiographic evaluation indicated concentric remodeling, along with an altered diastolic pattern in the high-risk group. Conclusions: Women at high risk of developing PE exhibit differences in lipid profile, angiogenic factors, and echocardiographic parameters, indicative of cardiac maladaptation or impairment during the first half of pregnancy. These findings suggest a link between subclinical cardiovascular dysfunction, PE development and later CVD risk.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Gender differences in hazardous drinking among middle-aged in Europe, the role of social context and women's empowerment

  • Bosque Prous, Marina|||0000-0002-8830-8880
  • Espelt, Albert|||0000-0002-8625-4356
  • Borrell i Thió, Carme|||0000-0002-1170-2505
  • Bartroli, Montserrat|||0000-0002-4553-9961
  • Guitart, Anna M.
  • Villalbí, Joan Ramón|||0000-0001-6915-2545
  • Brugal, María Teresa|||0000-0003-0580-676X
Background: The aim of this study was to estimate the magnitude of gender differences in hazardous drinking among middle-aged people and to analyse whether these differences are associated with contextual factors, such as public policies or socioeconomic factors. Methods: Cross-sectional design. The study population included 50- to 64-year-old residents of 16 European countries who participated in the Survey of Health, Ageing and Retirement in Europe project conducted in 2010-12 (n = 26 017). We estimated gender differences in hazardous drinking in each country. To determine whether different social context or women's empowerment variables were associated with gender differences in hazardous drinking, we fitted multilevel Poisson regression models adjusted for various individual and country-level variables, which yielded prevalence ratios and their 95% confidence intervals (95% CI). Results: Prevalence of hazardous drinking was significantly higher in men than women [30.2% (95% CI: 29.1-31.4%) and 18.6% (95% CI: 17.7-19.4%), respectively] in most countries, although the extent of these differences varied between countries. Among individuals aged 50-64 years in Europe, risk of becoming a hazardous drinker was 1.69 times higher (95% CI: 1.45-1.97) in men, after controlling for individual and country-level variables. We also found that lower values of the gender empowerment measure and higher unemployment rates were associated with higher gender differences in hazardous drinking. Conclusion: Countries with the greatest gender differences in hazardous drinking were those with the most restrictions on women's behaviour, and the greatest gender inequalities in daily life. Lower gender differences in hazardous drinking seem to be related to higher consumption among women.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Binge drinking and well-being in European older adults, Do gender and region matter?

  • Fuentes, Sonsoles|||0000-0003-1710-3332
  • Bilal, Usama|||0000-0002-9868-7773
  • Galán, Ignacio|||0000-0003-0624-9993
  • Villalbí, Joan Ramón|||0000-0001-6915-2545
  • Espelt, Albert|||0000-0002-8625-4356
  • Bosque Prous, Marina|||0000-0002-8830-8880
  • Franco, Manuel
  • Lazo, Mariana|||0000-0002-3178-6734
Background: We aimed to describe gender and region differences in the prevalence of binge drinking and in the association between binge drinking and well-being, among older adult Europeans. Methods: This is a cross-sectional study using the Survey of Health, Ageing and Retirement in Europe (SHARE) wave 4, conducted between 2011 and 2012, including 58 489 individuals aged 50 years or older. Sixteen European countries were grouped in four drinking culture regions: South, Central, North and East. We categorized drinking patterns as: never, former, no-binge and binge drinkers. We used the CASP-12 questionnaire to measure well-being. To assess the association between binge drinking and well-being, we fitted two-level mixed effects linear models. Results: The highest percentage of binge drinkers was found in Central Europe (17.25% in men and 5.05% in women) and the lowest in Southern Europe (9.74% in men and 2.34% in women). Former, never and binge drinkers had a significant negative association with well-being as compared with no-binge drinkers. There was a significant interaction in this association by gender and region. Overall, associations were generally stronger in women and in Southern and Eastern Europe. The negative association of binge drinking with well-being was especially strong in Southern European women (ß =-3.80, 95%CI: -5.16 to-2.44, P value <0.001). Conclusion: In Southern and Eastern European countries the association between binge drinking and well-being is stronger, especially in women, compared with Northern and Central Europe. Cultural factors (such as tolerance to drunkenness) should be further explored.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

  • Maxwell, Christopher|||0000-0002-0713-7136
  • Benítez, Javier J.
  • Gómez-Baldó, Laia
  • Osorio, Ana|||0000-0001-8124-3984
  • Bonifaci, Núria|||0000-0002-8193-6825
  • Fernández-Ramires, Ricardo|||0000-0002-6974-2593
  • Costes, Sylvain|||0000-0002-8542-2389
  • Guinó, Elisabet|||0000-0003-0093-2652
  • Chen, Helen
  • Evans, Gareth|||0000-0002-8482-5784
  • Mohan, Pooja
  • Català, Isabel
  • Petit Montserrat, Anna|||0000-0002-9284-095X
  • Aguilar, Helena
  • Villanueva, Alejandro|||0000-0001-5164-0006
  • Aytes, Alvaro|||0000-0003-0725-5340
  • Serra-Musach, Jordi
  • Rennert, Gad|||0000-0002-8512-068X
  • Lejbkowicz, Flavio|||0000-0001-5718-0418
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Manoukian, Siranoush
  • Peissel, Bernard|||0000-0001-9233-3571
  • Ripamonti, Carla Barbara|||0000-0002-2892-8164
  • Bonanni, Bernardo|||0000-0003-3589-2128
  • Viel, Alessandra|||0000-0003-2804-0840
  • Allavena, Anna
  • Bernard, Loris
  • Radice, Paolo|||0000-0001-6298-4111
  • Friedman, Eitan|||0000-0002-6745-1733
  • Kaufman, Bella
  • Laitman, Yael
  • Dubrovsky, Maya
  • Milgrom, Roni
  • Jakubowska, Anna|||0000-0002-5650-0501
  • Cybulski, Cezary|||0000-0002-2819-3057
  • Gorski, Bohdan
  • Jaworska, Katarzyna
  • Durda, Katarzyna
  • Sukiennicki, Grzegorz
  • Lubinski, Jan|||0000-0003-2931-3003
  • Shugart, Yin Yao
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Letrero, Richard
  • Weber, Barbara L.
  • Hogervorst, Frans B. L.
  • Rookus, Matti A.
  • Collee, J. Magriet
  • Devilee, Peter|||0000-0002-8023-2009
  • Ligtenberg, Marjolijn J.
  • van der Luijt, Rob|||0000-0002-0018-1089
  • Aalfs, Cora M.
  • Waisfisz, Quinten|||0000-0002-7384-9182
  • Wijnen, Juul
  • van Roozendaal, Cornelis E. P.
  • HEBON, None
  • EMBRACE, None
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Peock, Susan
  • Cook, Margaret
  • Oliver, Clare
  • Frost, Debra
  • Harrington, Patricia
  • Lalloo, Fiona
  • Eeles, Rosalind|||0000-0002-3698-6241
  • Izatt, Louise|||0000-0003-1258-4843
  • Chu, Carol
  • Eccles, Diana M.|||0000-0002-9935-3169
  • Douglas, Fiona
  • Brewer, Carole
  • Nevanlinna, Heli|||0000-0002-0916-2976
  • Heikkinen, Tuomas|||0000-0003-1154-6204
  • Couch, Fergus J.
  • Wang, Xianshu
  • Lindor, Noralane M.
  • Godwin, Andrew K.|||0000-0002-3987-9580
  • Caligo, Maria|||0000-0003-0589-1829
  • Lombardi, Grazia
  • Loman, Niklas
  • Karlsson, Per
  • Ehrencrona, Hans|||0000-0002-5589-3622
  • von Wachenfeldt, Anna
  • SWE-BRCA, None
  • Barkardottir, Rosa
  • Hamann, Ute|||0000-0001-6705-7624
  • Rashid, Muhammad U.|||0000-0002-7684-3122
  • Lasa, Adriana|||0000-0001-9957-9646
  • Caldes, Trinidad
  • Andrés Conejero, Raquel
  • Schmitt, Michael
  • Assmann, Volker
  • Stevens, Kristen
  • Offit, Kenneth
  • Curado, João
  • Tilgner, Hagen U.|||0000-0002-7058-3606
  • Guigó, Roderic|||0000-0002-5738-4477
  • Aiza, Gemma|||0000-0001-8654-3724
  • Brunet, Joan|||0000-0003-1945-3512
  • Castellsagué, Joan|||0000-0002-2579-3137
  • Martrat, Griselda
  • Urruticoechea, Ander|||0000-0003-0359-3641
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Tihomirova, L.
  • Goldgar, D. E.
  • Buys, S.
  • John, Esther M.
  • Miron, A.
  • Southey, M.
  • Daly, M.B.
  • BCFR, None
  • Schmutzler, R.K.
  • Wappenschmidt, B.
  • Meindl, A.
  • Arnold, N.
  • Deissler, H.
  • Varon-Mateeva, Raymonda
  • Sutter, C.
  • Niederacher, D.
  • Imyamitov, E.
  • Sinilnikova, O.M.
  • Stoppa-Lyonne, D.
  • Mazoyer, S.
  • Verny-Pierre, C.
  • Castera, L.
  • de Pauw, A.
  • Bignon, Y.J.
  • Uhrhammer, N.
  • Peyrat, J.P.
  • Vennin, P.
  • Ferrer, S.
  • Collonge-Rame, M.A.
  • Mortemousque, I.
  • GEMO Study Collaborators, None
  • Spurdle, A.B.
  • Beesley, J.
  • Chen, X.
  • Healey, S.
  • Barcellos-Hoff, M.H.
  • Gruber, S.B.
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Capella, Gabriel|||0000-0002-4669-7320
  • McGuffog, L.
  • Antoniou, A.C.
  • Chenevix-Trench, G.
  • Fleisch, M.C.
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Pujana, Miguel Angel|||0000-0003-3222-4044
Differentiated mammary epithelium shows apicobasal polarity, and loss of tissue organization is an early hallmark of breast carcinogenesis. In BRCA1 mutation carriers, accumulation of stem and progenitor cells in normal breast tissue and increased risk of developing tumors of basal-like type suggest that BRCA1 regulates stem/progenitor cell proliferation and differentiation. However, the function of BRCA1 in this process and its link to carcinogenesis remain unknown. Here we depict a molecular mechanism involving BRCA1 and RHAMM that regulates apicobasal polarity and, when perturbed, may increase risk of breast cancer. Starting from complementary genetic analyses across families and populations, we identified common genetic variation at the low-penetrance susceptibility HMMR locus (encoding for RHAMM) that modifies breast cancer risk among BRCA1, but probably not BRCA2, mutation carriers: n = 7,584, weighted hazard ratio (<inf.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cannabinoid type-1 receptors in CaMKII neurons drive impulsivity in pathological eating behavior

  • Martín-García, Elena|||0000-0002-4487-3028
  • Domingo-Rodriguez, Laura|||0000-0003-3286-6696
  • Lutz, Beat|||0000-0002-1062-6889
  • Maldonado, Rafael|||0000-0002-4359-8773
  • Ruiz de Azua, Inigo
Overconsumption of palatable food and energy accumulation are evolutionary mechanisms of survival when food is scarce. These innate mechanisms becom detrimental in obesogenic environment promoting obesity and related comorbidities, including mood disorders. This study aims at elucidating the role of the endocannabinoid system in energy accumulation and hedonic feeding. We applied a genetic strategy to reconstitute cannabinoid type-1 receptor (CB1) expression at functional levels specifically in CaMKII+ neurons (CaMKII-CB1-RS) and adipocytes (Ati-CB1-RS), respectively, in a CB1 deficient background. Rescued CB1 expression in CaMKII+ neurons, but not in adipocytes, promotes feeding behavior, leading to fasting-induced hyperphagia, increased motivation, and impulsivity to palatable food seeking. In a diet-induced obesity model, CB1 re-expression in CaMKII+ neurons, but not in adipocytes, compared to complete CB1 deficiency, was sufficient to largely restore weight gain, food intake without any effect on glucose intolerance associated with high-fat diet consumption. In a model of glucocorticoid-mediated metabolic syndrome, CaMKII-CB1-RS mice showed all metabolic alterations linked to the human metabolic syndrome except of glucose intolerance. In a binge-eating model mimicking human pathological feeding, CaMKII-CB1-RS mice showed increased seeking and compulsive behavior to palatable food, suggesting crucial roles in foraging and an enhanced susceptibility to addictive-like eating behaviors. Importantly, other contingent behaviors, including increased cognitive flexibility and reduced anxiety-like behaviors, but not depressive-like behaviors, were also observed. CB1 in CaMKII+ neurons is instrumental in feeding behavior and energy storage under physiological conditions. The exposure to risk factors (hypercaloric diet, glucocorticoid dysregulation) leads to obesity, metabolic syndrome, binge-eating and food addiction.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Ophthalmic artery Doppler and carotid intima-media thickness 3-6 years postpartum in women with and without a history of placental insufficiency

  • García Manau, Pablo|||0000-0002-2415-1626
  • Platero, Judit|||0000-0001-6007-9855
  • Costa, Noah
  • Garcia, Zoraida
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Pellicer, Claudia
  • Ullmo, Johana|||0000-0002-9313-917X
  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Jordi, Mariona
  • Choliz, Marta
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Trilla, Cristina|||0000-0002-5650-1790
  • Domínguez Gallardo, Carla|||0000-0002-5365-1005
  • Llurba, Elisa|||0000-0003-4048-6407
Preeclampsia and fetal growth restriction, which are clinical presentations of placental dysfunction, are frequently associated with angiogenic imbalance during pregnancy and increased long-term cardiovascular risk. Whether this risk is driven by the pre-pregnancy risk factors, clinical disease, or by an elevated sFlt-1/PlGF ratio remains unclear. This study aimed to assess the association between vascular assessments (ophthalmic artery Doppler and carotid intima-media thickness) 3-6 years postpartum and a history of preeclampsia and fetal growth restriction, and to evaluate if associations were impacted by an angiogenic imbalance during pregnancy. This was a cross-sectional study, which included individuals prospectively recruited during their index pregnancy between 2018 and 2021 and re-evaluated 3-6 years postpartum. Preeclampsia, fetal growth restriction, and sFlt-1/PlGF values were defined from pregnancy data. Postpartum assessment included ophthalmic artery Doppler and carotid intima-media thickness performed by a single operator. Multivariable linear regression models assessed associations between placental dysfunction, angiogenic imbalance, and vascular parameters, adjusting for maternal covariates. 354 participants were included, 148 with and 206 without a history of preeclampsia or fetal growth restriction. Both placental dysfunction and angiogenic imbalance during pregnancy were independently associated with a significantly higher ophthalmic artery peak systolic velocity ratio 3-6 years postpartum. Participants with a history of placental dysfunction showed higher values compared to those without [0.75 (0.67-0.81) vs. 0.69 (0.63-0.78), p = 0.03], as did those with an elevated sFlt-1/PlGF ratio during pregnancy [0.76 (0.66-0.82) vs. 0.70 (0.64-0.78), p = 0.03]. The highest values were observed in women who had experienced both conditions. When preeclampsia and fetal growth restriction were analyzed separately, the association remained significant for preeclampsia, whereas in the fetal growth restriction group, a significant difference was observed only in the right eye. No statistically significant differences were observed in carotid intima-media thickness. Both a history of angiogenic imbalance and a clinical placental dysfunction presentation (particularly preeclampsia) during pregnancy were associated with increased ophthalmic artery peak systolic velocity ratio 3-6 years postpartum, whereas carotid intima-media thickness did not differ between the study groups. Both angiogenic imbalance and a history of placental dysfunction during pregnancy are associated with increased ophthalmic artery peak systolic velocity ratio 3-6 years postpartum, especially in cases where clinical disease (particularly preeclampsia) develops.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Long-Term Biochemical and Cardiovascular Profiles 3-6 Years After Preeclampsia, Impact of Angiogenic Imbalance During Pregnancy

  • Costa, Noah
  • Platero, Judit|||0000-0001-6007-9855
  • García Manau, Pablo|||0000-0002-2415-1626
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Jordi, Mariona
  • García Ruiz, Zoraida|||0009-0009-4631-763X
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Ullmo, Johana|||0000-0002-9313-917X
  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Choliz, Marta
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
  • Pellicer, Claudia
  • Medina Mallen, Maria del Carmen|||0000-0002-1219-5947
Background/Objectives: Preeclampsia is associated with long-term cardiovascular and metabolic risks. This study aimed to evaluate metabolic and cardiovascular biochemical profiles in women with a history of preeclampsia and angiogenic imbalance during pregnancy. Methods: We conducted a cross-sectional study at Hospital de la Santa Creu i Sant Pau between August 2023 and July 2025. Participants had been prospectively enrolled during pregnancy (2018-2022) and were re-evaluated 3 to 6 years later. Blood and urine samples were collected after a 12-h fast to assess hematological, metabolic, and cardiovascular markers. Angiogenic profiles were determined using sFlt-1/PlGF ratios obtained during pregnancy. Multivariable linear regression models were used to assess associations with a history of PE and angiogenic imbalance, adjusting for relevant confounders. Results: 363 participants were included. 113 (31.1%) had a history of preeclampsia. Women with previous preeclampsia showed slightly higher high-sensitivity troponin T concentrations [4.0 (3.0-6.0) ng/L vs. 3.2 (3.0-5.0) ng/L, p = 0.03]. Women with sFlt-1/PlGF ≥38 exhibited significantly higher urinary protein [0.09 (0.07-0.18) g/L vs. 0.08 (0.07-0.13) g/L, p = 0.01], potassium [4.25 (4.07-4.40) mmol/L vs. 4.19 (4.02-4.37) mmol/L, p = 0.048], and LDH concentrations [168 (150-189) U/L vs. 163 (149-177) U/L, p = 0.046], and lower leukocyte counts [6150 (5348-7055) vs. 6250 (5430-7450) U/mL, p = 0.03]. Conclusions: Women with angiogenic imbalance during pregnancy display subtle alterations in renal and endothelial function markers years after delivery, whereas those with preeclampsia show slightly higher troponin concentrations. These findings, though clinically irrelevant, suggest that pregnancy-related vascular dysfunction may have different long-term manifestations depending on whether the maternal cardiovascular system was sufficiently compromised to develop overt preeclampsia.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

N-terminal pro B-type natriuretic peptide as biomarker to predict pre-eclampsia and maternal-fetal complications

  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Universitat Autònoma de Barcelona.
  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Platero, Judit|||0000-0001-6007-9855
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • García Manau, Pablo|||0000-0002-2415-1626
  • Ullmo, Johana|||0000-0002-9313-917X
  • Sánchez García, Olga|||0000-0002-5279-440X
  • Vila-Cortés, M.
  • Pelegay, M. J.
  • Ricart, M
  • Muñoz-Abellana, B.
  • Barrios, X. Gabaldó
Objective: A soluble fms-like tyrosine kinase-1 (sFlt-1)-to-placental growth factor (PlGF) ratio cut-off of 38 is currently considered optimal for ruling out pre-eclampsia (PE); however, implementation of this ratio in clinical practice is limited. N-terminal pro B-type natriuretic peptide (NT-proBNP) is elevated in PE owing to the cardiovascular effects of this disease. This study aimed to identify the predictive performance of NT-proBNP to detect PE and placental complications within 1 week after assessment, and compare it with the predictive performance of the sFlt-1/PlGF ratio. High-sensitivity troponin T (hs-TnT) and uric acid were also evaluated. Methods: This was a prospective nested case-control study conducted in five Spanish centers between March 2018 and December 2020, and comprised women with a singleton pregnancy and suspected PE between 24 + 0 and 41 + 0 weeks' gestation. We evaluated the ability of the sFlt-1/PlGF ratio, NT-proBNP, hs-TnT and uric acid to predict the development of any-onset (at any gestational age), early-onset (before 34 weeks) or term (at or after 37 weeks) PE within 1 week or 4 weeks after assessment. Predictive performance was assessed by estimating negative predictive values, positive predictive values, sensitivity, specificity and areas under the receiver-operating-characteristics curves (AUCs) for these biomarkers, with corresponding 95% CIs. We performed post-hoc exploratory analyses of associations between the sFlt-1/PlGF ratio, NT-proBNP, hs-TnT and uric acid in women who developed PE, as well as in women who developed complicated PE (PE plus fetal growth restriction, stillbirth or placental abruption) within 1 week and 4 weeks after assessment. Results: A total of 323 women with suspected PE at or before 41 + 0 weeks were enrolled in the study, of whom seven were lost to follow-up. The final analysis included 316 eligible participants, with 424 samples. The overall incidence of PE was 23.4% (n = 74) and early-onset PE developed in 8.5% (n = 27) of cases. The sFlt-1/PlGF ratio and NT-proBNP exhibited similar abilities to predict early-onset PE within 1 week after assessment (AUC, 0.970 (95% CI, 0.932-1.000) and 0.971 (95% CI, 0.942-1.000), respectively). hs-TnT and uric acid demonstrated inferior predictive capability compared with the sFlt-1/PlGF ratio for the prediction of any-onset PE, early-onset PE and term PE within 1 week and 4 weeks after assessment. The optimal cut-off for NT-proBNP was 116 pg/mL. At this cut-off, NT-proBNP showed a sensitivity of 90.9% (95% CI, 70.8-98.9%) and a specificity of 94.3% (95% CI, 91.2-96.5%), with a positive predictive value of 5.7% (95% CI, 3.7-8.7%) and a negative predictive value of 99.9% (95% CI, 99.9-100%) in predicting early-onset PE within 1 week of assessment, which was comparable with that of the sFlt-1/PlGF ratio. Participants with PE-related complications had higher levels of all biomarkers, but only NT-proBNP showed a similar predictive ability to the sFlt-1/PlGF ratio for complicated PE within 1 week after assessment (AUC, 0.818 (95% CI, 0.706-0.930) vs 0.822 (95% CI, 0.723-0.921), respectively). Conclusion: An NT-proBNP cut-off value of 116 pg/mL has a similar diagnostic performance to that of the sFlt-1/PlGF ratio in predicting the diagnosis of early-onset PE within 1 week after assessment. Thus, NT-proBNP could be used in clinical practice for the early identification and management of PE, particularly in cases for which the sFlt-1/PlGF ratio is not available. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.
Repisalud
Publication Artículo científico (JournalArticle)

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

  • Sordo, Luis
  • Barrio, Gregorio
  • Bravo, Maria Jose
  • Indave-Ruiz, Blanca Iciar
  • Degenhardt, Louisa
  • Wiessing, Lucas
  • Ferri, Marica
  • Pastor-Barriuso, Roberto
Objective To compare the risk for all cause and overdose mortality in people with opioid dependence during and after substitution treatment with methadone or buprenorphine and to characterise trends in risk of mortality after initiation and cessation of treatment.Design Systematic review and meta-analysis.Data sources Medline, Embase, PsycINFO, and LILACS to September 2016.Study selection Prospective or retrospective cohort studies in people with opioid dependence that reported deaths from all causes or overdose during follow-up periods in and out of opioid substitution treatment with methadone or buprenorphine.Data extraction and synthesis Two independent reviewers performed data extraction and assessed study quality. Mortality rates in and out of treatment were jointly combined across methadone or buprenorphine cohorts by using multivariate random effects meta-analysis.Results There were 19 eligible cohorts, following 122 885 people treated with methadone over 1.3-13.9 years and 15 831 people treated with buprenorphine over 1.1-4.5 years. Pooled all cause mortality rates were 11.3 and 36.1 per 1000 person years in and out of methadone treatment (unadjusted out-to-in rate ratio 3.20, 95% confidence interval 2.65 to 3.86) and reduced to 4.3 and 9.5 in and out of buprenorphine treatment (2.20, 1.34 to 3.61). In pooled trend analysis, all cause mortality dropped sharply over the first four weeks of methadone treatment and decreased gradually two weeks after leaving treatment. All cause mortality remained stable during induction and remaining time on buprenorphine treatment. Overdose mortality evolved similarly, with pooled overdose mortality rates of 2.6 and 12.7 per 1000 person years in and out of methadone treatment (unadjusted out-to-in rate ratio 4.80, 2.90 to 7.96) and 1.4 and 4.6 in and out of buprenorphine treatment.Conclusions Retention in methadone and buprenorphine treatment is associated with substantial reductions in the risk for all cause and overdose mortality in people dependent on opioids. The induction phase onto methadone treatment and the time immediately after leaving treatment with both drugs are periods of particularly increased mortality risk, which should be dealt with by both public health and clinical strategies to mitigate such risk. These findings are potentially important, but further research must be conducted to properly account for potential confounding and selection bias in comparisons of mortality risk between opioid substitution treatments, as well as throughout periods in and out of each treatment.
Repisalud
Publication Artículo científico (JournalArticle)

Pain Characteristics, Cardiovascular Risk Factors, and Cardiovascular Disease.

  • Rodríguez-Sánchez, Isabel
  • Ortolá, Rosario
  • Graciani, Auxiliadora
  • Martínez-Gómez, David
  • Banegas, Jose R
  • Rodríguez-Artalejo, Fernando
  • García-Esquinas, Esther
Background: There is unclear evidence that chronic pain may increase the risk of cardiovascular disease (CVD) incidence and mortality. This work evaluated the association between chronic pain, incidence of CVD, and changes in CVD risk factors. Methods: Cohort of 1091 community-dwelling individuals of at least 60 years, free from CVD at baseline, followed up for 6 years. Data on psychosocial factors and CVD risk factors were obtained through validated questionnaires and laboratory measurements. A pain scale ranging from 0 (no pain) to 6 (worst pain) was created according to pain frequency, location, and intensity. Results: The cumulative incidence of CVD was 4.2% at 3 years and 7.7% at 5 years of follow-up. Compared to individuals without pain in the first 3 years (2012-2015), those with maintained scores of at least 2 showed a mean reduction of 3.57 (-5.77 to -1.37) METs-h/week in recreational physical activity, a 0.38-point (0.04-0.73) increase in psychological distress, and a 1.79 (1.03-3.11) higher odds of poor sleep. These associations held in the second follow-up period, when individuals with maintained pain also worsened their diet quality. A 1-point increase in the pain scale in 2012 was associated with a 1.21 (1.03-1.42) and 1.18 (0.97-1.44) increased CVD incidence in 2015 and 2017, respectively; none of the studied factors mediated this relationship. Conclusions: Older adults with chronic pain show important reductions in recreational physical activity and deterioration in mental health, sleep, and diet quality, which may well aggravate pain. Future studies should evaluate whether these factors mediate the increased risk of CVD observed in older adults with chronic pain.
Repisalud
Publication Artículo científico (JournalArticle)

Job Loss, Unemployment and the Incidence of Hazardous Drinking during the Late 2000s Recession in Europe among Adults Aged 50-64 Years

  • Bosque-Prous, Marina
  • Espelt, Albert
  • Sordo, Luis
  • Guitart, Anna M
  • Brugal, M Teresa
  • Bravo, Maria Jose
BACKGROUND: To estimate the incidence of hazardous drinking in middle-aged people during an economic recession and ascertain whether individual job loss and contextual changes in unemployment influence the incidence rate in that period. METHODS: Longitudinal study based on two waves of the SHARE project (Survey of Health, Ageing and Retirement in Europe). Individuals aged 50-64 years from 11 European countries, who were not hazardous drinkers at baseline (n = 7,615), were selected for this study. We estimated the cumulative incidence of hazardous drinking (≥40g and ≥20g of pure alcohol on average in men and women, respectively) between 2006 and 2012. Furthermore, in the statistical analysis, multilevel Poisson regression models with robust variance were fitted and obtained Risk Ratios (RR) and their 95% Confidence Intervals (95%CI). RESULTS: Over a 6-year period, 505 subjects became hazardous drinkers, with cumulative incidence of 6.6 per 100 persons between 2006 and 2012 (95%CI:6.1-7.2). Age [RR = 1.02 (95%CI:1.00-1.04)] and becoming unemployed [RR = 1.55 (95%CI:1.08-2.23)] were independently associated with higher risk of becoming a hazardous drinker. Conversely, having poorer self-perceived health was associated with lower risk of becoming a hazardous drinker [RR = 0.75 (95%CI:0.60-0.95)]. At country-level, an increase in the unemployment rate during the study period [RR = 1.32 (95%CI:1.17-1.50)] and greater increases in the household disposable income [RR = 0.97 (95%CI:0.95-0.99)] were associated with risk of becoming a hazardous drinker. CONCLUSIONS: Job loss among middle-aged individuals during the economic recession was positively associated with becoming a hazardous drinker. Changes in country-level variables were also related to this drinking pattern.
Repisalud
Publication Artículo científico (JournalArticle)

Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression

  • Coiras, Mayte
  • Lopez-Huertas, Maria Rosa
  • Rullas, Joaquin
  • Mittelbrunn, Maria
  • Alcamí, José
BACKGROUND: In HIV-infected T lymphocytes, NF-kappaB/Rel transcription factors are major elements involved in the activation of LTR-dependent transcription from latency. Most NF-kappaB heterodimer p65/p50 is sequestered as an inactive form in the cytoplasm of resting T lymphocytes via its interaction with I kappaB inhibitors. In these cells, both absolute HIV latency and low level ongoing HIV replication have been described. These situations could be related to differences in the balance between NF-kappaB and I kappaB alpha ratio. Actually, control of I kappaB alpha by cellular factors such as Murr-1 plays a critical role in maintaining HIV latency in unstimulated T lymphocytes. Formerly, our group demonstrated the presence of nuclear I kappaB alpha in T cells after PMA activation. Now we attempt to determine the dynamics of NF-kappaB/I kappaB alpha nucleocytosolic transport in absence of activation as a mechanism to explain both the maintenance of latency and the existence of low level ongoing HIV replication in resting CD4+ T lymphocytes. RESULTS AND CONCLUSION: We show that the inhibition of the nuclear export by leptomycin B in resting CD4+ T cells resulted in nuclear accumulation of both I kappaB alpha and p65/RelA, as well as formation of NF-kappaB/I kappaB alpha complexes. This proves the existence of a rapid shuttling of I kappaB alpha between nucleus and cytosol even in absence of cellular activation. The nuclear accumulation of I kappaB alpha in resting CD4+ T lymphocytes results in inhibition of HIV-LTR dependent transcription as well as restrains HIV replication in CD4+ T lymphocytes. On the other hand, basal NF-kappaB activity detected in resting CD4+ T lymphocytes was related to low level HIV replication in these cells.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A PIF-SAUR module safeguards hypocotyl elongation from ABA inhibition in the dark

  • Cañibano, Esther
  • Rodríguez-Sánchez, Natalia
  • Gómez-Soto, Daniela
  • El Kendi, Fatima Zahra
  • Kinoshita, Toshinori
  • Oliveros, Juan Carlos
  • Bourbousse, Clara
  • Fonseca, Sandra
  • Lozano-Juste, Jorge|||0000-0001-7034-566X
[EN] Driven by cell elongation, hypocotyl growth is tightly controlled by light and responds to the stress signaling hormone abscisic acid (ABA). However, the molecular connections between ABA and light to control cell elongation are poorly understood. Here, we show that, in Arabidopsis, ABA inhibits hypocotyl elongation in the light but not in the dark. In the dark, hypocotyl sensitivity to ABA is restored in pifq and cop1-4 mutants, suggesting that an active light signaling pathway is necessary for hypocotyl responsiveness to ABA. Through an RNA sequencing subtractive approach, we identified ABA differentially expressed genes that correlate with ABA inhibition of hypocotyl elongation, including several SAUR genes. The abrogation of PP2C.D2-SAUR interaction in the pp2c.d2/PP2C.D2(M331K)-GFP line restored ABA sensitivity in the dark, suggesting that SAUR proteins are key to maintain hypocotyls insensitive to ABA. This hypocotyl-specific mechanism enables growth toward the light, overriding ABA inhibition of cell elongation, ensuring subsequent seedling establishment and survival., This work was supported by PID2023-152283NB-I00 (to S.F.); by a Europa Excelencia project EUR2022-134066 funded by Ministerio de Ciencia, Innovacion y Universidades (to S.F.); by a Beca Leonardo a Investigadoresy Creadores Culturales (IN[21]_CMA_BIO_0136) from the BBVA Foundation (to S.F.); by grant ANR-20-CE13-0028 from the Agence Nationale de la Recherche (to C.B.); by CNS2023-145540, PID2021-128826OA-I00 and RYC2020-029097-I from MICIN/AEI (to J.L.-J.), Plan GenT (CISEJI/2022/26) from Generalitat Valenciana (GVA) and the AGROALNEXT/2022/067 grant supported by MICIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana (to J.L.-J.).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Improving river hydromorphological assessment through better integration of riparian vegetation: Scientific evidence and guidelines

  • González del Tánago, Marta
  • Martínez-Fernández, Vanesa
  • Aguiar, Francisca C.
  • Bertoldi, Walter
  • Dufour, Simon
  • García de Jalón, Diego
  • Mandzukovski, Dejan
  • Rodríguez-González, Patricia María
  • Garófano-Gómez, Virginia|||0000-0001-5516-5695
[EN] River hydromorphology has long been subjected to huge anthropogenic pressures with severe negative impacts on related ecosystems¿ functioning and water quality. Therefore, improving river hydromorphological conditions represents a priority task in sustainable river management and requires proper assessment tools. It is well known that riparian vegetation plays a crucial role in sustaining river hydromorphological conditions. However, it has been nearly neglected in most hydromorphological assessment protocols, including the European Water Framework Directive (WFD). This paper reviews and synthesizes the relevance of riparian vegetation for river hydromorphology, focusing on its contribution to streamflow and sediment regime conditions. We also examine how riparian vegetation is considered in the WFD and how it is included in national hydromorphological protocols currently in use. Our findings point to a temporal mismatch between the date when the WFD came into force and the emergence of scientific and technologic advances in riparian vegetation dynamism and bio-geomorphic modeling. To overcome this misalignment, we present promising approaches for the characterization and assessment of riparian vegetation, which include the identification of vegetation units and indicators at multiple scales to support management and restoration measures. We discuss the complexity of riparian vegetation assessment, particularly with respect to the establishment of river-type-based reference conditions and the monitoring and management targets, and propose some attributes that can serve as novel indicators of the naturalness vs. artificiality of riparian vegetation. We argue that the hydromorphological context of the WFD should be revisited and offer guidance to integrate riparian vegetation in river hydromorphological monitoring and assessment., The work leading to this paper was developed within the COST Action (CA16208) - CONVERGES (Knowledge Conversion for Enhancing Management of European Riparian Ecosystems and Services) , supported by COST (European Cooperation in Science and Technology; www.cost. eu) . Vanesa MartinezFernandez was funded by a "Juan de la Cierva" research contract (Spanish MINECO grant no. FJC2018-035451-I at National Museum of Natural Sciences, CSIC, Spain. Francisca C.Aguiar is supported by national funds via FCT under the contracts Norma TransitoriaDL57/2016/CP1382/CT0028. The Portuguese Foundation for Science and Technology (FCT) supported Patricia Maria RodriguezGonzalez through FCT investigator programme IF/00059/2015 and the Forest Research Centre through grants UID/AGR/00239/2019 and UIDB/00239/2020.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Unravelling the role of environmentally realistic concentrations of titanium dioxide nanoparticles in altering gametogenesis and gonadal health of female Pacific oysters (Magallana gigas): a histopathological approach

  • Fernández-García, Fátima|||0009-0001-5070-3762
  • Asturiano, Juan F.|||0000-0002-6441-5294
  • Martins, M.
  • Raymond, E.
  • Carvalhais, A.
  • Oliveira, I. B.
  • Pachecho, M.
  • Mieiro, C.
[EN] Titanium dioxide nanoparticles (TiO2 NPs) raise environmental concerns due to their potential adverse effects on marine bivalves. However, research on females, particularly their gonad quality and reproduction, remains limited. Despite the availability of numerous health status biomarkers, histopathological analysis remains crucial for assessing toxicological effects. This study aimed to shed light on the potential reprotoxicity of environmentally realistic concentrations of TiO2 NPs during gametogenesis in female Magallana gigas. Oysters were exposed to waterborne 10 and 100 mu g/L of TiO2 NPs for 3 and 7 days. Thereafter, females were identified, and the gonadal health status was assessed through qualitative and quantitative histology alongside titanium bioaccumulation evaluation. Partial indices for interlobular and intralobular alterations were applied for the first time to the gonad, improving the understanding of histopathological alterations caused by TiO2 NPs. Our results indicated that the severity of histopathological alterations was concentration and time-dependent, even though no bioaccumulation was detected. We observed an acceleration of gametogenic stage development and disturbances in sex determination. This study provides tools to assess TiO2 NPs' impacts on bivalve populations and ecosystem balance, especially in highly touristic marine areas., The contract of F. Fernandez-Garcia was supported by the Spanish Ministry of Science and Innovation (MCIN) with funding from the European Union NextGenerationEU (PRTRC17.I1) and the Generalitat Valenciana to SEASPERM (THINKINAZUL/2021/012) . This work was supported by the research project "NanoReproTox-Unraveling the ecological impacts of nanoparticles toxicity in the reproduction of marine organisms" funded by Fundacao para a Ciencia e Tecnologia (FCT, I.P.) (PTDC/CTA-AMB/30,908/2017) in its State Budget component (OE) and co-funded by the Operational Program Competiveness and Internationalization (POCI) (POCI-01-0145-FEDER-30,908) , and the Regional Operational Program of Lisboa and Regional Operational Program of Algarve, in its FEDER/FNR component. FCT also funded individual grants/contracts and institutional strategic projects as follows: A. Carvalhais (10.54499/2020.05105.BD) , I.B. Oliveira (10.13039/501,100,001,871.CEECIND/01,368/2018) , C. Mieiro (10.54499/DL57/2016/CP1482/CT0028) , CESAM under the project/grant UID/50006 + LA/P/0094/2020, CIIMAR (UIDB/04,423/2020, UIDP/04,423/2020 and LA/P/0101/2020) and through the strategic projects UIDB/04,292/2020 (https://doi.org/10.54499/UIDB/04 292/2020) and UIDP/04,292/2020 (https://doi.org/10.544 99/UIDP/04292/2020) granted to MARE-Marine and Environmental Sciences Centre, and the project LA/P/0069/2020 (https://doi.org/10.5 4499/LA/P/0069/2020) granted to the Associate Laboratory ARNET-Aquatic Research Network.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Implementation of the Recovery Model and Its Outcomes in Patients with Severe Mental Disorder

  • Sánchez Guarnido, Antonio José
  • Ruiz-Granados, María Isabel
  • Garrido-Cervera, José Antonio
  • Herruzo Cabrera, Javier
  • Herruzo Pino, Carlos
Background: The recovery model assumes that the patient can experience personal growth even while maintaining symptoms of a mental disorder. In order to achieve this recovery, the practices of professionals must also change. However, in our setting, there are limited data on the implementation of practices based on the recovery model and their effect on personal recovery. Objective: To describe the association between professionals’ practices and patients’ personal recovery. Methods: An observational and cross-sectional study in which the Recovery Self-Assessment (RSA) was used to assess the degree of implementation of the different practices and the Recovery Assessment Scale (RAS) was used to assess the personal recovery of 307 patients with severe mental disorders. Results: Patients attended by professionals who followed the recovery model obtained a greater personal recovery (p < 0.001, d = 1.10). The dimension associated with greater recovery was that of working toward life goals. The least implemented dimensions had to do with offering treatment options and patient participation in decision-making. This study was conducted in accordance with STROBE (STrengthening the Reporting of OBservational studies in Epidemiology). Conclusions: Although this is a cross-sectional study that does not allow us to establish causal relationships, it shows that the model with which mental health professionals work is associated with patients’ chances of recovery. We therefore consider that it is important to foster the implementation of practices based on the recovery model within mental health care.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients., Deletion at 6q24.2–26 predicts longer survival of high-grade serous epithelial ovarian cancer patients

  • Kamieniak, Marta M.
  • Rico, Daniel
  • Milne, Roger L.
  • Muñoz-Repeto, Ivan
  • Ibáñez, Kristina
  • Grillo, Miguel A.
  • Domingo, Samuel
  • Borrego, Salud
  • Cazorla, Alicia
  • García-Bueno, José M.
  • Hernando, Susana
  • García-Donas, Jesús
  • Hernández-Agudo, Elena
  • Y Cajal, Teresa Ramón
  • Robles-Díaz, Luis
  • Márquez-Rodas, Ivan
  • Cusidó, Maite
  • Sáez, Raquel
  • Lacambra-Calvet, Carmen
  • Osorio, Ana
  • Urioste, Miguel
  • Cigudosa, Juan C.
  • Paz-Ares, Luis
  • Palacios Calvo, José
  • Benítez, Javier
  • García, María J.
Standard treatments for advanced high-grade serous ovarian carcinomas (HGSOCs) show significant side-effects and provide only short-term survival benefits due to disease recurrence. Thus, identification of novel prognostic and predictive biomarkers is urgently needed. We have used 42 paraffin-embedded HGSOCs, to evaluate the utility of DNA copy number alterations, as potential predictors of clinical outcome. Copy number-based unsupervised clustering stratified HGSOCs into two clusters of different immunohistopathological features and survival outcome (HR = 0.15, 95%CI = 0.03–0.81; Padj = 0.03). We found that loss at 6q24.2–26 was significantly associated with the cluster of longer survival independently from other confounding factors (HR = 0.06, 95%CI = 0.01–0.43, Padj = 0.005). The prognostic value of this deletion was validated in two independent series, one consisting of 36 HGSOCs analyzed by fluorescent in situ hybridization (P = 0.04) and another comprised of 411 HGSOCs from the Cancer Genome Atlas study (TCGA) (HR = 0.67, 95%CI = 0.48–0.93, Padj = 0.019). In addition, we confirmed the association of low expression of the genes from the region with longer survival in 799 HGSOCs (HR = 0.74, 95%CI = 0.61–0.90, log-rank P = 0.002) and 675 high-FIGO stage HGSOCs (HR = 0.76, 95%CI = 0.61–0.96, log-rank P = 0.02) available from the online tool KM-plotter. Finally, by integrating copy number, RNAseq and survival data of 296 HGSOCs from TCGA we propose a few candidate genes that can potentially explain the association. Altogether our findings indicate that the 6q24.2–26 deletion is an independent marker of favorable outcome in HGSOCs with potential clinical value as it can be analyzed by FISH on tumor sections and guide the selection of patients towards more conservative therapeutic strategies in order to reduce side-effects and improve quality of life., This study was financially supported by the Fondo de Investigación Sanitaria (FIS), Instituto de Salud Carlos III (grants PS09/01094 and PI12/01319). MJG is recipient of a research contract from the Instituto de Salud Carlos III of the Ministerio Español de Sanidad y Consumo (Miguel Servet tipo II Program, CPII 13/00047). MMK and KI have financial support from the Fundación La Caixa. DR and KI are supported by grant BIO2012-40205. LP-A, JCC and JP are recipients of financial support from Red Temática de Investigación Cooperativa en Cáncer (RTICC) (grants RD12/0036/0028, RD12/0036/0037 and RD12/0036/0064)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Cardiovascular risk biomarkers and metabolically unhealthy status in prepubertal children: Comparison of definitions

  • Rupérez, A.I.
  • Olza, J.
  • Gil-Campos, M.
  • Leis, R.
  • Bueno, G.
  • Aguilera, C.M.
  • Gil, A.
  • Moreno, L.A.
Background and aims: The early onset of cardio-metabolic abnormalities, known as metabolically unhealthy (MU) status, is highly associated with obesity and cardiovascular disease (CVD), as well as with increased morbidity and mortality later in life. Given the lack of a consensus MU classification for prepubertal children, we aimed to compare available MU definitions in terms of their association with CVD risk biomarkers. Methods and results: A total of 930 prepubertal children (622 with overweight/obesity, 462 males) aged 5–10.9 years were recruited, anthropometric measures were taken and biomarkers were analyzed. Children were classified using eight MU definitions based on different cut-offs for blood pressure, triacylglycerides, high-density lipoprotein cholesterol, glucose and homeostasis model assessment for insulin resistance (HOMA-IR). MU prevalence in children with overweight/obesity ranged between 30% and 60% across definitions. Plasma concentrations of resistin, leptin, myeloperoxidase (MPO) and total plasminogen activator inhibitor 1 (tPAI-1) were higher, and those of adiponectin were lower, in MU compared to MH children with overweight/obesity. Linear regression analyses confirmed the contribution of MPO and tPAI-1 concentrations to MU status, with most significant results derived from definitions that use age and sex-specific criteria and that account for HOMA-IR. Conclusion: Plasma concentrations of MPO and tPAI-1 are increased in prepubertal MU children irrespective of having normal-weight or overweight/obesity. Inclusion of age and sex-specific cut-offs for cardio-metabolic components as well as insulin resistance criteria increases the quality of MU definitions as seen by their stronger association with CVD biomarkers concentrations.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Differential Impact of Ad Libitum or Intermittent High-Fat Diets on Bingeing Ethanol-Mediated Behaviors

  • Del Olmo, Nuria
  • Blanco-Gandía, M.Carmen
  • Mateos-García, Ana
  • Del Rio, Danila
  • Miñarro, José
  • Ruiz-Gayo, Mariano
  • Rodríguez-Arias, Marta
BACKGROUND: Dietary factors have significant effects on the brain, modulating mood, anxiety, motivation and cognition. To date, no attention has been paid to the consequences that the combination of ethanol (EtOH) and a high-fat diet (HFD) have on learning and mood disorders during adolescence. The aim of the present work was to evaluate the biochemical and behavioral consequences of ethanol binge drinking and an HFD consumption in adolescent mice. METHODS: Animals received either a standard diet or an HFD (ad libitum vs. binge pattern) in combination with ethanol binge drinking and were evaluated in anxiety and memory. The metabolic profile and gene expression of leptin receptors and clock genes were also evaluated. RESULTS: Excessive white adipose tissue and an increase in plasma insulin and leptin levels were mainly observed in ad libitum HFD + EtOH mice. An upregulation of the Lepr gene expression in the prefrontal cortex and the hippocampus was also observed in ad libitum HFD groups. EtOH-induced impairment on spatial memory retrieval was absent in mice exposed to an HFD, although the aversive memory deficits persisted. Mice bingeing on an HFD only showed an anxiolytic profile, without other alterations. We also observed a mismatch between Clock and Bmal1 expression in ad libitum HFD animals, which were mostly independent of EtOH bingeing. CONCLUSIONS: Our results confirm the bidirectional influence that occurs between the composition and intake pattern of a HFD and ethanol consumption during adolescence, even when the metabolic, behavioral and chronobiological effects of this interaction are dissociated.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Energy dense salty food consumption frequency is associated with diastolic hypertension in Spanish children

  • Pérez-Gimeno, Gloria
  • Rupérez, Azahara I.
  • Vázquez-Cobela, Rocío
  • Herráiz-Gastesi, Gonzalo
  • Gil-Campos, Mercedes
  • Aguilera, Concepción M.
  • Moreno, Luis A.
  • Leis Trabazo, María Rosaura
  • Bueno-Lozano, Gloria
High blood pressure (BP) is a risk factor for cardiovascular disease and sodium consumption is related to high BP. Moreover, sugar-sweetened beverages (SSB) and the Dietary Approach to Stop Hypertension (DASH) influence BP. For this reason, we investigated whether: 1) children with risk of elevated BP had a higher consumption frequency (CF) of energy-dense salty foods (EDSF), high-sugary foods (HSF) and SSB or a low DASH score; and 2) children with a higher CF of EDSF showed a worse anthropometric and metabolic profile. Anthropometry, BP and general biochemical parameters were measured in 687 Spanish children (5-16 years) with normal or excess weight. A food frequency questionnaire was used to calculate EDSF, HSF and SSB consumption, and modified DASH score. Results showed that sex and pubertal stage influenced modified DASH score. Diastolic hypertension was associated to higher CF of EDSF in the whole sample and to higher CF of SSB in pubertal children, both independently of nutritional status. In addition, CF of EDSF was positively associated with CF of HSF and SSB and inversely associated with modified DASH score. Targeted policies and intervention programs, specific for different age ranges, should be established that aim to reduce salt consumption from snacks and processed foods, which could reduce HSF and SSB consumption as well.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Social defeat stress: mechanisms underlying the increase in rewarding effects of drugs of abuse

  • Montagud-Romero, Sandra
  • Blanco-Gandía, María Carmen
  • Reguilón, Marina D.
  • Ferrer-Pérez, Carmen
  • Ballestín, Raul
  • Miñarro, José
  • Rodríguez-Arias, Marta
Social interaction is known to be the main source of stress in human beings, which explains the translational importance of this research in animals. Evidence reported over the last decade has revealed that, when exposed to social defeat experiences (brief episodes of social confrontations during adolescence and adulthood), the rodent brain undergoes remodeling and functional modifications, which in turn lead to an increase in the rewarding and reinstating effects of different drugs of abuse. The mechanisms by which social stress cause changes in the brain and behavior are unknown, and so the objective of this review is to contemplate how social defeat stress induces longlasting consequences that modify the reward system. First of all, we will describe the most characteristic results of the short-and longterm consequences of social defeat stress on the rewarding effects of drugs of abuse such as psychostimulants and alcohol. Secondly, and throughout the review, we will carefully assess the neurobiological mechanisms underlying these effects, including changes in the dopaminergic system, corticotrophin releasing factor signaling, epigenetic modifications and the neuroinflammatory response. To conclude, we will consider the advantages and disadvantages and the translational value of the social defeat stress model, and will discuss challenges and future directions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Neuroinflammatory and behavioral susceptibility profile of mice exposed to social stress towards cocaine effects

  • Ballestín, Raúl
  • Alegre-Zurano, Laia
  • Ferrer-Pérez, Carmen
  • Cantacorps, Lídia
  • Miñarro, José
  • Valverde, Olga
  • Rodríguez-Arias, Marta
Using the social defeat (SD) model, numerous studies have shown that stressed mice display an enhanced response to the motivational effects of cocaine in the self-administration (SA) and conditioned-place preference (CPP) paradigms. However, not all subjects exposed to stress express its harmful effects. Some are particularly susceptible to the deleterious effects of repeated SD, while resilient mice successfully cope with stressful experiences and display adjusted psychological functioning after stress. Vulnerability to develop stress-related disorders, such as depression, has been linked to coping strategies and more recently to individual differences in the immune system. However, no studies have evaluated if coping strategies and immune system reactivity to social stress experiences can also predict susceptibility to stress-induced enhancement of the cocaine response. We evaluated cocaine response in socially defeated mice in the CPP and SA paradigms. To evaluate neuroimmune reactivity to stress the pro-inflammatory cytokine IL-6 and the chemokine CX3CL1 were measured in the striatum and hippocampus. Behavioral phenotype during and after SD episodes was also evaluated. Our results showed that susceptible mice to the depressive-like behaviors effects of stress showed increased conditioned rewarding effects of cocaine in the CPP. In addition, susceptible mice displayed passive-reactive coping behavior during social stress episodes and more pronounced changes in neuroinflammatory markers after the last SD episode, which lasted for one month. Although the complex mechanisms underlying susceptibility or resilience to social stress are still unclear, our results point to multiple adaptive stress responses expressed at different phenotypic levels.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Social stress during adolescence activates long-term microglia inflammation insult in reward processing nuclei

  • Rodríguez Arias, Marta
  • Montagud Romero, Sandra
  • Guardia Carrión, Ana María
  • Ferrer Pérez, Carmen
  • Perez Villalba, Ana
  • Marco, Eva
  • Lopez Gallardo, Meritxell
  • Viveros, Maria Paz
  • Miñarro, José
The experience of social stress during adolescence is associated with higher vulnerability to drug use. Increases in the acquisition of cocaine self-administration, in the escalation of cocaine-seeking behavior, and in the conditioned rewarding effects of cocaine have been observed in rodents exposed to repeated social defeat (RSD). In addition, prolonged or severe stress induces a proinflammatory state with microglial activation and increased cytokine production. The aim of the present work was to describe the long-term effects induced by RSD during adolescence on the neuroinflammatory response and synaptic structure by evaluating different glial and neuronal markers. In addition to an increase in the conditioned rewarding effects of cocaine, our results showed that RSD in adolescence produced inflammatory reactivity in microglia that is prolonged into adulthood, affecting astrocytes and neurons of two reward-processing areas of the brain (the prelimbic cortex, and the nucleus accumbens core). Considered as a whole these results suggest that social stress experience modulates vulnerability to suffer a loss of glia-supporting functions and neuronal functional synaptic density due to drug consumption in later life.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Cognitive impairments associated with alterations in synaptic proteins induced by the genetic loss of adenosine A 2A receptors in mice

  • Moscoso-Castro, Maria
  • López-Cano, Marc
  • Gracia-Rubio, Irene
  • Ciruela, Francisco
  • Valverde, Olga
The study of psychiatric disorders usually focuses on emotional symptoms assessment. However, cognitive deficiencies frequently constitute the core symptoms, are often poorly controlled and handicap individual's quality of life. Adenosine receptors, through the control of both dopamine and glutamate systems, have been implicated in the pathophysiology of several psychiatric disorders such as schizophrenia and attention deficit/hyperactivity disorder. Indeed, clinical data indicate that poorly responsive schizophrenia patients treated with adenosine adjuvants show improved treatment outcomes. The A2A adenosine receptor subtype (A2AR) is highly expressed in brain areas controlling cognition and motivational responses including the striatum, hippocampus and cerebral cortex. Accordingly, we study the role of A2AR in the regulation of cognitive processes based on a complete cognitive behavioural analysis coupled with the assessment of neurogenesis and sub-synaptic protein expression in adult and middle-aged A2AR constitutional knockout mice and wild-type littermates. Our results show overall cognitive impairments in A2AR knockout mice associated with a decrease in new-born hippocampal neuron proliferation and concomitant changes in synaptic protein expression, in both the prefrontal cortex and the hippocampus. These results suggest a deficient adenosine signalling in cognitive processes, thus providing new opportunities for the therapeutic management of cognitive deficits associated with psychiatric disorders.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience

  • Vives Armengol, Joaquim
  • Coll, Ruth
  • Gálvez-Montón, Carolina
  • Prat-Vidal, Cristina
  • Gastelurrutia, Paloma
  • Bayes-Genis, Antoni
Medicament de teràpia avançada; Medicament en investigació; Translacional (regulació), Medicamento de terapia avanzada; Medicamento en investigación; Traslacional (regulación), Advanced therapy medicinal product; Investigational medicinal product; Translational (regulation), A systematic and ordered product development program, in compliance with current quality and regulatory standards, increases the likelihood of yielding a successful advanced therapy medicinal product (ATMP) for clinical use as safe and effective therapy. As this is a novel field, little accurate information is available regarding the steps to be followed, and the information to be produced to support the development and use of an ATMP. Notably, successful clinical translation can be somewhat cumbersome for academic researchers. In this article, we have provided a summary of the available information, supported by our experience in Spain throughout the development of an ATMP for myocardial infarction, from the pre-clinical stage to phase I clinical trial approval., This work was supported by the Spanish Cell Therapy Network (TerCel) [RD16/0011/0006 and RD16/0011/0028]; and CIBER Cardiovascular [CB16/11/00403] projects, as a part of the National R&D&I Plan, and was co-funded by the ISCIII-Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF); the Government of Catalonia: Agency for Management of University and Research Grants (AGAUR) [2017-SGR-483 and 2017-SGR-719], PERIS Program (Health Department) [SLT002/16/00234 and SLT002/16/00209] and CERCA Program; La Caixa Banking Foundation; grants from the Spanish Ministry of Science, Innovation and Universities (MICINN) [SAF2017-84324-C2-1-R]; Institute of Health Carlos III (ISCIII) [PI18/00256, PIC18/00014, ICI19/00039, and PI19/01788], and cofunded by European Union (ERDF/ESF) - A way to build Europe. This work has also been funded by the Sociedad Española de Cardiología and by the Call for Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine 2019 of Center for Regenerative Medicine of Barcelona (CMR[B]). The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy

  • Grau Vorster, Marta
  • Lopez Montañes, Maria
  • Canto Puig, Ester
  • Vives Armengol, Joaquim
  • Oliver-Vila, Irene
  • Barba Suñol, Pere
  • Rudilla Salvador, Francesc
Immunoteràpia adoptiva; Citotoxicitat; Limfòcits T específics del virus (VST), Inmunoterapia adoptiva; Citotoxicidad; Linfocitos T específicos de virus (VST), Adoptive immunotherapy; Cytotoxicity; Virus specific T lymphocytes (VST), Immunosuppressed patients are susceptible to virus reactivation or de novo infection. Adoptive immunotherapy, based on virus-specific T lymphocytes (VST), can prevent or treat viral diseases. However, donor availability, HLA-compatibility restrictions, high costs, and time required for the production of personalized medicines constitute considerable limitations to this treatment. Ex vivo rapid and large-scale expansion of VST, compliant with current good manufacturing practice (cGMP) standards, with an associated cell donor registry would overcome these limitations. This study aimed to characterize a VST product obtained through an expansion protocol transferable to cGMP standards. Antigenic stimulus consisted of cytomegalovirus (CMV) pp65 peptide pool-pulsed autologous dendritic cells (DCs) derived from monocytes. G-Rex technology, cytokines IL-2, IL-7, and IL-15, and anti-CD3 and anti-CD28 antibodies were used for culture. At day 14 of cell culture, the final product was characterized regarding T cell subsets, specificity, and functionality. The final product, comprised mainly CD4+ and CD8+ T lymphocytes (49.2 ± 24.7 and 42.3 ± 25.2, respectively). The culture conditions made it possible to achieve at least a 98.89-fold increase in pp65-specific CD3+ IFN-γ+ cells. These cells were specific, as pp65-specific cytotoxicity was demonstrated. Additionally, in complete HLA mismatch and without the presence of pp65, alloreactivity resulted in <5% cell lysis. In conclusion, a cGMP scalable process for the generation of a large number of doses of CMV-specific cytotoxic T cells was successfully performed., Work in our laboratory was supported by the Spanish Cell Therapy Network (TerCel, file No. RD16/0011/0028), and carried out as part of AdvanceCat with the support of ACCIÓ (Catalonia Trade & Investment; Catalan government) under the Catalonian ERDF operational program (European Regional Development Fund) 2014-2020. Our laboratory was certified by the Catalan government as a Consolidated Research Group (ref. 2017SGR719).
Docta Complutense
Publication Artículo científico (JournalArticle)

Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts

  • Santiago, Begoña
  • Galindo Izquierdo, María
  • Rivero, Miguel
  • Pablos Álvarez, José Luis
Objective To determine whether dysregulated apoptosis of systemic sclerosis (SSc) fibroblasts contributes to progressive fibrosis by promoting fibroblast longevity. Methods We examined the pattern of fibroblast proliferation and apoptosis in SSc skin lesions and the susceptibility of cultured SSc dermal fibroblasts to apoptosis. Skin biopsy samples from SSc patients and control subjects were used to establish fibroblast cultures and were examined histologically. In skin sections, apoptosis was examined by TUNEL, and proliferation by immunostaining for proliferating cell nuclear antigen. Susceptibility of fibroblasts to apoptosis induced in vitro by different stimuli was studied by TUNEL. Expression of Bcl-2, Bcl-x, and Bax proteins in cultured fibroblasts was studied by Western blotting. Results Proliferation of dermal fibroblasts was not observed in normal skin but was present in skin from patients with SSc and other inflammatory skin diseases. Apoptosis of fibroblasts in SSc fibrotic skin lesions was not observed. In vitro, SSc fibroblasts were specifically resistant to apoptosis induced by Fas receptor stimulation but had normal susceptibility to apoptosis induced by nonspecific stimuli (protein kinase inhibition or serum withdrawal). Decreased susceptibility to Fas stimulation was not caused by decreased levels of surface Fas receptor. In SSc fibroblasts, quiescence induced by confluence and serum starvation was followed by an abnormal down-regulation of proapoptotic Bax protein. Up-regulation of the Bax:Bcl-2 ratio in SSc fibroblasts by Bcl-2 antisense oligonucleotides restored their susceptibility to Fas-mediated apoptosis. Conclusion Our findings suggest that abnormal apoptotic regulation in fibroblasts can contribute to the pathogenesis of progressive fibrosis in SSc. Modulation of Bcl-2–related proteins appears to be a potential target for the development of apoptosis-based antifibrotic strategies.
Docta Complutense
Publication Artículo científico (JournalArticle)

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus

  • Pérez Hernández, Mercedes
  • Gutiérrez López, María Dolores
  • Fernández Valle, María Encarnación
  • Rubio Araiz, Ana
  • Vidal Casado, Rebeca
  • Gutiérrez López, María Dolores
  • O'Shea Gaya, María Esther
  • Colado Megías, María Isabel
The recreational drug of abuse, 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier (BBB) integrity in rats through an early P2X7 receptor-mediated event which induces MMP-9 activity. Increased BBB permeability often causes plasma proteins and water to access cerebral tissue leading to vasogenic edema formation. The current study was performed to examine the effect of a single neurotoxic dose of MDMA (12.5 mg/kg, i.p.) on in vivo edema development associated with changes in the expression of the perivascular astrocytic water channel, AQP4, as well as in the expression of the tight-junction (TJ) protein, claudin-5 and Evans Blue dye extravasation in the hippocampus of adult male Dark Agouti rats. We also evaluated the ability of the MMP-9 inhibitor, SB-3CT (25 mg/kg, i.p.), to prevent these changes in order to validate the involvement of MMP-9 activation in MDMA-induced BBB disruption. The results show that MDMA produces edema of short duration temporally associated with changes in AQP4 expression and a reduction in claudin-5 expression, changes which are prevented by SB-3CT. In addition, MDMA induces a short-term increase in both tPA activity and expression, a serine-protease which is involved in BBB disruption and upregulation of MMP-9 expression. In conclusion, this study provides evidence enough to conclude that MDMA induces edema of short duration due to BBB disruption mediated by MMP-9 activation.
Docta Complutense
Publication Artículo científico (JournalArticle)

Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor

  • Abuin Martínez, Cristina
  • Vidal Casado, Rebeca
  • Gutiérrez López, María Dolores
  • Pérez Hernández, Mercedes
  • O'Shea Gaya, María Esther
  • Giménez Gómez, Pablo
  • Morales Puerto, Nuria
  • O'Shea Gaya, María Esther
  • Colado Megías, María Isabel
3,4-Methylenedioxymethamphetamine (MDMA) is an amphetamine derivative that has been shown to produce serotonergic damage in the brains of primates, including humans, and of rats. Tryptophan, the precursor of serotonin, is primarily degraded through the kynurenine (KYN) pathway, producing among others KYN, the main metabolite of this route. KYN has been reported as an endogenous agonist of the aryl hydrocarbon receptor (AhR), a transcription factor involved in several neurological functions. This study aims to determine the effect of MDMA on the KYN pathway and on AhR activity and to establish their role in the long-term serotonergic neurotoxicity induced by the drug in rats. Our results show that MDMA induces the activation of the KYN pathway, mediated by hepatic tryptophan 2,3-dioxygenase (TDO). MDMA also activated AhR as evidenced by increased AhR nuclear translocation and CYP1B1 mRNA expression. Autoradiographic quantification of serotonin transporters showed that both the TDO inhibitor 680C91 and the AhR antagonist CH-223191 potentiated the neurotoxicity induced by MDMA, while administration of exogenous l-kynurenine or of the AhR positive modulator 3,3'-diindolylmethane (DIM) partially prevented the serotonergic damage induced by the drug. The results demonstrate for the first time that MDMA increases KYN levels and AhR activity, and these changes appear to play a role in limiting the neurotoxicity induced by the drug. This work provides a better understanding of the physiological mechanisms that attenuate the brain damage induced by MDMA and identify modulation of the KYN pathway and of AhR as potential therapeutic strategies to limit the negative effects of MDMA.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sex differences in the behavioural and hypothalamic-pituitary-adrenal response to contextual fear conditioning in rats

  • Daviu, Núria|||0000-0002-9843-2981
  • Andero Galí, Raül|||0000-0003-3641-8903
  • Armario Garcia, Antonio|||0000-0001-9524-3635
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
In recent years, special attention is being paid to sex differences in susceptibility to disease. In this regard, there is evidence that male rats present higher levels of both cued and contextual fear conditioning than females. However, little is known about the concomitant hypothalamic-pituitary-adrenal (HPA) axis response to those situations which is critical in emotional memories. Here, we studied the behavioural and HPA responses of male and female Wistar rats to context fear conditioning using electric footshock as the aversive stimulus. Fear-conditioned rats showed a much greater ACTH and corticosterone response than those merely exposed to the fear conditioning chamber without receiving shocks. Moreover, males presented higher levels of freezing whereas HPA axis response was greater in females. Accordingly, during the fear extinction tests, female rats consistently showed less freezing and higher extinction rate, but greater HPA activation than males. Exposure to an open-field resulted in lower activity/exploration in fear-conditioned males, but not females, suggesting greater conditioned cognitive generalization in males than females. It can be concluded that important sex differences in fear conditioning are observed in both freezing and HPA activation, but the two set of variables are affected in the opposite direction: enhanced behavioural impact in males, but enhanced HPA responsiveness in females. Thus, the role of sex differences on fear-related stimuli may depend on the variables chosen to evaluate it, the greater responsiveness of the HPA axis in females perhaps being an important factor to be further explored.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sex-dependent effects of an early life treatment in rats that increases maternal care, vulnerability or resilience?

  • Fuentes, Silvia|||0000-0002-8352-1068
  • Daviu, Núria|||0000-0002-9843-2981
  • Gagliano, Humberto Antonio|||0000-0001-8727-9080
  • Garrido, Pedro
  • Zelena, Dora
  • Monasterio, Nela
  • Armario Garcia, Antonio|||0000-0001-9524-3635
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
Early life stress (ELS) in rodents has profound long-term effects that are partially mediated by changes in maternal care. ELS not only induces "detrimental" effects in adulthood, increasing psychopathology, but also promotes resilience to further stressors. In Long-Evans rats, we evaluated a combination of two procedures as a model of ELS: restriction of bedding during the first post-natal days and exposure to a "substitute" mother. The maternal care of biological and "substitute" mothers was measured. The male and female offspring were evaluated during adulthood in several contexts. Anxiety was measured by the elevated plus-maze (EPM), acoustic startle response (ASR) and forced swim test (FST). In other group of animals, novelty-seeking was measured (activity in an inescapable novel environment, preference for novel environments and exploration of novel objects). Plasmatic ACTH and corticosterone in basal conditions and in response to stress were also measured. Cognitive impulsivity was assessed by a delay-discounting paradigm, and impulsive action, attention and compulsive-like behavior by a five choice serial reaction time task (5CSRTT). ELS decreased pup body weight and increased the care of the biological mother; however, the "substitute" mother did not exhibit overt maltreatment. A mixture of "detrimental" and "beneficial" effects was shown. In the 5CSRTT, attention was impaired in both genders, and in females, ELS increased compulsive-like behavior. Novel object exploration was only increased by ELS in males, but the preference for novel spaces decreased in both genders. Baseline anxiety (EPM and ASR) and recognition memory were not affected. Unexpectedly, ELS decreased the ACTH response to novelty and swim stress and increased active coping in the FST in both genders. Cognitive impulsivity was decreased only in females, but impulsive action was not affected. The enhancement in maternal care may "buffer" the effects of ELS in a context-dependent manner.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Markers of inflammation and mortality in a cohort of patients with alcohol dependence

  • Fuster, Daniel|||0000-0003-1262-5860
  • Sanvisens, Arantza|||0000-0001-6269-5491
  • Bolao, Ferran|||0000-0002-9104-6615
  • Zuluaga Cruz, Andrea Paola|||0000-0002-3003-4856
  • Rivas, Inmaculada|||0000-0003-2633-5530
  • Tor Aguilera, Jordi|||0000-0002-5355-9110
  • Muga, Roberto|||0000-0001-6301-431X
Abstract.Inflammation and intestinal permeability are believed to be paramount features in the development of alcohol-related liver damage. We aimed to assess the impact of 3 surrogate markers of inflammation (anemia, fibrinogen, and ferritin levels) on mid-term mortality of patients with alcohol dependence. This longitudinal study included patients with alcohol dependence admitted for hospital detoxification between 2000 and 2010. Mortality was ascertained from clinical charts and the mortality register. Associations between markers of inflammation and all-cause mortality were analyzed with mortality rates and Cox proportional hazards regression models. We also performed a subgroup analysis of mortality rates in patients with anemia, based on their mean corpuscular volume (MCV). We included 909 consecutive patients with alcohol dependence. Patients were mostly male (80.3%), had a median age of 44 years (interquartile range [IQR]: 38-50), and upon admission, their median alcohol consumption was 192 g/day (IQR: 120-265). At admission, 182 (20.5%) patients had anemia; 210 (25.9%) had fibrinogen levels.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Long-Term Mortality of Patients with an Alcohol-Related Wernicke-Korsakoff Syndrome

  • Sanvisens, Arantza|||0000-0001-6269-5491
  • Zuluaga Cruz, Andrea Paola|||0000-0002-3003-4856
  • Fuster, Daniel|||0000-0003-1262-5860
  • Rivas, Inmaculada|||0000-0003-2633-5530
  • Tor Aguilera, Jordi|||0000-0002-5355-9110
  • Marcos, Miguel|||0000-0003-1269-4487
  • Chamorro, Antonio-J.|||0000-0002-2345-2873
  • Muga, Roberto|||0000-0001-6301-431X
Aims: To characterize a series of contemporary patients with alcohol-related Wernicke's encephalopathy (WE) or Korsakoff's syndrome (KS) and to update the current prognosis of disease. Methods: Retrospective and prospective study of patients diagnosed with an alcohol-related WE or KS between 2002 and 2011 in a tertiary hospital. Socio-demographic, alcohol use characteristics, signs and symptoms, co-morbidity and blood parameters were obtained at admission. Patients were followed up until 2013 and causes of death were ascertained through the review of charts. Results: Sixty-one patients were included (51 with WE and 10 with KS). Among patients with WE, 78% were men and age at diagnosis was 57 years (interquartile range (IQR): 49-66). Twenty-three percent fulfilled the classic WE triad. Regarding Caine's criteria for WE, 70.6% presented with at least two out of four signs or symptoms. Median follow-up of patients with WE syndrome was 5.3 years (IQR: 2.6-8.8), the cumulated mortality was 45% and death rate of 7.4 × 100 person-years (95% confidence interval (CI): 4.8-10.9). Overall, 50% of patients would be expected to die within 8 years of WE episode and main causes of death included serious bacterial infections (44.5%) and cancer (33.3%). Conclusions: Survival of patients with an alcohol-related Wernicke-Korsakoff syndrome is poor; pursuing treatment of alcohol use disorder and early diagnosis of thiamine deficiency is a priority for improving clinical outcomes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Passive smoking at home is a risk factor for community-acquired pneumonia in older adults, a population-based case-control study

  • Almirall i Pujol, Jordi|||0000-0002-3821-4341
  • Serra-Prat, Mateu|||0000-0002-6554-9913
  • Bolibar i Ribas, Ignasi|||0000-0002-4529-1935
  • Palomera, Elisabet|||0000-0002-4384-5746
  • Roig, Jordi
  • Hospital, Imma
  • Carandell, Eugenia
  • Agustí, Mercè
  • Ayuso, Pilar
  • Estela, Andreu
  • Torres, Antoni|||0000-0002-8643-2167
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain, a cohort study

  • Muga, Roberto|||0000-0001-6301-431X
  • Rivas, Inmaculada|||0000-0003-2633-5530
  • Faure, Eva|||0000-0002-5056-0888
  • Fuster, Daniel|||0000-0003-1262-5860
  • Zuluaga Cruz, Andrea Paola|||0000-0002-3003-4856
  • Rubio, Manuela
  • Muñoz, Trinidad
  • Torrens, Marta
  • Tor Aguilera, Jordi|||0000-0002-5355-9110
  • Sanvisens, Arantza|||0000-0001-6269-5491
Opioid substitution therapy has improved the survival of heroin users with and without HIV infection. We aimed to analyze sex differences in mortality rates and predictors of death among those admitted to a methadone treatment program (MTP). Longitudinal study of patients enrolled in a MTP from 1992 to 2010. Socio-demographic and drug use characteristics, and markers of viral infections were assessed at entry. Vital status was ascertained by clinical charts and the mortality register. Four calendar periods were defined according to the introduction of preventive and treatment interventions in Spain. Predictors of death were analyzed by Cox regression models. 1,678 patients (82.8% men) were included; age at first heroin use was 18.6 years (IQR: 16-23 years), and age at first entry into a MTP was 30.7 years (IQR: 26-36 years). A total of 441 (26.3%) deaths occurred during 15,124 person-years (p-y) of follow-up (median: 9.2 years, IQR: 4-13 years). HIV infection was the main predictor of death in men (HR = 3.5, 95% CI: 2.1-5.7) and women (HR = 3.2, 95% CI: 1.2-8.7) and main cause of death was HIV/AIDS. Overall mortality rate was 2.9 per 100 p-y (95% CI: 2.7-3.2 per 100 p-y) and death rates decreased over time: 7.4 per 100 p-y (95% CI: 6.3-8.8 per 100 p-y) for the 1992-1996 period to 1.9 per 100 p-y (95% CI: 1.6-2.4 per 100 p-y) for the 2007-2010 period. In women, a slightly increase in mortality was observed in recent periods specifically among HIV-positive women (3.7 per 100 p-y in period 2002-2006 and 4.5 per 100 p-y in 2007-2010). Significant reductions in mortality of patients in MTP are observed after nineteen years of observation. However, HIV infection shows a great impact on survival, particularly among HIV-infected women. The online version of this article (doi:10.1186/1471-2334-14-504) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

PsyGeNET, a knowledge platform on psychiatric disorders and their genes

  • Gutiérrez-Sacristán, Alba
  • Grosdidier, Solène
  • Valverde, Olga|||0000-0003-2264-7852
  • Torrens, Marta|||0000-0001-6222-4761
  • Bravo, Àlex
  • Piñero, Janet|||0000-0003-1244-7654
  • Sanz, Ferran|||0000-0002-7534-7661
Summary: PsyGeNET (Psychiatric disorders and Genes association NETwork) is a knowledge platform for the exploratory analysis of psychiatric diseases and their associated genes. PsyGeNET is composed of a database and a web interface supporting data search, visualization, filtering and sharing. PsyGeNET integrates information from DisGeNET and data extracted from the literature by text mining, which has been curated by domain experts. It currently contains 2642 associations between 1271 genes and 37 psychiatric disease concepts. In its first release, PsyGeNET is focused on three psychiatric disorders: major depression, alcohol and cocaine use disorders. PsyGeNET represents a comprehensive, open access resource for the analysis of the molecular mechanisms underpinning psychiatric disorders and their comorbidities.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association between neurological soft signs, temperament and character in patients with schizophrenia and non-psychotic relatives

  • Galindo, Liliana|||0000-0002-2396-4772
  • Pastoriza, Francisco
  • Bergé Baquero, Daniel|||0000-0003-2544-1016
  • Mané, Anna|||0000-0003-2127-349X
  • Picado, Marisol
  • Bulbena Vilarrasa, Antonio|||0000-0003-2404-2478
  • Robledo, Patricia
  • Pérez Solà, Víctor|||0000-0002-5825-2337
  • Vilarroya Oliver, Óscar|||0000-0001-8285-5624
  • Cloninger, Claude Robert
The heritability of schizophrenia and most personality traits has been well established, but the role of personality in susceptibility to schizophrenia remains uncertain. The aim of this study was to test for an association between personality traits and Neurological Soft Signs (NSS), a well-known biological marker of schizophrenia, in non-psychotic relatives of patients with schizophrenia. For this purpose, we evaluated the NSS scale and personality measured by the Temperament and Character inventory (TCI-R) in three groups of subjects: 29 patients with schizophrenia, 24 unaffected relatives and 37 controls. The results showed that patients with schizophrenia were more asocial (higher harm avoidance and lower reward dependence), more perseverative (higher persistence), and more schizotypal (lower self-directedness and cooperativeness, higher self-transcendence). The unaffected relatives showed higher harm avoidance, lower self-directedness and cooperativeness than the healthy controls. Higher NSS scores and sub-scores were found in patients and non-psychotic relatives compared with the controls. Among all the patients, total NSS scores were positively correlated with harm avoidance but negatively correlated with novelty seeking and persistence. Total NSS were also correlated with low scores on self-directedness and cooperativeness, which are indicators of personality disorder. Our results show that susceptibility to NSS and to schizophrenia are both related to individual differences in the temperament and character features in non-psychotic relatives of patients with schizophrenia. High harm avoidance, low persistence, low self-directedness and low cooperativeness contribute to both the risk of NSS and schizophrenia. These findings highlight the value of using both assessments to study high risk populations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Treatment of Comorbid Alcohol Dependence and Anxiety Disorder, Review of the Scientific Evidence and Recommendations for Treatment

  • Gimeno, Carmen
  • Dorado, Marisa Luisa
  • Roncero, Carlos|||0000-0003-1421-7385
  • Szerman, Nestor|||0000-0002-9821-7958
  • Vega Astudillo, Pablo|||0000-0002-6085-8602
  • Balanzá-Martínez, Vicent|||0000-0001-7772-7396
  • Alvarez, F. Javier
Patients with alcohol-use disorders (AUDs) have a high prevalence of anxiety disorders (AnxDs). "Co-occurring disorders" refers to the coexistence of an AUD and/or drug related disorders with another non-addictive psychiatric disorder. The aim of this study was to assess the effectiveness of psychopharmacological treatments and psychotherapy in patients with AUD and AnxD and to propose recommendations for the treatment of patients with comorbid AnxDs and AUDs. Randomized clinical trials, meta-analyses, and clinical guidelines were retrieved from PubMed, Embase, and Cochrane databases. Paroxetine was found to be effective in social anxiety patients with alcohol dependence. Selective serotonin reuptake inhibitors (SSRIs), especially sertraline, showed effective results in posttraumatic stress disorder and in comorbid AnxD-AUD. However, SSRIs should be used with caution when patients are actively drinking because they may increase alcohol consumption. Buspirone, gabapentin, and pregabalin were found to be effective in comorbid AnxD-AUD. The treatment of dual AnxDs should start as early as possible. Since AUDs and AnxDs can reinforce each other, treatments targeting both pathologies can be effective. Women suffer from higher levels of stress and AnxDs than men, and they are also more vulnerable to maintaining alcohol consumption levels. Further research is needed in this comorbid patient population, including the study of different types of patients and gender perspectives.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Dual Depression, A Sex Perspective

  • Farré Martínez, Adriana|||0000-0001-5399-9389
  • Tirado-Muñoz, Judit
  • Torrens, Marta
Mood and substance use disorders (SUDs) are mental conditions that are highly prevalent in the general population. Cooccurrence of major depression and SUD, also known as dual depression, is very common in the field of substance addiction. Sex differences are found in both major depression and SUD. This review, after presenting the state of the art of dual depression as regards prevalence, ethiopathologic mechanisms, and clinical aspects, is focused on dual depression in women. An overview of some potential factors associated with the sex gap in dual depression such as injecting, sexual risk behavior, intimate partner violence, and the reproductive cycle is presented.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

PMut, a web-based tool for the annotation of pathological variants on proteins, 2017 update

  • López-Ferrando, Víctor
  • Gazzo, Andrea
  • de la Cruz, Xavier|||0000-0002-9738-8472
  • Orozco López, Modesto|||0000-0002-8608-3278
  • Gelpí, Josep Ll|||0000-0002-0566-7723
We present here a full update of the PMut predictor, active since 2005 and with a large acceptance in the field of predicting Mendelian pathological mutations. PMut internal engine has been renewed, and converted into a fully featured standalone training and prediction engine that not only powers PMut web portal, but that can generate custom predictors with alternative training sets or validation schemas. PMut Web portal allows the user to perform pathology predictions, to access a complete repository of pre-calculated predictions, and to generate and validate new predictors. The default predictor performs with good quality scores (MCC values of 0.61 on 10-fold cross validation, and 0.42 on a blind test with SwissVar 2016 mutations). The PMut portal is freely accessible at http://mmb.irbbarcelona.org/PMut. A complete help and tutorial is available at http://mmb.irbbarcelona.org/PMut/help.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Is systematic training in opioid overdose prevention effective?

  • Espelt, Albert|||0000-0002-8625-4356
  • Bosque Prous, Marina|||0000-0002-8830-8880
  • Folch, Cinta|||0000-0001-8400-2668
  • Sarasa-Renedo, Ana
  • Majó, Xavier|||0000-0003-4338-6014
  • Casabona-Barbarà, Jordi|||0000-0003-4816-5536
  • Brugal, María Teresa|||0000-0003-0580-676X
The objectives were to analyze the knowledge about overdose prevention, the use of naloxone, and the number of fatal overdoses after the implementation of Systematic Training in Overdose Prevention (STOOP) program. We conducted a quasi-experimental study, and held face-to-face interviews before (n = 725) and after (n = 722) implementation of systematic training in two different samples of people who injected opioids attending harm reduction centers. We asked participants to list the main causes of overdose and the main actions that should be taken when witnessing an overdose. We created two dependent variables, the number of (a) correct and (b) incorrect answers. The main independent variable was Study Group: Intervention Group (IG), Comparison Group (CG), Pre-Intervention Group With Sporadic Training in Overdose Prevention (PREIGS), or Pre-Intervention Group Without Training in Overdose Prevention (PREIGW). The relationship between the dependent and independent variables was assessed using a multivariate Poisson regression analysis. Finally, we conducted an interrupted time series analysis of monthly fatal overdoses before and after the implementation of systematic program during the period 2006±2015. Knowledge of overdose prevention increased after implementing systematic training program. Compared to the PREIGW, the IG gave more correct answers (IRR = 1.40;95%CI:1.33± 1.47), and fewer incorrect answers (IRR = 0.33;95%CI:0.25±0.44). Forty percent of people who injected opioids who received a naloxone kit had used the kit in response to an overdose they witnessed. These courses increase knowledge of overdose prevention in people who use opioids, give them the necessary skills to use naloxone, and slightly diminish the number of fatal opioid overdoses in the city of Barcelona.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Job Loss, Unemployment and the Incidence of Hazardous Drinking during the Late 2000s Recession in Europe among Adults Aged 50-64 Years

  • Bosque Prous, Marina|||0000-0002-8830-8880
  • Espelt, Albert|||0000-0002-8625-4356
  • Sordo, Luis|||0000-0003-1760-9472
  • Guitart, Anna M.|||0009-0004-7493-4954
  • Brugal, María Teresa|||0000-0003-0580-676X
  • Bravo, Maria J.
Background: To estimate the incidence of hazardous drinking in middle-aged people during an economic recession and ascertain whether individual job loss and contextual changes in unemployment influence the incidence rate in that period. Methods: Longitudinal study based on two waves of the SHARE project (Survey of Health, Ageing and Retirement in Europe). Individuals aged 50-64 years from 11 European countries, who were not hazardous drinkers at baseline (n = 7,615), were selected for this study. We estimated the cumulative incidence of hazardous drinking (≥40g and ≥20g of pure alcohol on average in men and women, respectively) between 2006 and 2012. Furthermore, in the statistical analysis, multilevel Poisson regression models with robust variance were fitted and obtained Risk Ratios (RR) and their 95% Confidence Intervals (95%CI). Results: Over a 6-year period, 505 subjects became hazardous drinkers, with cumulative incidence of 6.6 per 100 persons between 2006 and 2012 (95%CI:6.1-7.2). Age [RR = 1.02 (95%CI:1.00-1.04)] and becoming unemployed [RR = 1.55 (95%CI:1.08-2.23)] were independently associated with higher risk of becoming a hazardous drinker. Conversely, having poorer self-perceived health was associated with lower risk of becoming a hazardous drinker [RR = 0.75 (95%CI:0.60-0.95)]. At country-level, an increase in the unemployment rate during the study period [RR = 1.32 (95%CI:1.17-1.50)] and greater increases in the household disposable income [RR = 0.97 (95%CI:0.95-0.99)] were associated with risk of becoming a hazardous drinker. Conclusions: Job loss among middle-aged individuals during the economic recession was positively associated with becoming a hazardous drinker. Changes in country-level variables were also related to this drinking pattern.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Long-term moderate treadmill exercise promotes stress-coping strategies in Male and female rats

  • F. Lalanza, Jaume|||0000-0003-2481-2188
  • Sánchez Roige, Sandra|||0000-0001-6137-5699
  • Cigarroa, Igor|||0000-0003-0418-8787
  • Gagliano, Humberto Antonio|||0000-0001-8727-9080
  • Fuentes, Silvia|||0000-0002-8352-1068
  • Armario Garcia, Antonio|||0000-0001-9524-3635
  • Capdevila Ortís, Lluís|||0000-0002-7319-4745
  • Escorihuela, Rosa M.|||0000-0001-9368-5173
Recent evidence has revealed the impact of exercise in alleviating anxiety and mood disorders; however, the exercise protocol that exerts such benefit is far from known. The current study was aimed to assess the effects of long-term moderate exercise on behavioural coping strategies (active vs. passive) and Hypothalamic-Pituitary-Adrenal response in rats. Sprague-Dawley male and female rats were exposed to 32-weeks of treadmill exercise and then tested for two-way active avoidance learning (shuttle-box). Two groups were used as controls: a non-handled sedentary group, receiving no manipulation, and a control group exposed to a stationary treadmill. Female rats displayed shorter escape responses and higher number of avoidance responses, reaching criterion for performance earlier than male rats. In both sexes, exercise shortened escape latencies, increased the total number of avoidances and diminished the number of trials needed to reach criterion for performance. Those effects were greater during acquisition in female rats, but remained over the shuttle-box sessions in treadmill trained male rats. In females, exercise did not change ACTH and corticosterone levels after shuttle-box acquisition. Collectively, treadmill exercise improved active coping strategies in a sex-dependent manner. In a broader context, moderate exercise could serve as a therapeutic intervention for anxiety and mood disorders.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Controllability affects endocrine response of adolescent male rats to stress as well as impulsivity and behavioral flexibility during adulthood

  • Sanchís Ollé, Maria|||0000-0001-8707-2637
  • Fuentes, Silvia|||0000-0002-8352-1068
  • Úbeda-Contreras Gallego de la Sacristana, Jesús|||0000-0002-9965-3532
  • F. Lalanza, Jaume|||0000-0003-2481-2188
  • Ramos-Prats, A.
  • Armario Garcia, Antonio|||0000-0001-9524-3635
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
Exposure to stress during adolescence exerts a long-term impact on behavior and might contribute to the development of several neuropsychiatric disorders. In adults, control over stress has been found to protect from the negative consequences of stress, but the influence of controllability at early ages has not been extensively studied. Here, we evaluated in a rodent model the effects of repeated exposure in adolescent male rats to controllable versus uncontrollable foot-shock stress (CST or UST, respectively). Rats were assigned to three groups: non-stress (stress-naïve), CST (exposed to 8 sessions of a two-way shuttle active avoidance task over a period of 22 days) and UST (receiving the same amount of shocks as CST, regardless of their actual behavior). During adulthood, different cohorts were tested in several tasks evaluating inhibitory control and cognitive flexibility: 5-choice serial reaction time, delay-discounting, gambling test and probabilistic reversal learning. Results showed that the hypothalamic-pituitary-adrenal response to the first shock session was similar in CST and UST animals, but the response to the 8 session was lower in CST animals. In adulthood, the UST animals presented impaired motor (but not cognitive) impulsivity and more perseverative behavior. The behavioral effects of UST were associated with increased number of D2 dopamine receptors in dorsomedial striatum, but not in other striatal regions. In summary, UST exposure during adolescence induced long-term impairments in impulsivity and compulsivity, whereas CST had only minor effects. These data support a critical role of stress uncontrollability on the long-lasting consequences of stress, as a risk factor for mental illnesses.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Osteogenic commitment of Wharton's jelly mesenchymal stromal cells, Mechanisms and implications for bioprocess development and clinical application

  • Cabrera-Pérez, Raquel|||0000-0002-4858-0142
  • Monguió-Tortajada, Marta|||0000-0003-2125-0810
  • Gámez-Valero, Ana|||0000-0002-9530-2751
  • Rojas-Márquez, R.
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
  • Rudilla, F..
  • Vives Armengol, Joaquim|||0000-0001-9719-5235
Background: Orthopaedic diseases are one of the major targets for regenerative medicine. In this context, Wharton's jelly (WJ) is an alternative source to bone marrow (BM) for allogeneic transplantation since its isolation does not require an invasive procedure for cell collection and does not raise major ethical concerns. However, the osteogenic capacity of human WJ-derived multipotent mesenchymal stromal cells (MSC) remains unclear. Methods: Here, we compared the baseline osteogenic potential of MSC from WJ and BM cell sources by cytological staining, quantitative real-time PCR and proteomic analysis, and assessed chemical and biological strategies for priming undifferentiated WJ-MSC. Concretely, different inhibitors/activators of the TGFβ1-BMP2 signalling pathway as well as the secretome of differentiating BM-MSC were tested. Results: Cytochemical staining as well as gene expression and proteomic analysis revealed that osteogenic commitment was poor in WJ-MSC. However, stimulation of the BMP2 pathway with BMP2 plus tanshinone IIA and the addition of extracellular vesicles or protein-enriched preparations from differentiating BM-MSC enhanced WJ-MSC osteogenesis. Furthermore, greater outcome was obtained with the use of conditioned media from differentiating BM-MSC. Conclusions: Altogether, our results point to the use of master banks of WJ-MSC as a valuable alternative to BM-MSC for orthopaedic conditions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Inflammatory mediators and dual depression, Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders

  • García Marchena, Nuria|||0000-0002-0575-3613
  • Barrera-Conde, Marta|||0000-0002-0106-0000
  • Mestre-Pintó, Joan-Ignasi|||0000-0003-0387-9375
  • Araos, Pedro|||0000-0001-5172-8796
  • Serrano, Antonia
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Papaseit, Esther|||0000-0003-2620-4274
  • Fonseca, Francina|||0000-0002-0779-6545
  • Ruiz, Juan Jesús
  • Rodríguez de Fonseca, Fernando|||0000-0002-4516-5795
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Pavón, Francisco Javier
  • Torrens, Marta
Major depressive disorder (MDD) is the most prevalent comorbid mental disorder among people with substance use disorders. The MDD can be both primary and substance-induced and its accurate diagnosis represents a challenge for clinical practice and treatment response. Recent studies reported alterations in the circulating expression of inflammatory mediators in patients with psychiatric disorders, including those related to substance use. The aim of the study was to explore TNF-α, IL-1β, CXCL12, CCL2, CCL11 (eotaxin-1) and CX3CL1 (fractalkine) as potential biomarkers to identify comorbid MDD and to distinguish primary MDD from substance-induced MDD in patients with substance disorders. Patients diagnosed with cocaine (CUD, n = 64) or alcohol (AUD, n = 65) use disorders with/without MDD were recruited from outpatient treatment programs [CUD/non-MDD (n = 31 CUD/primary MDD (n = 18 CUD/cocaine-induced MDD (N = 15 AUD/non-MDD (n = 27 AUD/primary MDD (n = 16) and AUD/alcohol-induced MDD (n = 22)]. Sixty-two healthy subjects were also recruited as control group. Substance and mental disorders were assessed according to "Diagnostic and Statistical Manual of Mental Disorders, 4 edition, text revision" (DSM-IV-TR) and a blood sample was collected for determinations in the plasma. The cocaine group showed lower TNF-α (p<0.05) and CCL11 (p<0.05), and higher IL-1β (p<0.01) concentrations than the control group. In contrast, the alcohol group showed higher IL-1β (p<0.01) and lower CXCL12 (p<0.01) concentrations than the control group. Regarding MDD, we only observed alterations in the cocaine group. Thus, CUD/MDD patients showed lower IL-1β (p<0.05), CXCL12 (p<0.05) and CCL11 (p<0.05), and higher CXC3CL1 (p<0.05) concentrations than CUD/non-MDD patients. Moreover, while CUD/primary MDD patients showed higher CCL11 (p<0.01) concentrations than both CUD/non-MDD and CUD/cocaine-induced MDD patients, CUD/cocaine-induced MDD patients showed lower CXCL12 (p<0.05) concentrations than CUD/non-MDD patients. Finally, a logistic regression model in the cocaine group identified CXCL12, CCL11 and sex to distinguish primary MDD from cocaine-induced MDD providing a high discriminatory power. The present data suggest an association between changes in inflammatory mediators and the diagnosis of primary and substance-induced MDD, namely in CUD patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

  • Jiménez De Ory, S.
  • Ramos Amador, José Tomás
  • Fortuny Guasch, Claudia
  • González-Tomé, María Isabel
  • Mellado Peña, María José|||0000-0003-2251-9666
  • Moreno Pérez, David|||0000-0002-7017-4095
  • Gavilán, C.
  • Menasalvas, A. I.
  • Piqueras, Ana Isabel
  • Frick, Marie Antoinette|||0000-0002-2553-5090
  • Muñoz-Fernández, M. A.
  • Navarro, Maria Luisa
Background There are not enough nationwide studies on perinatal HIV transmission in connection with a combination of antiretroviral treatments in Spain. Our objectives were to study sociodemographic changes and trends in the rates of HIV diagnoses and perinatal transmission in Spain from 1997 to 2015. Methods A retrospective study using data from Spanish Paediatric HIV Network (CoRISpe) and Spanish Minimum Basic Data Set (MDBS) was performed. HIV- diagnosed children between 1997 and 2015 were selected. Sociodemographic, clinical and immunovirological data of HIV-infected children and their mothers were studied in four calendar periods (P1: 1997-2000; P2: 2001-2005; P3: 2006-2010; P4: 2011-2015). Rates of perinatal HIV diagnoses and transmission from 1997 to 2015 were calculated. Results A total of 532 HIV-infected children were included in this study. Of these children, 406 were Spanish (76.3%) and 126 immigrants (23.7%). A decrease in the number of HIV diagnoses, 203 (38.2%) children in the first (P1), 149 (28%) in the second (P2), 130 (24.4%) in the third (P3) and 50 (9.4%) in the fourth (P4) calendar periods was studied. The same decrease in the Spanish HIV-infected children (P1, 174 (46.6%), P2, 115 (30.8%), P3, 65 (17.4%) and P4, 19 (5.1%)) was monitored. However, an increase in the number of HIV diagnoses by sexual contact (P1: 0%; P2: 1.3%; P3: 4.6%; P4: 16%) was observed. The rates of new perinatal HIV diagnoses and perinatal transmission in Spanish children decreased from 0.167 to 0.005 per 100,000 inhabitants and 11.4% to 0.4% between 1997 and 2015, respectively. Conclusions A decline of perinatal HIV diagnoses and transmission was observed. However, an increase of teen-agers HIV diagnoses with sexual infection was studied. Public awareness campaigns directed to teen-agers are advisable to prevent HIV infection by sexual contact.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination

  • Pallarès, Victor|||0000-0002-9851-0345
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Falgàs, Aïda|||0000-0002-5040-2265
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Morris, Gordon A.|||0000-0003-2588-6349
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Álamo, Patricia|||0000-0003-0510-5701
  • Sierra, Jorge|||0000-0002-7966-0356
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Mangues, Ramon|||0000-0003-2661-9525
Background: current acute myeloid leukemia (AML) therapy fails to eliminate quiescent leukemic blasts in the bone marrow, leading to about 50% of patient relapse by increasing AML burden in the bone marrow, blood, and extramedullar sites. We developed a protein-based nanoparticle conjugated to the potent antimitotic agent Auristatin E that selectively targets AML blasts because of their CXCR4 receptor overexpression (CXCR4+) as compared to normal cells. The therapeutic rationale is based on the involvement of CXCR4 overexpression in leukemic blast homing and quiescence in the bone marrow, and the association of these leukemic stem cells with minimal residual disease, dissemination, chemotherapy resistance, and lower patient survival. - Methods: monomethyl Auristatin E (MMAE) was conjugated with the CXCR4 targeted protein nanoparticle T22-GFP-H6 produced in E. coli. Nanoconjugate internalization and in vitro cell viability assays were performed in CXCR4+ AML cell lines to analyze the specific antineoplastic activity through the CXCR4 receptor. In addition, a disseminated AML animal model was used to evaluate the anticancer effect of T22-GFP-H6-Auristatin in immunosuppressed NSG mice (n = 10/group). U of Mann-Whitney test was used to consider if differences were significant between groups. - Results: T22-GFP-H6-Auristatin was capable to internalize and exert antineoplastic effects through the CXCR4 receptor in THP-1 and SKM-1 CXCR4+ AML cell lines. In addition, repeated administration of the T22-GFP-H6-Auristatin nanoconjugate (9 doses daily) achieves a potent antineoplastic activity by internalizing specifically in the leukemic cells (luminescent THP-1) to selectively eliminate them. This leads to reduced involvement of leukemic cells in the bone marrow, peripheral blood, liver, and spleen, while avoiding toxicity in normal tissues in a luminescent disseminated AML mouse model. - Conclusions: a novel nanoconjugate for targeted drug delivery of Auristatin reduces significantly the acute myeloid leukemic cell burden in the bone marrow and blood and blocks its dissemination to extramedullar organs in a CXCR4+ AML model. This selective drug delivery approach validates CXCR4+ AML cells as a target for clinical therapy, not only promising to improve the control of leukemic dissemination but also dramatically reducing the severe toxicity of classical AML therapy.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product, A Spanish Experience

  • Gastelurrutia, Paloma|||0000-0001-6974-9210
  • Prat-Vidal, Cristina|||0000-0002-5621-1101
  • Vives Armengol, Joaquim|||0000-0001-9719-5235
  • Coll-Bonet, Ruth|||0000-0003-0174-379X
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
A systematic and ordered product development program, in compliance with current quality and regulatory standards, increases the likelihood of yielding a successful advanced therapy medicinal product (ATMP) for clinical use as safe and effective therapy. As this is a novel field, little accurate information is available regarding the steps to be followed, and the information to be produced to support the development and use of an ATMP. Notably, successful clinical translation can be somewhat cumbersome for academic researchers. In this article, we have provided a summary of the available information, supported by our experience in Spain throughout the development of an ATMP for myocardial infarction, from the pre-clinical stage to phase I clinical trial approval.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Towards the standardization of methods of tissue processing for the isolation of mesenchymal stromal cells for clinical use

  • García Muñoz, Elisabeth
  • Vives Armengol, Joaquim|||0000-0001-9719-5235
Multipotent mesenchymal stromal cells (MSCs) are currently the most extensively studied type of adult stem cells in advanced stages of development in the field of regenerative medicine. The biological properties of MSCs have generated great hope for their therapeutic use in degenerative and autoimmune conditions that, at present, lack effective treatment options. Over the last decades, MSCs have been typically obtained from adult bone marrow, but the extraction process is highly invasive and the quality and numbers of isolated cells is drastically influenced by patient age, medication and associated comorbidities. Therefore, there is currently an open discussion on the convenience of allogeneic over autologous treatments, despite potential disadvantages such as rejection by the host. This shift to the allogeneic setting entails the need for high production of MSCs to ensure availability of sufficient cell numbers for transplantation, and therefore making the search for alternative tissue sources of highly proliferative MSC cultures with low levels of senescence occurrence, which is one of the greatest current challenges in the scale up of therapeutic cell bioprocessing. Herein we (i) present the main isolation protocols of MSCs from bone marrow, adipose tissue and Wharton's jelly of the umbilical cord; and (ii) compare their qualities from a bioprocess standpoint, addressing both quality and regulatory aspects, in view of their anticipated clinical use.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction

  • Domingo-Rodriguez, Laura|||0000-0003-3286-6696
  • Ruiz de Azua, Inigo
  • Dominguez, Eduardo
  • Senabre, Eric|||0000-0001-8507-8154
  • Serra, Irene
  • Kummer, Sami
  • Navandar, Mohit
  • Baddenhausen, Sarah|||0000-0001-9847-6960
  • Hofmann, Clementine
  • Andero Galí, Raül|||0000-0003-3641-8903
  • Gerber, Susanne
  • Navarrete, Marta|||0000-0003-2097-4788
  • Dierssen, Mara|||0000-0003-0853-6865
  • Lutz, Beat|||0000-0002-1062-6889
  • Martín-García, Elena|||0000-0002-4487-3028
  • Maldonado, Rafael|||0000-0002-4359-8773
Food addiction is linked to obesity and eating disorders and is characterized by a loss of behavioral control and compulsive food intake. Here, using a food addiction mouse model, we report that the lack of cannabinoid type-1 receptor in dorsal telencephalic glutamatergic neurons prevents the development of food addiction-like behavior, which is associated with enhanced synaptic excitatory transmission in the medial prefrontal cortex (mPFC) and in the nucleus accumbens (NAc). In contrast, chemogenetic inhibition of neuronal activity in the mPFC-NAc pathway induces compulsive food seeking. Transcriptomic analysis and genetic manipulation identified that increased dopamine D2 receptor expression in the mPFC-NAc pathway promotes the addiction-like phenotype. Our study unravels a new neurobiological mechanism underlying resilience and vulnerability to the development of food addiction, which could pave the way towards novel and efficient interventions for this disorder. Food addiction is linked to obesity and eating disorders. In a mouse model of food addiction, the authors show that a medial prefrontal cortex-nucleus accumbens pathway is involved in vulnerability and resilience against the development of food addiction-like behavior.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The challenge of developing human 3D organoids into medicines

  • Vives Armengol, Joaquim|||0000-0001-9719-5235
  • Batlle Morera, Laura|||0000-0002-6924-9002
The capacity of organoids to generate complex 3D structures resembling organs is revolutionizing the fields of developmental and stem cell biology. We are currently establishing the foundations for translational applications of organoids such as drug screening, personalized medicine and launching the future of cell therapy using organoids. However, clinical translation of organoids into cell replacement therapies is halted due to (A) a few preclinical studies demonstrating their efficacy and (B) the lack of robust, reproducible, and scalable methods of production in compliance with current pharmaceutical standards. In this issue of Stem Cell Research & Therapy [ref], Dossena and collaborators present a validated bioprocess design for large-scale production of human pancreatic organoids from cadaveric tissue in accordance with current good manufacturing practice. The authors also propose a set of specifications of starting materials and critical quality attributes of final products that are of interest to other developments provided that this type of medicines are different than any other medicinal product due to their complex composition and living nature of the active ingredient. Although large-scale production of functional cells secreting insulin is still a challenge, the development of methods such as the one presented by Dossena and collaborators contributes to move toward clinical use of organoids in the treatment of type 1 diabetes and opens avenues for future clinical use of organoids in degenerative pathologies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Epigenome-wide association study of attention-deficit/hyperactivity disorder in adults

  • Rovira, Paula|||0000-0003-2177-8412
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Arribas, Lorena|||0000-0002-9683-9999
  • Shireby, Gemma
  • Hannon, Eilis|||0000-0001-6840-072X
  • Mill, Jonathan|||0000-0003-1115-3224
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Soler Artigas, María|||0000-0002-3213-1107
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder that often persists into adulthood. There is growing evidence that epigenetic dysregulation participates in ADHD. Given that only a limited number of epigenome-wide association studies (EWASs) of ADHD have been conducted so far and they have mainly focused on pediatric and population-based samples, we performed an EWAS in a clinical sample of adults with ADHD. We report one CpG site and four regions differentially methylated between patients and controls, which are located in or near genes previously involved in autoimmune diseases, cancer or neuroticism. Our sensitivity analyses indicate that smoking status is not responsible for these results and that polygenic risk burden for ADHD does not greatly impact the signatures identified. Additionally, we show an overlap of our EWAS findings with genetic signatures previously described for ADHD and with epigenetic signatures for smoking behavior and maternal smoking. These findings support a role of DNA methylation in ADHD and emphasize the need for additional efforts in larger samples to clarify the role of epigenetic mechanisms on ADHD across the lifespan.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Phenol-Enriched Virgin Olive Oil Promotes Macrophage-Specific Reverse Cholesterol Transport In Vivo

  • Cedó, Lídia|||0000-0003-4354-3411
  • Fernández-Castillejo, Sara|||0000-0002-8109-9713
  • Rubió, Laura
  • Metso, Jari
  • Santos, David|||0000-0003-1157-4969
  • Muñoz Aguayo, Daniel|||0000-0001-8173-0168
  • Rivas-Urbina, Andrea|||0000-0002-0111-0477
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Méndez Lara, Karen Alejandra|||0000-0002-8372-2310
  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Jauhiainen, Matti|||0000-0002-3836-3785
  • Motilva, Maria-José|||0000-0001-8985-7737
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
  • Solà, Rosa|||0000-0002-8359-235X
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
The intake of olive oil (OO) enriched with phenolic compounds (PCs) promotes ex vivo HDL-mediated macrophage cholesterol efflux in humans. We aimed to determine the effects of PC-enriched virgin OO on reverse cholesterol transport (RevCT) from macrophages to feces in vivo. Female C57BL/6 mice were given intragastric doses of refined OO (ROO) and a functional unrefined virgin OO enriched with its own PC (FVOO) for 14 days. Our experiments included two independent groups of mice that received intragastric doses of the phenolic extract (PE) used to prepare the FVOO and the vehicle solution (saline), as control, for 14 days. FVOO intake led to a significant increase in serum HDL cholesterol and its ability to induce macrophage cholesterol efflux in vitro when compared with ROO group. This was concomitant with the enhanced macrophage-derived [ 3 H]cholesterol transport to feces in vivo. PE intake per se also increased HDL cholesterol levels and significantly promoted in vivo macrophage-to-feces RevCT rate when compared with saline group. PE upregulated the expression of the main macrophage transporter involved in macrophage cholesterol efflux, the ATP binding cassette a1. Our data provide direct evidence of the crucial role of OO PCs in the induction of macrophage-specific RevCT in vivo.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Alcohol Induced Depression, Clinical, Biological and Genetic Features

  • Farré Martínez, Adriana|||0000-0001-5399-9389
  • Tirado, Judit
  • Spataro, Nino|||0000-0002-2127-2238
  • Alías Ferri, María|||0000-0002-2237-8392
  • Torrens, Marta
  • Fonseca, Francina|||0000-0002-0779-6545
Background: In clinical practice, there is the need to have clinical and biological markers to identify induced depression. The objective was to investigate clinical, biological and genetic differences between Primary Major Depression (Primary MD) and Alcohol Induced MD (AI-MD). Methods: Patients, of both genders, were recruited from psychiatric hospitalisation units. The PRISM instrument was used to establish the diagnoses. Data on socio-demographic/family history, clinical scales for depression, anxiety, personality and stressful life events were recorded. A blood test was performed analysing biochemical parameters and a Genome Wide Association Study (GWAS) to identify genetic markers associated with AI-MD. Results: A total of 80 patients were included (47 Primary MD and 33 AI-MD). The AI-MD group presented more medical comorbidities and less family history of depression. There were differences in traumatic life events, with higher scores in the AI-MD (14.21 ± 11.35 vs. 9.30 ± 7.38; p = 0.021). DSM-5 criteria were different between groups with higher prevalence of weight changes and less anhedonia, difficulties in concentration and suicidal thoughts in the AI-MD. None of the genetic variants reached significance beyond multiple testing thresholds; however, some suggestive variants were observed. Conclusions: This study has found clinical and biological features that may help physicians to identify AI-MD and improve its therapeutic approach.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application

  • Álvarez Palomo, Belén|||0000-0002-3894-044X
  • Vives Armengol, Joaquim|||0000-0001-9719-5235
  • Casaroli-Marano, Ricardo Pedro|||0000-0003-1812-9323
  • G. Gómez, Susana
  • Rodríguez Gómez, Luciano
  • Edel, Michael J.|||0000-0002-5619-8680
  • Querol, Sergi|||0000-0002-1105-8633
In this article, we will discuss the main aspects to be considered to define standard operation procedures (SOPs) for the creation of an induced pluripotent stem cell (iPSC) bank using cord blood (CB)-or similar cell type-bank guidelines for clinical aims. To do this, we adapt the pre-existing SOP for CB banking that can be complementary for iPSCs. Some aspects of iPSC manufacturing and the particular nature of these cells call for special attention, such as the potential multiple applications of the cells, proper explanation to the donor for consent of use, the genomic stability and the risk of genetic privacy disclosure. Some aspects of the iPSC SOP are solidly established by CB banking procedures, other procedures have good consensus in the scientific and medical community, while others still need to be further debated and settled. Given the international sharing vocation of iPSC banking, there is an urgent need by scientists, clinicians and regulators internationally to harmonize standards and allow future sample interchange between many iPSC bank initiatives that are springing up worldwide.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sex-dependent impact of early-life stress and adult immobilization in the attribution of incentive salience in rats

  • Fuentes, Silvia|||0000-0002-8352-1068
  • Carrasco, Javier|||0000-0001-6436-0863
  • Hatto, Abigail
  • Navarro, Juan
  • Armario Garcia, Antonio|||0000-0001-9524-3635
  • Monsonet, Manel|||0000-0003-1898-3212
  • Ortiz de Pablo, Jordi|||0000-0002-9748-2290
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
Early life stress (ELS) induces long-term effects in later functioning and interacts with further exposure to other stressors in adulthood to shape our responsiveness to reward-related cues. The attribution of incentive salience to food-related cues may be modulated by previous and current exposures to stressors in a sex-dependent manner. We hypothesized from human data that exposure to a traumatic (severe) adult stressor will decrease the attribution of incentive salience to reward-associated cues, especially in females, because these effects are modulated by previous ELS. To study these factors in Long-Evans rats, we used as an ELS model of restriction of nesting material and concurrently evaluated maternal care. In adulthood, the offspring of both sexes were exposed to acute immobilization (IMO), and several days after, a Pavlovian conditioning procedure was used to assess the incentive salience of food-related cues. Some rats developed more attraction to the cue predictive of reward (sign-tracking) and others were attracted to the location of the reward itself, the food-magazine (goal-tracking). Several dopaminergic markers were evaluated by in situ hybridization. The results showed that ELS increased maternal care and decreased body weight gain (only in females). Regarding incentive salience, in absolute control animals, females presented slightly greater sign-tracking behavior than males. Non-ELS male rats exposed to IMO showed a bias towards goal-tracking, whereas in females, IMO produced a bias towards sign-tracking. Animals of both sexes not exposed to IMO displayed an intermediate phenotype. ELS in IMO-treated females was able to reduce sign-tracking and decrease tyrosine hydroxylase expression in the ventral tegmental area and dopamine D1 receptor expression in the accumbens shell. Although the predicted greater decrease in females in sign-tracking after IMO exposure was not corroborated by the data, the results highlight the idea that sex is an important factor in the study of the long-term impact of early and adult stressors.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Acute Pharmacological Effects of 2C-B in Humans, An Observational Study

  • Papaseit, Esther|||0000-0003-2620-4274
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Torrens, Marta
  • Ventura, Mireia|||0000-0003-1133-6872
  • Pujadas, Mitona|||0000-0002-0506-3030
  • Torre, Rafael de la|||0000-0002-6765-1866
  • González, Débora|||0000-0002-5353-4351
2,5-dimethoxy-4-bromophenethylamine (2C-B) is a psychedelic phenylethylamine derivative, structurally similar to mescaline. It is a serotonin 5-hydroxytryptamine-2A (5-HT), 5-hydroxytryptamine-2B (5-HT), and 5-hydroxytryptamine-2C (5-HT) receptor partial agonist used recreationally as a new psychoactive substance. It has been reported that 2C-B induces mild psychedelic effects, although its acute pharmacological effects and pharmacokinetics have not yet been fully studied in humans. An observational study was conducted to assess the acute subjective and physiological effects, as well as pharmacokinetics of 2C-B. Sixteen healthy, experienced drug users self-administered an oral dose of 2C-B (10, 15, or 20 mg). Vital signs (blood pressure and heart rate) were measured at baseline 1, 2, 3, 4, and 6 hours (h). Each participant completed subjective effects using three rating scales: the visual analog scale (VAS), the Addiction Research Centre Inventory (ARCI), and the Evaluation of the Subjective Effects of Substances with Abuse Potential (VESSPA-SSE) at baseline, 2-3 and 6 h after self-administration (maximum effects along 6 h), and the Hallucinogenic Rating Scale (maximum effects along 6 h). Oral fluid (saliva) was collected to assess 2C-B and cortisol concentrations during 24 h. Acute administration of 2C-B increased blood pressure and heart rate. Scores of scales related to euphoria increased (high, liking, and stimulated), and changes in perceptions (distances, colors, shapes, and lights) and different body feelings/surrounding were produced. Mild hallucinating effects were described in five subjects. Maximum concentrations of 2C-B and cortisol were reached at 1 and 3 h after self-administration, respectively. Oral 2C-B at recreational doses induces a constellation of psychedelic/psychostimulant-like effects similar to those associated with serotonin-acting drugs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Rituximab, plasma exchange and immunoglobulins, an ineffective treatment for chronic active antibody-mediated rejection

  • Piñeiro, Gastón Julio|||0000-0003-3806-4731
  • De Sousa-Amorim, Erika
  • Solé, Manel|||0000-0003-0131-272X
  • Ríos, José|||0000-0002-0716-8784
  • Lozano, Miquel|||0000-0003-2593-833X
  • Cofan, Frederic|||0000-0003-4163-9620
  • Ventura-Aguiar, Pedro|||0000-0003-3381-7503
  • Cucchiari, David|||0000-0002-7594-1070
  • Revuelta, Ignacio|||0000-0002-3584-4516
  • Cid, Joan|||0000-0001-5445-4508
  • Palou, Eduard|||0000-0003-1544-1485
  • Campistol Plana, Josep M.|||0000-0002-6841-1119
  • Oppenheimer, Federico|||0000-0002-1117-831X
  • Rovira, Jordi|||0000-0001-8737-5005
  • Diekmann, Fritz|||0000-0001-6199-3016
Chronic active antibody-mediated rejection (c-aABMR) is an important cause of allograft failure and graft loss in long-term kidney transplants. To determine the efficacy and safety of combined therapy with rituximab, plasma exchange (PE) and intravenous immunoglobulins (IVIG), a cohort of patients with transplant glomerulopathy (TG) that met criteria of active cABMR, according to BANFF'17 classification, was identified. We identified 62 patients with active c-aABMR and TG (cg ≥ 1). Twenty-three patients were treated with the combination therapy and, 39 patients did not receive treatment and were considered the control group. There were no significant differences in the graft survival between the two groups. The number of graft losses at 12 and 24 months and the decline of eGFR were not different and independent of the treatment. A decrease of eGFR≥13 ml/min between 6 months before and c-aABMR diagnosis, was an independent risk factor for graft loss at 24 months (OR = 5; P = 0.01). Infections that required hospitalization during the first year after c-aABMR diagnosis were significantly more frequent in treated patients (OR = 4.22; P = 0.013), with a ratio infection/patient-year of 0.65 and 0.20 respectively. Treatment with rituximab, PE, and IVIG in kidney transplants with c-aABMR did not improve graft survival and was associated with a significant increase in severe infectious complications.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products

  • Mirabel, Clémentine
  • Puente-Massaguer, Eduard|||0000-0002-2816-7051
  • del Mazo-Barbara, Anna
  • Reyes, Blanca
  • Morton, Philip
  • Gòdia, Francesc|||0000-0002-4060-9887
  • Vives Armengol, Joaquim|||0000-0001-9719-5235
Successful delivery of cell-based therapeutics into patients is compromised by their short shelf-life upon release from production facilities due to the living nature of the active component that rapidly loses viability, and therefore its properties. In this context, the use of appropriate additives may contribute to the stabilisation of the cellular component within specifications for a longer time until administration. In the present study, we evaluated the effect of different formulations on the stability of viability, identity, and potency of clinical grade multipotent mesenchymal stromal cells in suspension, both electrolyte solution and protein content were found to impact on their shelf-life. Particularly cryopreservation of cells in a Plasmalyte 148 supplemented with 2% (w/v) AlbIX (a yeast-derived recombinant albumin) and 10% (v/v) dimethyl sulfoxide, and final formulation post-thawing in Plasmalyte 148 supplemented with 2% (w/v) AlbIX enabling prolonged stability from 24 h up to 72 h in optimal conditions. Further investigation on the mechanisms of action involved revealed a delay of apoptosis progression into late stage when AlbIX was present. The use of optimal formulations for each cell type of interest is crucial to extend the shelf life of cell-based pharmaceuticals and contribute to solve logistical challenges. We demonstrated that the use of Plasmalyte 148 supplemented with 2% (w/v) AlbIX resulted in superior stability of multipotent mesenchymal stromal cells without affecting their identity and multipotency. The online version of this article (10.1186/s12967-018-1659-4) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Drug Interactions With New Synthetic Opioids

  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Papaseit, Esther|||0000-0003-2620-4274
  • Fonseca, Francina|||0000-0002-0779-6545
  • Farré Martínez, Adriana|||0000-0001-5399-9389
  • Torrens, Marta
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
Fentanyl, fentanyl analogs, and other new synthetic opioids (NSO) have burst onto the illegal drug market as new psychoactive substances (NPS). They are often sold as heroin to unsuspecting users and produce euphoria through their agonist action on μ- opioid receptors. Their high consumption, often combined with other substances, has led to multiple intoxications during recent years. In some countries, such as the United States, the consumption of opioids, whether for medical or recreational purposes, has become epidemic and is considered a public health problem. Fentanyl analogs are more potent than fentanyl which in turn is 50 times more potent than morphine. Furthermore, some fentanyl analogs have longer duration of action and therefore interactions with other substances and medicines can be more serious. This review is focused on the potentially most frequent interactions of opioid NPS taking into account the drugs present in the reported cases of poly-intoxication, including other illegal drugs of abuse and medication. Substances involved are mainly antidepressants, antihistamines, antipsychotics, benzodiazepines, analgesics, anesthetics, psychostimulants, other opioids, alcohol, and illegal drugs of abuse. The interactions can be produced due to pharmacokinetic and pharmacodynamic mechanisms. Naloxone can be used as an antidote, although required doses might be higher than for traditional opioid intoxications. It is crucial that doctors who habitually prescribe opioids, which are often misused by patients and NPS users, be aware of designer opioids' potentially life-threatening drug-drug interactions in order to prevent new cases of intoxication.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mesenchymal stem cells for cardiac repair, are the actors ready for the clinical scenario?

  • Roura, Santiago|||0000-0003-4063-9661
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
  • Mirabel, Clémentine
  • Vives Armengol, Joaquim|||0000-0001-9719-5235
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
For years, sufficient progress has been made in treating heart failure following myocardial infarction; however, the social and economic burdens and the costs to world health systems remain high. Moreover, treatment advances have not resolved the underlying problem of functional heart tissue loss. In this field of research, for years we have actively explored innovative biotherapies for cardiac repair. Here, we present a general, critical overview of our experience in using mesenchymal stem cells, derived from cardiac adipose tissue and umbilical cord blood, in a variety of cell therapy and tissue engineering approaches. We also include the latest advances and future challenges, including good manufacturing practice and regulatory issues. Finally, we evaluate whether recent approaches hold potential for reliable translation to clinical trials.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders, Relationship to Psychiatric Comorbidity

  • Pedraz, María
  • Martín-Velasco, Ana Isabel
  • García Marchena, Nuria|||0000-0002-0575-3613
  • Araos, Pedro|||0000-0001-5172-8796
  • Serrano, Antonia
  • Romero-Sanchiz, Pablo
  • Suárez, Juan
  • Castilla-Ortega, Estela
  • Barrios, Vicente
  • Campos-Cloute, Rafael
  • Ruiz, Juan Jesús
  • Torrens, Marta
  • Chowen, Julie A.|||0000-0002-4770-2291
  • Argente, Jesús|||0000-0001-5826-0276
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Santín, Luis Javier
  • Villanúa, María Ángeles
  • Rodríguez de Fonseca, Fernando|||0000-0002-4516-5795
  • Pavón, Francisco Javier
Recent studies have identified biomarkers related to the severity and pathogenesis of cocaine addiction and common comorbid psychiatric disorders. Monitoring these plasma mediators may improve the stratification of cocaine users seeking treatment. Because the neurotrophic factors are involved in neural plasticity, neurogenesis and neuronal survival, we have determined plasma concentrations of brain-derived neurotrophic factor (BDNF), insulin-like growth factor 1 (IGF-1) and IGF-1 binding protein 3 (IGFBP-3) in a cross-sectional study with abstinent cocaine users who sought outpatient treatment for cocaine (n = 100) and age/body mass matched controls (n = 85). Participants were assessed with the diagnostic interview 'Psychiatric Research Interview for Substance and Mental Disorders'. Plasma concentrations of these peptides were not different in cocaine users and controls. They were not associated with length of abstinence, duration of cocaine use or cocaine symptom severity. The pathological use of cocaine did not influence the association of IGF-1 with age observed in healthy subjects, but the correlation between IGF-1 and IGFBP-3 was not significantly detected. Correlation analyses were performed between these peptides and other molecules sensitive to addiction: BDNF concentrations were not associated with inflammatory mediators, lipid derivatives or IGF-1 in cocaine users, but correlated with chemokines (fractalkine/CX3CL1 and SDF-1/CXCL12) and N-acyl-ethanolamines (N-palmitoyl-, N-oleoyl-, N-arachidonoyl-, N-linoleoyl- and N-dihomo-γ-linolenoyl-ethanolamine) in controls; IGF-1 concentrations only showed association with IGFBP-3 concentrations in controls; and IGFBP-3 was only correlated with N-stearoyl-ethanolamine concentrations in cocaine users. Multiple substance use disorders and life-time comorbid psychopathologies were common in abstinent cocaine users. Interestingly, plasma BDNF concentrations were exclusively found to be decreased in users diagnosed with both primary and cocaine-induced disorders for mood and anxiety disorders. In summary, BDNF, IGF-1 and IGFBP-3 were not affected by a history of pathological use of cocaine supported by the absence of associations with other molecules sensitive to cocaine addiction. However, BDNF was affected by comorbid mood disorders. Further research is necessary to elucidate the role of BDNF and IGF-1 in the transition to cocaine addiction and associated psychiatric comorbidity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions

  • González, Débora|||0000-0002-5353-4351
  • Torrens, Marta|||0000-0001-6222-4761
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
Background. 2C-B (Nexus) is one of the most widespread novel psychoactive substances. There is limited information about its pharmacological properties, and few studies in humans concern its acute and chronic effects. 2C-B has been classified as a stimulant, hallucinogen, entactogen, and/or empathogen. Objectives. To evaluate the emotional, subjective, and cardiovascular effects of 2C-B. Methods. Twenty healthy recreational 2C-B users (12 women) self-administered a 20 mg dose of 2C-B. Evaluations included emotional (IAPS, FERT, and speech), subjective (visual analog scales, ARCI, VESSPA, HRS, and POMS questionnaires), and cardiovascular effects (blood pressure and heart rate). Results. Positive subjective effects predominated with a reduction of anger under the influence of 2C-B. It did, however, increase reactivity to negative emotional stimuli and decrease the ability to recognize expressions of happiness. Augmented emotionality in speech could be appreciated by others. 2C-B induced euphoria and well-being, changes in perceptions, and slight hallucinogenic states. Mild sympathetic actions were observed. Conclusions. The specific profile that 2C-B exerts on emotions suggests its classification as an entactogen with psychedelic properties.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cross sectional study of factors associated to self-reported blood-borne infections among drug users

  • Reyes-Urueña, Juliana|||0000-0002-3122-6518
  • Brugal, María Teresa|||0000-0003-0580-676X
  • Majo, Xavier
  • Domingo Salvany, Antònia|||0000-0003-3302-4538
  • Caylà, Joan A.|||0000-0003-3891-111X
The study's aim was to estimate the self-reported prevalence of Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV), and to describe their associated risk factors in a population of users of illicit drugs recruited in Catalonia- Spain, during 2012. Cross-sectional study. People with illicit drugs use were selected in three different types of healthcare centres. The questionnaire was a piloted, structured ad hoc instrument. An analysis was made to identify factors associated to self-reported HCV, HIV and co-infection. Correlates of reported infections were determined using univariate and multivariate Poisson regression (with robust variance). Among 512 participants, 39.65 % self-reported positive serostatus for HCV and 14.84 % for HIV, co-infection was reported by 13.48 %. Among the 224 injecting drug users (IDUs), 187 (83.48 %), 68 (30.36 %) and 66 (29.46 %) reported being positive for HCV, HIV and co-infection, respectively. A higher proportion of HIV-infected cases was observed among women, (18.33 % vs. 13.78 % in men). Prevalence of HCV, HIV and co-infection were higher among participants with early onset of drug consumption, long periods of drug injection or who were unemployed. A positive serostatus was self-reported by 21(7.34 %) participants who did not report any injection; among them 16 and eight, reported being positive for HCV and HIV, respectively; three reported co-infection. Only two people declared exchanging sex for money. For those that reported a negative test, the median time since the last HIV test was 11.41 months (inter-quartile range (IQR) 4-12) and for the HCV test was 4.5 months (IQR 2-7). Among drug users in Catalonia, HIV, HCV and co-infection prevalence are still a big issue especially among IDUs. Women and drug users who have never injected drugs are groups with a significant risk of infection; this might be related to their high-risk behaviours and to being unaware of their serological status.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Relationship between the Use of Inhaled Steroids for Chronic Respiratory Diseases and Early Outcomes in Community-Acquired Pneumonia

  • Almirall i Pujol, Jordi|||0000-0002-3821-4341
  • Bolibar i Ribas, Ignasi|||0000-0002-4529-1935
  • Serra-Prat, Mateu|||0000-0002-6554-9913
  • Palomera, Elisabet|||0000-0002-4384-5746
  • Roig, Jordi
  • Hospital, Imma
  • Carandell, Eugenia
  • Agustí, Mercè
  • Ayuso, Pilar
  • Estela, Andreu
  • Torres, Antoni|||0000-0002-8643-2167
The role of inhaled steroids in patients with chronic respiratory diseases is a matter of debate due to the potential effect on the development and prognosis of community-acquired pneumonia (CAP). We assessed whether treatment with inhaled steroids in patients with chronic bronchitis, COPD or asthma and CAP may affect early outcome of the acute pneumonic episode. Over 1-year period, all population-based cases of CAP in patients with chronic bronchitis, COPD or asthma were registered. Use of inhaled steroids were registered and patients were followed up to 30 days after diagnosis to assess severity of CAP and clinical course (hospital admission, ICU admission and mortality). Of 473 patients who fulfilled the selection criteria, inhaled steroids were regularly used by 109 (23%). In the overall sample, inhaled steroids were associated with a higher risk of hospitalization (OR=1.96, p = 0.002) in the bivariate analysis, but this effect disappeared after adjusting by other severity-related factors (adjusted OR=1.08, p=0.787). This effect on hospitalization also disappeared when considering only patients with asthma (OR=1.38, p=0.542), with COPD alone (OR=4.68, p=0.194), but a protective effect was observed in CB patients (OR=0.15, p=0.027). Inhaled steroids showed no association with ICU admission, days to clinical recovery and mortality in the overall sample and in any disease subgroup. Treatment with inhaled steroids is not a prognostic factor in COPD and asthmatic patients with CAP, but could prevent hospitalization for CAP in patients with clinical criteria of chronic bronchitis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4 + Diffuse Large B-Cell Lymphoma Cells

  • Falgàs, Aïda|||0000-0002-5040-2265
  • Pallarès, Victor|||0000-0002-9851-0345
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Núñez, Yáiza|||0000-0001-7268-2125
  • Sierra, Jorge|||0000-0002-7966-0356
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Mangues, Ma Antonia|||0000-0002-1438-8515
  • Álamo, Patricia|||0000-0003-0510-5701
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
Around 40-50% of diffuse large-B cell lymphoma (DLBCL) patients suffer from refractory disease or relapse after R-CHOP first-line treatment. Many ongoing clinical trials for DLBCL patients involve microtubule targeting agents (MTAs), however, their anticancer activity is limited by severe side effects. Therefore, we chose to improve the therapeutic window of the MTA monomethyl auristatin E developing a nanoconjugate, T22-AUR, that selectively targets the CXCR4 receptor, which is overexpressed in many DLBCL cells (CXCR4 +) and associated with poor prognosis. The T22-AUR specificity towards CXCR4 receptor was performed by flow cytometry in different DLBCL cell lines and running biodistribution assays in a subcutaneous mouse model bearing CXCR4 + DLBCL cells. Moreover, we determined T22-AUR cytotoxicity using cell viability assays, cell cycle analysis, DAPI staining and immunohistochemistry. Finally, the T22-AUR antineoplastic effect was evaluated in vivo in an extranodal CXCR4 + DLBCL mouse model whereas the toxicity analysis was assessed by histopathology in non-infiltrated mouse organs and by in vitro cytotoxic assays in human PBMCs. We demonstrate that the T22-AUR nanoconjugate displays CXCR4-dependent targeting and internalization in CXCR4 + DLBCL cells in vitro as well as in a subcutaneous DLBCL mouse model. Moreover, it shows high cytotoxic effect in CXCR4 + DLBCL cells, including induction of G2/M mitotic arrest, DNA damage, mitotic catastrophe and apoptosis. Furthermore, the nanoconjugate shows a potent reduction in lymphoma mouse dissemination without histopathological alterations in non-DLBCL infiltrated organs. Importantly, T22-AUR also exhibits lack of toxicity in human PBMCs. T22-AUR exerts in vitro and in vivo anticancer effect on CXCR4 + DLBCL cells without off-target toxicity. Thus, T22-AUR promises to become an effective therapy for CXCR4 + DLBCL patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

  • Esquirol, Albert|||0000-0002-6062-5980
  • Pascual, Maria Jesús|||0000-0002-9859-0816
  • Kwon, Mi|||0000-0002-3855-7774
  • Pérez, Ariadna
  • Parody Porras, Rocío
  • Ferrá, Christelle|||0000-0003-4571-5125
  • García Cadenas, Irene|||0000-0002-2994-9055
  • Herruzo, Beatriz
  • Dorado-Herrero, Nieves
  • Hernani, Rafael|||0000-0003-1043-8076
  • Sánchez Ortega, Isabel
  • Torrent Catarineu, Anna|||0000-0002-3727-5716
  • Sierra, Jorge|||0000-0002-7966-0356
  • Martino Bofarull, Rodrigo|||0000-0001-5143-4042
Severe infections and their attributable mortality are major complications in recipients of allogeneic hematopoietic stem cell transplantation (alloSCT). We herein report 236 adult patients who received haploSCT with PTCy. The median follow-up for survivors was 37 months. The overall incidence of bloodstream infections by gram-positive and gram-negative bacteria at 37 months was 51% and 46%, respectively. The incidence of cytomegalovirus infection was 69%, while Epstein Barr virus infections occurred in 10% of patients and hemorrhagic cystitis in 35% of cases. Invasive fungal infections occurred in 11% at 17 months. The 3-year incidence of infection-related mortality was 19%. The median interval from transplant to IRM was 3 months (range 1-30), 53% of IRM occurred.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control

  • Moyano, Ana
  • Blanch-Lombarte, Oscar|||0000-0002-8317-7535
  • Tarancon-Diez, Laura
  • Pedreño López, Núria|||0000-0001-6927-2301
  • Arenas, Miguel
  • Alvaro, Tamara
  • Casado, Concepcion
  • Olivares, Isabel
  • Vera, Mar|||0000-0002-3841-7747
  • Rodriguez, Carmen
  • Del Romero, Jorge
  • López-Galíndez, Cecilio|||0000-0002-2324-9584
  • Ruiz-Mateos, Ezequiel|||0000-0001-6747-7813
  • Prado, Julia G.|||0000-0002-5439-4645
  • Pernas, María
Long-Term Non-Progressors (LTNPs) are untreated Human Immunodeficiency virus type 1 (HIV-1) infected individuals able to control disease progression for prolonged periods. However, the LTNPs status is temporary, as viral load increases followed by decreases in CD4 + T-cell counts. Control of HIV-1 infection in LTNPs viremic controllers, have been associated with effective immunodominant HIV-1 Gag-CD8 + T-cell responses restricted by protective HLA-B alleles. Individuals carrying HLA-B*14:02 control HIV-1 infection is related to an immunodominant Env-CD8 + T-cell response. Limited data are available on the contribution of HLA-B*14:02 CD8 + T -cells in LTNPs. In this study, we performed a virological and immunological detailed analysis of an HLA-B*14:02 LNTP individual that lost viral control (LVC) 27 years after HIV-1 diagnosis. We analysed viral evolution and immune escape in HLA-B*14:02 restricted CD8 + T -cell epitopes and identified viral evolution at the Env-EL9 epitope selecting the L592R mutation. By IFN-γ ELISpot and immune phenotype, we characterized HLA- B*14:02 HIV-1 CD8 + T cell responses targeting, Gag-DA9 and Env-EL9 epitopes before and after LVC. We observed an immunodominant response against the Env-EL9 epitope and a decreased of the CD8 T + cell response over time with LVC. Loss of Env-EL9 responses was concomitant with selecting K588R + L592R mutations at Env-EL9. Finally, we evaluated the impact of Env-EL9 escape mutations on HIV-1 infectivity and Env protein structure. The K588R + L592R escape variant was directly related to HIV-1 increase replicative capacity and stability of Env at the LVC. These findings support the contribution of immunodominant Env-EL9 CD8 + T-cell responses and the imposition of immune escape variants with higher replicative capacity associated with LVC in this LNTP. These data highlight the importance of Env-EL9 specific-CD8 + T-cell responses restricted by the HLA-B*14:02 and brings new insights into understanding long-term HIV-1 control mediated by Env mediated CD8 + T-cell responses. The online version contains supplementary material available at 10.1186/s12977-022-00591-7.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model

  • Pallarès, Victor|||0000-0002-9851-0345
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Falgàs, Aïda|||0000-0002-5040-2265
  • Aviñó, Ana|||0000-0003-3047-738X
  • Núñez, Yáiza|||0000-0001-7268-2125
  • Garcia León, Annabel|||0000-0003-3007-9306
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Álamo, Patricia|||0000-0003-0510-5701
  • Sierra, Jorge|||0000-0002-7966-0356
  • Cedó, Lídia|||0000-0003-4354-3411
  • Eritja, Ramon|||0000-0001-5383-9334
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Mangues, Ramon|||0000-0003-2661-9525
Current therapy in acute myeloid leukemia (AML) is based on chemotherapeutic drugs administered at high doses, lacking targeting selectivity and displaying poor therapeutic index because of severe adverse effects. Here, we develop a novel nanoconjugate that combines a self-assembled, multivalent protein nanoparticle, targeting the CXCR4 receptor, with an Oligo-Ara-C prodrug, a pentameric form of Ara-C, to highly increase the delivered payload to target cells. This 13.4 nm T22-GFP-H6-Ara-C nanoconjugate selectively eliminates CXCR4 AML cells, which are protected by its anchoring to the bone marrow (BM) niche, being involved in AML progression and chemotherapy resistance. This nanoconjugate shows CXCR4-dependent internalization and antineoplastic activity in CXCR4 AML cells in vitro. Moreover, repeated T22-GFP-H6-Ara-C administration selectively eliminates CXCR4 leukemic cells in BM, spleen and liver. The leukemic dissemination blockage induced by T22-GFP-H6-Ara-C is significantly more potent than buffer or Oligo-Ara-C-treated mice, showing no associated on-target or off-target toxicity and, therefore, reaching a highly therapeutic window. In conclusion, T22-GFP-H6-Ara-C exploits its 11 ligands-multivalency to enhance target selectivity, while the Oligo-Ara-C prodrug multimeric form increases 5-fold its payload. This feature combination offers an alternative nanomedicine with higher activity and greater tolerability than current intensive or non-intensive chemotherapy for AML patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Combining Three Different Pretransplantation Scores Improves Predictive Value in Patients after Haploidentical Stem Cell Transplantation with Thiotepa, Busulfan, and Fludarabine Conditioning and Post-Transplantation Cyclophosphamide

  • Esquirol, Albert|||0000-0002-6062-5980
  • Pascual, Maria Jesus
  • García Cadenas, Irene|||0000-0002-2994-9055
  • Herruzo, Beatriz
  • Ferrá, Christelle|||0000-0003-4571-5125
  • Pérez, Ariadna
  • Torio, Alberto
  • Torrent Catarineu, Anna|||0000-0002-3727-5716
  • Cuesta, Marian
  • Martino Bofarull, Rodrigo|||0000-0001-5143-4042
  • Sierra, Jorge|||0000-0002-7966-0356
One hundred and sixty-one patients underwent haploidentical stem cell transplantation (haploSCT) with thiotepa, busulfan, and fludarabine conditioning followed by post-transplantation cyclophosphamide (PTCy) (on days +3 and +4) and tacrolimus as graft-versus-host disease prophylaxis. Forty-two percent of patients had a high or very high revised Disease Risk Index (rDRI), 55% had an European Society for Blood and Marrow Transplantation risk score (EBMT-RS) ≥4, and 36% had an age-adjusted Hematopoietic Cell Transplant Comorbidity Index (HCT-CI-age) score ≥3. Each of these was considered an unfavorable score. Using the pretransplantation unfavorable scores that had an independent impact on each transplantation outcome studied in multivariate analysis allowed for better stratification of patient outcomes. Thus, the 3-year overall survival (OS) in patients with 0, 1, 2, and 3 unfavorable scores was 86%, 56%, 36%, and 24%, respectively. Nonrelapse mortality (NRM) was negatively impacted by the EBMT-RS and the HCT-CI-age score (3-year NRM in patients with 0, 1, and 2 unfavorable scores was 12%, 33%, and 43%, respectively), whereas the EBMT-RS and the rDRI had an impact on the 3-year relapse incidence (8%, 18%, and 41% in patients with 0, 1, and 2 unfavorable scores, respectively). In conclusion, our study shows that combining 2 or 3 of these well-defined pretransplantation scores improves the ability to predict transplantation outcomes in the setting of haploSCT with PTCy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4+ lymphoma cells without toxicity in immunocompromised and immunocompetent mice

  • Falgàs, Aïda|||0000-0002-5040-2265
  • Garcia León, Annabel|||0000-0003-3007-9306
  • Núñez, Yáiza|||0000-0001-7268-2125
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Aragó, Marc|||0000-0002-9645-0131
  • Álamo, Patricia|||0000-0003-0510-5701
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Sierra, Jorge|||0000-0002-7966-0356
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
High rates of relapsed and refractory diffuse large B-cell lymphoma (DLBCL) patients and life-threatening side effects associated with immunochemotherapy make an urgent need to develop new therapies for DLBCL patients. Immunotoxins seem very potent anticancer therapies but their use is limited because of their high toxicity. Accordingly, the self-assembling polypeptidic nanoparticle, T22-DITOX-H6, incorporating the diphtheria toxin and targeted to CXCR4 receptor, which is overexpressed in DLBCL cells, could offer a new strategy to selectively eliminate CXCR4 DLBCL cells without adverse effects. In these terms, our work demonstrated that T22-DITOX-H6 showed high specific cytotoxicity towards CXCR4 DLBCL cells at the low nanomolar range, which was dependent on caspase-3 cleavage, PARP activation and an increase of cells in early/late apoptosis. Repeated nanoparticle administration induced antineoplastic effect, in vivo and ex vivo, in a disseminated immunocompromised mouse model generated by intravenous injection of human luminescent CXCR4 DLBCL cells. Moreover, T22-DITOX-H6 inhibited tumor growth in a subcutaneous immunocompetent mouse model bearing mouse CXCR4 lymphoma cells in the absence of alterations in the hemogram, liver or kidney injury markers or on-target or off-target organ histology. Thus, T22-DITOX-H6 demonstrates a selective cytotoxicity towards CXCR4 DLBCL cells without the induction of toxicity in non-lymphoma infiltrated organs nor hematologic toxicity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers

  • Garrido-Giménez, Carmen|||0000-0003-2180-1715
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Álvarez Menéndez, Francisco V.|||0000-0002-2553-5402
  • Nan, Madalina Nicoleta|||0009-0001-2794-447X
  • Carretero, Francisco
  • Fernández-Oliva, Antonio|||0000-0002-8610-2600
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Sánchez García, Olga|||0000-0002-5279-440X
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Alijotas-Reig, Jaume|||0000-0002-9212-3619
  • Llurba, Elisa|||0000-0003-4048-6407
N-terminal pro-brain natriuretic peptide (NT-proBNP) and uric acid are elevated in pregnancies with preeclampsia (PE). Short-term prediction of PE using angiogenic factors has many false-positive results. Our objective was to validate a machine-learning model (MLM) to predict PE in patients with clinical suspicion, and evaluate if the model performed better than the sFlt-1/PlGF ratio alone. A multicentric cohort study of pregnancies with suspected PE between 24 +0 and 36 +6 weeks was used. The MLM included six predictors: gestational age, chronic hypertension, sFlt-1, PlGF, NT-proBNP, and uric acid. A total of 936 serum samples from 597 women were included. The PPV of the MLM for PE following 6 weeks was 83.1% (95% CI 78.5-88.2) compared to 72.8% (95% CI 67.4-78.4) for the sFlt-1/PlGF ratio. The specificity of the model was better; 94.9% vs. 91%, respectively. The AUC was significantly improved compared to the ratio alone [0.941 (95% CI 0.926-0.956) vs. 0.901 (95% CI 0.880-0.921), p < 0.05]. For prediction of preterm PE within 1 week, the AUC of the MLM was 0.954 (95% CI 0.937-0.968); significantly greater than the ratio alone [0.914 (95% CI 0.890-0.934), p < 0.01]. To conclude, an MLM combining the sFlt-1/PlGF ratio, NT-proBNP, and uric acid performs better to predict preterm PE compared to the sFlt-1/PlGF ratio alone, potentially increasing clinical precision.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Inhaled amikacin for pneumonia treatment and dissemination prevention, an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia

  • Motos, Ana|||0000-0002-3757-1232
  • Yang, Hua
  • Li Bassi, Gianluigi
  • Yang, Minlan
  • Meli, Andrea
  • Battaglini, Denise
  • Cabrera, Roberto
  • Bobi, Joaquim|||0000-0002-9026-5226
  • Pagliara, Francesco
  • Frigola, Gerard|||0000-0001-6794-6456
  • Camprubí-Rimblas, Marta|||0000-0002-4085-5324
  • Fernández Barat, Laia|||0000-0001-7528-9636
  • Rigol, Montserrat
  • Ferrer-Segarra, Antoni
  • Kiarostami, Kasra
  • Martínez Hernández, Daniel|||0000-0001-7492-5311
  • Nicolau, David P.
  • Artigas Raventós, Antoni|||0000-0002-8029-1017
  • Pelosi, Paolo|||0000-0001-5055-3023
  • Vila Estapé, Jordi|||0000-0002-8025-3926
  • Torres, Antoni|||0000-0002-8643-2167
Pseudomonas aerugino sa pneumonia is commonly treated with systemic antibiotics to ensure adequate treatment of multidrug resistant (MDR) bacteria. However, intravenous (IV) antibiotics often achieve suboptimal pulmonary concentrations. We therefore aimed to evaluate the effect of inhaled amikacin (AMK) plus IV meropenem (MEM) on bactericidal efficacy in a swine model of monolateral MDR P. aeruginosa pneumonia. We ventilated 18 pigs with monolateral MDR P. aeruginosa pneumonia for up to 102 h. At 24 h after the bacterial challenge, the animals were randomized to receive 72 h of treatment with either inhaled saline (control), IV MEM only, or IV-MEM plus inhaled AMK (MEM + AMK). We dosed IV MEM at 25 mg/kg every 8 h and inhaled AMK at 400 mg every 12 h. The primary outcomes were the P. aeruginosa burden and histopathological injury in lung tissue. Secondary outcomes included the P. aeruginosa burden in tracheal secretions and bronchoalveolar lavage fluid, the development of antibiotic resistance, the antibiotic distribution, and the levels of inflammatory markers. The median (25-75th percentile) P. aeruginosa lung burden for animals in the control, MEM only, and MEM + AMK groups was 2.91 (1.75-5.69), 0.72 (0.12-3.35), and 0.90 (0-4.55) log CFU/g (p = 0.009). Inhaled therapy had no effect on preventing dissemination compared to systemic monotherapy, but it did have significantly higher bactericidal efficacy in tracheal secretions only. Remarkably, the minimum inhibitory concentration of MEM increased to.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo

  • Núñez, Yáiza|||0000-0001-7268-2125
  • Garcia León, Annabel|||0000-0003-3007-9306
  • Falgàs, Aïda|||0000-0002-5040-2265
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Sierra, Jorge|||0000-0002-7966-0356
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
Despite advances in the development of targeted therapies for acute myeloid leukemia (AML), most patients relapse. For that reason, it is still necessary to develop novel therapies that improve treatment effectiveness and overcome drug resistance. We developed T22-PE24-H6, a protein nanoparticle that contains the exotoxin A from the bacterium Pseudomonas aeruginosa and is able to specifically deliver this cytotoxic domain to CXCR4 + leukemic cells. Next, we evaluated the selective delivery and antitumor activity of T22-PE24-H6 in CXCR4 + AML cell lines and BM samples from AML patients. Moreover, we assessed the in vivo antitumor effect of this nanotoxin in a disseminated mouse model generated from CXCR4 + AML cells. T22-PE24-H6 showed a potent, CXCR4-dependent antineoplastic effect in vitro in the MONO-MAC-6 AML cell line. In addition, mice treated with nanotoxins in daily doses reduced the dissemination of CXCR4 + AML cells compared to buffer-treated mice, as shown by the significant decrease in BLI signaling. Furthermore, we did not observe any sign of toxicity or changes in mouse body weight, biochemical parameters, or histopathology in normal tissues. Finally, T22-PE24-H6 exhibited a significant inhibition of cell viability in CXCR4 high AML patient samples but showed no activity in CXCR4 low samples. These data strongly support the use of T22-PE24-H6 therapy to benefit high-CXCR4-expressing AML patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus

  • Rodríguez-Calvo, Ricardo|||0000-0001-7513-0983
  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Pérez-Montes de Oca, Alejandra|||0000-0001-8807-1935
  • Julián, María Teresa|||0000-0003-2524-1823
  • Domingo, Mar|||0000-0002-2935-1272
  • Codina, Pau|||0000-0002-2469-5711
  • Santiago Vacas, Evelyn|||0000-0001-7511-406X
  • Cediel, Germán|||0000-0001-9667-7507
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Rossell, Joana|||0000-0003-1500-6379
  • Masana, Luis|||0000-0002-0789-4954
  • Mauricio, Didac|||0000-0002-2868-0250
  • Lupón, Josep|||0000-0002-5601-9611
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
Subjects with type 2 diabetes mellitus (T2D) are at increased risk for heart failure (HF). The cardiac-specific (FABP3) and adipose-tissue-specific (FABP4) types of the fatty acid binding proteins have been associated with both all-cause and cardiovascular (CV) mortality. The aim of this study was to explore the prognosis value of FABP3 and FABP4 in ambulatory subjects with chronic HF (CHF), with and without T2D. A prospective study involving 240 ambulatory CHF subjects was performed. Patients were followed-up for a mean of 5.78 ± 3.30 years and cause of death (if any) was recorded. Primary endpoints were defined as all-cause and CV death, and a composite endpoint that included CV death or hospitalization for HF was included as a secondary endpoint. Baseline serum samples were obtained and the serum FABP3 and FABP4 concentrations were assessed by sandwich enzyme-linked immunosorbent assay. Survival analysis was performed with multivariable Cox regressions, using Fine and Gray competing risks models when needed, to explore the prognostic value of FABP3 and FABP4 concentrations, adjusting for potential confounders. Type 2 diabetes mellitus was highly prevalent, accounting for 47.5% for total subjects with CHF. Subjects with T2D showed higher mortality rates (T2D: 69.30%; non-T2D: 50.79%, p = 0.004) and higher serum FABP3 (1829.3 (1104.9-3440.5) pg/mL vs. 1396.05 (820.3-2362.16) pg/mL, p = 0.007) and FABP4 (45.5 (27.6-79.8) ng/mL vs. 34.1 (24.09-55.3) ng/mL, p = 0.006) concentrations compared with non-T2D CHF subjects. In the whole study cohort, FABP3 was independently associated with all-cause death, and both FABP3 and FABP4 concentrations were associated with CV mortality. The predictive values of these two molecules for all-cause (FABP3: HR 1.25, 95% CI 1.09-1.44; p = 0.002. FABP4: HR 2.21, 95% CI 1.12-4.36; p = 0.023) and CV mortality (FABP3: HR 1.28, 95% CI 1.09-1.50; p = 0.002. FABP4: HR 4.19, 95% CI 2.21-7.95; p < 0.001) were only statistically significant in the subgroup of subjects with T2D. Notably, FABP4 (HR 2.07, 95% CI 1.11-3.87; p = 0.022), but not FABP3, also predicted the occurrence of the composite endpoint (death or hospitalization for HF) only in subjects with T2D. All these associations were not found in CHF subjects without T2D. Our findings support the usefulness of serum FABP3 and FABP4 concentrations as independent predictors for the occurrence of all-cause and CV mortality in ambulatory subjects with CHF with T2D.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Longitudinal Behavior of Left-Ventricular Strain in Fetal Growth Restriction

  • Domínguez Gallardo, Carla|||0000-0002-5365-1005
  • Ginjaume García, Nuria|||0000-0003-0785-0115
  • Ullmo, Johana|||0000-0002-9313-917X
  • Fernández-Oliva, Antonio|||0000-0002-8610-2600
  • Parra Roca, Juan|||0000-0001-6011-7815
  • Vázquez Fariñas, Ana|||0000-0001-6732-1667
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
Fetal growth restriction (FGR) is associated with an increased risk of adverse outcomes resulting from adaptive cardiovascular changes in conditions of placental insufficiency, leading to cardiac deformation and dysfunction, which can be evaluated with 2D speckle tracking echocardiography (2D-STE). The aim of the present study was to evaluate whether reduced fetal growth is associated with cardiac left-ventricle (LV) dysfunction, using 2D-STE software widely used in postnatal echocardiography. A prospective longitudinal cohort study was performed, and global (GLO) and segmental LV longitudinal strain was measured offline and compared between FGR and appropriate-for-gestational-age (AGA) fetuses throughout gestation. All cases of FGR fetuses were paired 1:2 to AGA fetuses, and linear mixed model analysis was performed to compare behavior differences between groups throughout pregnancy. Our study shows LV fetal longitudinal strain in FGR and AGA fetuses differed upon diagnosis and behaved differently throughout gestation. FGR fetuses had lower LV strain values, both global and segmental, in comparison to AGA, suggesting subclinical cardiac dysfunction. Our study provides more data regarding fetal cardiac function in cases of placental dysfunction, as well as highlights the potential use of 2D-STE in the follow-up of cardiac function in these fetuses.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association of circulating microRNAs with coronary artery disease and usefulness for reclassification of healthy individuals, The REGICOR study

  • Degano, Irene R.|||0000-0003-1914-6934
  • Camps-Vilaró, Anna|||0000-0001-9644-8421
  • Subirana, Isaac|||0000-0003-1676-0197
  • García-Mateo, Nadia
  • Cidad, Pilar
  • Muñoz Aguayo, Daniel|||0000-0001-8173-0168
  • Puigdecanet, Eulàlia|||0000-0001-6067-9332
  • Nonell, Lara|||0000-0002-8538-8213
  • Vila-Domènech, Joan Salvador|||0000-0002-0413-9291
  • Crepaldi, Felipe Mingorance|||0000-0002-8500-1162
  • Gonzalo Calvo, David de|||0000-0003-2240-3532
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
  • Pérez-García, María Teresa|||0000-0001-8540-8117
  • Elosua, Roberto|||0000-0001-8235-0095
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Marrugat, Jaume|||0000-0003-3320-554X
Risk prediction tools cannot identify most individuals at high coronary artery disease (CAD) risk. Oxidized low-density lipoproteins (oxLDLs) and microRNAs are actively involved in atherosclerosis. Our aim was to examine the association of CAD and oxLDLs-induced microRNAs, and to assess the microRNAs predictive capacity of future CAD events. Human endothelial and vascular smooth muscle cells were treated with oxidized/native low-density lipoproteins, and microRNA expression was analyzed. Differentially expressed and CAD-related miRNAs were examined in serum samples from (1) a case-control study with 476 myocardial infarction (MI) patients and 487 controls, and (2) a case-cohort study with 105 incident CAD cases and 455 randomly-selected cohort participants. MicroRNA expression was analyzed with custom OpenArray plates, log rank tests and Cox regression models. Twenty-one microRNAs, two previously undescribed (hsa-miR-193b-5p and hsa-miR-1229-5p), were up- or down-regulated upon cell treatment with oxLDLs. One of the 21, hsa-miR-122-5p, was also upregulated in MI cases (fold change = 4.85). Of the 28 CAD-related microRNAs tested, 11 were upregulated in MI cases -1 previously undescribed (hsa-miR-16-5p)-, and 1/11 was also associated with CAD incidence (adjusted hazard ratio = 0.55 (0.35-0.88)) and improved CAD risk reclassification, hsa-miR-143-3p. We identified 2 novel microRNAs modulated by oxLDLs in endothelial cells, 1 novel microRNA upregulated in AMI cases compared to controls, and one circulating microRNA that improved CAD risk classification.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A functional virgin olive oil enriched with olive oil and thyme phenolic compounds improves the expression of cholesterol efflux-related genes, A randomized, crossover, controlled trial

  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Arranz, Sara|||0000-0003-2397-5145
  • Carrión, Silvia|||0000-0002-1354-2488
  • Subirana, Isaac|||0000-0003-1676-0197
  • Muñoz Aguayo, Daniel|||0000-0001-8173-0168
  • Blanchart, Gemma|||0000-0003-1965-8235
  • Kool, Marjon
  • Solà, Rosa|||0000-0002-8359-235X
  • Motilva, María José
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Rubió, Laura
  • Fernández-Castillejo, Sara|||0000-0002-8109-9713
  • Pedret, Anna
  • Estruch, Ramón|||0000-0003-1260-4445
  • Covas Planells, Maria Isabel
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Hernáez, Álvaro|||0000-0001-8593-1477
  • Castañer, Olga|||0000-0003-3169-997X
The consumption of antioxidant-rich foods such as virgin olive oil (VOO) promotes high-density lipoprotein (HDL) anti-atherogenic capacities. Intake of functional VOOs (enriched with olive/thyme phenolic compounds (PCs)) also improves HDL functions, but the gene expression changes behind these benefits are not fully understood. Our aim was to determine whether these functional VOOs could enhance the expression of cholesterol efflux-related genes. In a randomized, double-blind, crossover, controlled trial, 22 hypercholesterolemic subjects ingested for three weeks 25 mL/day of: (1) a functional VOO enriched with olive oil PCs (500 mg/kg); (2) a functional VOO enriched with olive oil (250 mg/kg) and thyme PCs (250 mg/kg; FVOOT), and; (3) a natural VOO (olive oil PCs: 80 mg/kg, control intervention). We assessed whether these interventions improved the expression of cholesterol efflux-related genes in peripheral blood mononuclear cells by quantitative reverse-transcription polymerase chain reactions. The FVOOT intervention upregulated the expression of CYP27A1 (P = 0.041 and P = 0.053, versus baseline and the control intervention, respectively), CAV1 (P = 0.070, versus the control intervention), and LXRβ, RXRα, and PPARβ/δ (P = 0.005, P = 0.005, and P = 0.038, respectively, relative to the baseline). The consumption of a functional VOO enriched with olive oil and thyme PCs enhanced the expression of key cholesterol efflux regulators, such as CYP27A1 and nuclear receptor-related genes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis

  • Clemente, Cristina
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Alonso-Herranz, Laura
  • Martín-Alonso, Mara
  • Pollán, Ángela
  • Camafeita, Emilio|||0000-0002-4577-5331
  • Martínez, Fernando|||0000-0003-1904-5164
  • Mota, Rubén A.
  • Núñez, Vanessa
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Seiki, Motoharu
  • Martínez-González, José|||0000-0002-3894-7166
  • Andrés, Vicente|||0000-0002-0125-7209
  • Ricote, Mercedes
  • Arroyo, Alicia G.
Matrix metalloproteinases are involved in vascular remodeling. Little is known about their immune regulatory role in atherosclerosis. Here we show that mice deficient for MT4-MMP have increased adherence of macrophages to inflamed peritonea, and larger lipid deposits and macrophage burden in atherosclerotic plaques. We also demonstrate that MT4-MMP deficiency results in higher numbers of patrolling monocytes crawling and adhered to inflamed endothelia, and the accumulation of Mafb+ apoptosis inhibitor of macrophage (AIM)+ macrophages at incipient atherosclerotic lesions in mice. Functionally, MT4-MMP-null Mafb+AIM+ peritoneal macrophages express higher AIM and scavenger receptor CD36, are more resistant to apoptosis, and bind acLDL avidly, all of which contribute to atherosclerosis. CCR5 inhibition alleviates these effects by hindering the enhanced recruitment of MT4-MMP-null patrolling monocytes to early atherosclerotic lesions, thus blocking Mafb+AIM+ macrophage accumulation and atherosclerosis acceleration. Our results suggest that MT4-MMP targeting may constitute a novel strategy to boost patrolling monocyte activity in early inflammation.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Adaptation of the hypothalamus-pituitary-adrenal axis to daily repeated stress does not follow the rules of habituation, A new perspective

  • Rabasa, Cristina
  • Gagliano, Humberto Antonio|||0000-0001-8727-9080
  • Pastor Ciurana, Jordi
  • Fuentes, Silvia|||0000-0002-8352-1068
  • Belda, Xavier|||0000-0003-0374-9546
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
  • Armario Garcia, Antonio|||0000-0001-9524-3635
Repeated exposure to a wide range of stressors differing in nature and intensity results in a reduced response of prototypical stress markers (i.e. plasma levels of ACTH and adrenaline) after an acute challenge with the same (homotypic) stressor. This reduction has been considered to be a habituation-like phenomenon. However, direct experimental evidence for this assumption is scarce. In the present work we demonstrate in adult male rats that adaptation of the hypothalamus-pituitary-adrenal (HPA) axis to repeated stress does not follow some of the critical rules of habituation. Briefly, adaptation was stronger and faster with more severe stressors, maximally observed even with a single exposure to severe stressors, extremely long-lasting, negatively related to the interval between the exposures and positively related to the length of daily exposure. We offer a new theoretical view to explain adaptation to daily repeated stress.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Early life stress in rats sex-dependently affects remote endocrine rather than behavioral consequences of adult exposure to contextual fear conditioning

  • Fuentes, Silvia|||0000-0002-8352-1068
  • Daviu, Núria|||0000-0002-9843-2981
  • Gagliano, Humberto Antonio|||0000-0001-8727-9080
  • Belda, Xavier|||0000-0003-0374-9546
  • Armario Garcia, Antonio|||0000-0001-9524-3635
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
Exposure to electric foot-shocks can induce in rodents contextual fear conditioning, generalization of fear to other contexts and sensitization of the hypothalamic-pituitary-adrenal (HPA) axis to further stressors. All these aspects are relevant for the study of post-traumatic stress disorder. In the present work we evaluated in rats the sex differences and the role of early life stress (ELS) in fear memories, generalization and sensitization. During the first postnatal days subjects were exposed to restriction of nesting material along with exposure to a "substitute" mother. In the adulthood they were exposed to (i) a contextual fear conditioning to evaluate long-term memory and extinction and (ii) to a novel environment to study cognitive fear generalization and HPA axis heterotypic sensitization. ELS did not alter acquisition, expression or extinction of context fear conditioned behavior (freezing) in either sex, but reduced activity in novel environments only in males. Fear conditioning associated hypoactivity in novel environments (cognitive generalization) was greater in males than females but was not specifically affected by ELS. Although overall females showed greater basal and stress-induced levels of ACTH and corticosterone, an interaction between ELS, shock exposure and sex was found regarding HPA hormones. In males, ELS did not affect ACTH response in any situation, whereas in females, ELS reduced both shock-induced sensitization of ACTH and its conditioned response to the shock context. Also, shock-induced sensitization of corticosterone was only observed in males and ELS specifically reduced corticosterone response to stressors in males but not females. In conclusion, ELS seems to have only a minor impact on shock-induced behavioral conditioning, while affecting the unconditioned and conditioned responses of HPA hormones in a sex-dependent manner.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Brewpitopes, a pipeline to refine B-cell epitope predictions during public health emergencies

  • Farriol-Duran, Roc
  • López-Aladid, Ruben
  • Porta-Pardo, Eduard|||0000-0001-7900-4239
  • Torres, Antoni|||0000-0002-8643-2167
  • Fernández Barat, Laia|||0000-0001-7528-9636
The application of B-cell epitope identification to develop therapeutic antibodies and vaccine candidates is well established. However, the validation of epitopes is time-consuming and resource-intensive. To alleviate this, in recent years, multiple computational predictors have been developed in the immunoinformatics community. Brewpitopes is a pipeline that curates bioinformatic B-cell epitope predictions obtained by integrating different state-of-the-art tools. We used additional computational predictors to account for subcellular location, glycosylation status, and surface accessibility of the predicted epitopes. The implementation of these sets of rational filters optimizes in vivo antibody recognition properties of the candidate epitopes. To validate Brewpitopes, we performed a proteome-wide analysis of SARS-CoV-2 with a particular focus on S protein and its variants of concern. In the S protein, we obtained a fivefold enrichment in terms of predicted neutralization versus the epitopes identified by individual tools. We analyzed epitope landscape changes caused by mutations in the S protein of new viral variants that were linked to observed immune escape evidence in specific strains. In addition, we identified a set of epitopes with neutralizing potential in four SARS-CoV-2 proteins (R1AB, R1A, AP3A, and ORF9C). These epitopes and antigenic proteins are conserved targets for viral neutralization studies. In summary, Brewpitopes is a powerful pipeline that refines B-cell epitope bioinformatic predictions during public health emergencies in a high-throughput capacity to facilitate the optimization of experimental validation of therapeutic antibodies and candidate vaccines.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease, Real-World Data and Challenges

  • Redondo, Sara|||0000-0001-8967-7410
  • Esquirol, Albert|||0000-0002-6062-5980
  • Novelli, Silvana|||0000-0001-8750-0195
  • Caballero, Ana Carolina|||0000-0002-4950-5259
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Oñate, Guadalupe|||0000-0003-2180-2371
  • López, Jordi
  • Moreno, Carol|||0000-0003-3275-0271
  • Saavedra, Silvana|||0000-0001-5699-0531
  • Granell, Miquel|||0000-0002-0366-3673
  • Briones Meijide, Javier|||0000-0003-2750-3735
  • Sierra, Jorge|||0000-0002-7966-0356
  • Martino Bofarull, Rodrigo|||0000-0001-5143-4042
  • García Cadenas, Irene|||0000-0002-2994-9055
Steroid-refractory (SR) chronic graft-versus-host disease (cGVHD) is a major obstacle in recipients of allogeneic stem cell transplantation (HCT). Ruxolitinib is the first agent to demonstrate superior efficacy to the best available therapy, but real-life data are still lacking. Here we describe the results of ruxolitinib compassionate use for the treatment of SR/steroid-dependent cGVHD in a tertiary care university hospital. In this retrospective single-center study, we evaluated the outcomes of 48 patients diagnosed with SR-cGVHD who were treated with ruxolitinib. Forty-seven (98%) had moderate-severe disease, and 27 (56%) had received ≥2 lines of prior therapy (excluding steroids). Results were analyzed using SPSS version 26.0.01 and R version 3.4.3. The overall response rate was 77% (37 of 48), with 15% (7 of 37) in complete remission. The median time to response was 2 months (range, 0.5 to 8 months). Steroid tapering was achieved in 26 patients (54%) and definitive discontinuation was achieved in 10 patients (21%) after a median of 20 months (range, 1.5 to 60 months). Toxicity was predominantly hematologic, including a 33% rate of anemia and a 17% rate of thrombocytopenia. Overall survival at 2 years was significantly higher in responders compared with nonresponders (88% [95% confidence interval (CI), 65% to 96%] versus 49% [95% CI, 12% to 78%]; P =.01). At last follow-up, tapering of ruxolitinib had been started in 8 of 37 responders (22%). Our experience supports the efficacy of ruxolitinib in the treatment of SR-cGVHD, along with its steroid-sparing effect and manageable toxicity. Gradual tapering of ruxolitinib seems feasible without cases of GVHD flare. More studies and longer follow-up are needed to confirm these data, as well as to identify the ideal dose adjustments in cases of toxicity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fetal Left Ventricle Function Evaluated by Two-Dimensional Speckle-Tracking Echocardiography across Clinical Stages of Severity in Growth-Restricted Fetuses

  • Domínguez Gallardo, Carla|||0000-0002-5365-1005
  • Ginjaume García, Nuria|||0000-0003-0785-0115
  • Ullmo, Johana|||0000-0002-9313-917X
  • Parra Roca, Juan|||0000-0001-6011-7815
  • Vázquez Fariñas, Ana|||0000-0001-6732-1667
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Llurba, Elisa|||0000-0003-4048-6407
Fetal growth restriction (FGR) can result in adverse perinatal outcomes due to cardiac dysfunction. This study used 2D speckle-tracking echocardiography to assess left ventricle (LV) longitudinal strain across FGR severity stages. A prospective longitudinal cohort study measured global (GLS) and segmental LV longitudinal strain in FGR fetuses, with evaluations conducted at various time points. FGR was classified into subtypes based on published criteria using fetal weight centile and Doppler parameters. A linear mixed model was employed to analyze repeated measures and compare Z-score measurements between groups throughout gestational age. The study included 40 FGR fetuses and a total of 107 evaluations were performed: 21 from small for gestational age (SGA), 74 from the FGR stage I, and 12 from the FGR stage ≥ II. The results indicate that SGA and stage I FGR fetuses exhibit higher LV GLS than stages ≥ II. Throughout gestation, SGA and FGR stage I fetuses showed similar behavior with consistently better LV GLS values when compared to FGR stages ≥ II. No significant differences were observed in LV GLS strain behavior between SGA and FGR stage I. In conclusion, all FGRs show signs of early cardiac dysfunction, with severe cases demonstrating significantly a lower LV GLS when compared to mild cases, suggesting deterioration of cardiac dysfunction with progression of fetal compromise.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients

  • Kamieniak, Marta M.
  • Rico, Daniel|||0000-0002-6561-2310
  • Milne, Roger L.|||0000-0001-5764-7268
  • Muñoz-Repeto, Ivan
  • Ibáñez, Kristina
  • Grillo, Miguel A.
  • Domingo, Samuel
  • Borrego, Salud|||0000-0002-2513-6161
  • Cazorla-Jiménez, Alicia|||0000-0002-9534-8418
  • García-Bueno, José María|||0000-0003-3892-8894
  • Hernando, Susana
  • García Donas, J.|||0000-0001-7731-3601
  • Hernández-Agudo, Elena
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Robles-Díaz, Luis|||0000-0002-8909-8520
  • Márquez Rodas, Ivan|||0000-0002-2476-668X
  • Cusidó, Maite|||0000-0003-1631-1500
  • Sáez, Raquel
  • Lacambra, Carmen
  • Osorio, Ana|||0000-0001-8124-3984
  • Urioste, Miguel|||0000-0001-7583-7305
  • Cigudosa, Juan C.
  • Paz-Ares, Luis|||0000-0002-3327-3246
  • Palacios, José|||0000-0002-6730-5066
  • Benitez, Javier|||0000-0002-0923-7202
  • García, María J.
Standard treatments for advanced high-grade serous ovarian carcinomas (HGSOCs) show significant side-effects and provide only short-term survival benefits due to disease recurrence. Thus, identification of novel prognostic and predictive biomarkers is urgently needed. We have used 42 paraffin-embedded HGSOCs, to evaluate the utility of DNA copy number alterations, as potential predictors of clinical outcome. Copy number-based unsupervised clustering stratified HGSOCs into two clusters of different immunohistopathological features and survival outcome (HR=0.15, 95%CI=0.03-0.81; P=0.03). We found that loss at 6q24.2-26 was significantly associated with the cluster of longer survival independently from other confounding factors (HR=0.06, 95%CI=0.01-0.43, P=0.005). The prognostic value of this deletion was validated in two independent series, one consisting of 36 HGSOCs analyzed by fluorescent in situ hybridization (P=0.04) and another comprised of 411 HGSOCs from the Cancer Genome Atlas study (TCGA) (HR=0.67, 95%CI=0.48-0.93, P=0.019). In addition, we confirmed the association of low expression of the genes from the region with longer survival in 799 HGSOCs (HR=0.74, 95%CI=0.61-0.90, log-rank P=0.002) and 675 high-FIGO stage HGSOCs (HR=0.76, 95%CI=0.61-0.96, log-rank P=0.02) available from the online tool KM-plotter. Finally, by integrating copy number, RNAseq and survival data of 296 HGSOCs from TCGA we propose a few candidate genes that can potentially explain the association. Altogether our findings indicate that the 6q24.2-26 deletion is an independent marker of favorable outcome in HGSOCs with potential clinical value as it can be analyzed by FISH on tumor sections and guide the selection of patients towards more conservative therapeutic strategies in order to reduce side-effects and improve quality of life.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience

  • Vives Armengol, Joaquim
  • Coll, Ruth
  • Gálvez-Montón, Carolina
  • Prat-Vidal, Cristina
  • Gastelurrutia, Paloma
  • Bayes-Genis, Antoni
Medicament de teràpia avançada; Medicament en investigació; Translacional (regulació), Medicamento de terapia avanzada; Medicamento en investigación; Traslacional (regulación), Advanced therapy medicinal product; Investigational medicinal product; Translational (regulation), A systematic and ordered product development program, in compliance with current quality and regulatory standards, increases the likelihood of yielding a successful advanced therapy medicinal product (ATMP) for clinical use as safe and effective therapy. As this is a novel field, little accurate information is available regarding the steps to be followed, and the information to be produced to support the development and use of an ATMP. Notably, successful clinical translation can be somewhat cumbersome for academic researchers. In this article, we have provided a summary of the available information, supported by our experience in Spain throughout the development of an ATMP for myocardial infarction, from the pre-clinical stage to phase I clinical trial approval., This work was supported by the Spanish Cell Therapy Network (TerCel) [RD16/0011/0006 and RD16/0011/0028]; and CIBER Cardiovascular [CB16/11/00403] projects, as a part of the National R&D&I Plan, and was co-funded by the ISCIII-Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF); the Government of Catalonia: Agency for Management of University and Research Grants (AGAUR) [2017-SGR-483 and 2017-SGR-719], PERIS Program (Health Department) [SLT002/16/00234 and SLT002/16/00209] and CERCA Program; La Caixa Banking Foundation; grants from the Spanish Ministry of Science, Innovation and Universities (MICINN) [SAF2017-84324-C2-1-R]; Institute of Health Carlos III (ISCIII) [PI18/00256, PIC18/00014, ICI19/00039, and PI19/01788], and cofunded by European Union (ERDF/ESF) - A way to build Europe. This work has also been funded by the Sociedad Española de Cardiología and by the Call for Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine 2019 of Center for Regenerative Medicine of Barcelona (CMR[B]). The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy

  • Grau Vorster, Marta
  • Lopez Montañes, Maria
  • Canto Puig, Ester
  • Vives Armengol, Joaquim
  • Oliver-Vila, Irene
  • Barba Suñol, Pere
  • Rudilla Salvador, Francesc
Immunoteràpia adoptiva; Citotoxicitat; Limfòcits T específics del virus (VST), Inmunoterapia adoptiva; Citotoxicidad; Linfocitos T específicos de virus (VST), Adoptive immunotherapy; Cytotoxicity; Virus specific T lymphocytes (VST), Immunosuppressed patients are susceptible to virus reactivation or de novo infection. Adoptive immunotherapy, based on virus-specific T lymphocytes (VST), can prevent or treat viral diseases. However, donor availability, HLA-compatibility restrictions, high costs, and time required for the production of personalized medicines constitute considerable limitations to this treatment. Ex vivo rapid and large-scale expansion of VST, compliant with current good manufacturing practice (cGMP) standards, with an associated cell donor registry would overcome these limitations. This study aimed to characterize a VST product obtained through an expansion protocol transferable to cGMP standards. Antigenic stimulus consisted of cytomegalovirus (CMV) pp65 peptide pool-pulsed autologous dendritic cells (DCs) derived from monocytes. G-Rex technology, cytokines IL-2, IL-7, and IL-15, and anti-CD3 and anti-CD28 antibodies were used for culture. At day 14 of cell culture, the final product was characterized regarding T cell subsets, specificity, and functionality. The final product, comprised mainly CD4+ and CD8+ T lymphocytes (49.2 ± 24.7 and 42.3 ± 25.2, respectively). The culture conditions made it possible to achieve at least a 98.89-fold increase in pp65-specific CD3+ IFN-γ+ cells. These cells were specific, as pp65-specific cytotoxicity was demonstrated. Additionally, in complete HLA mismatch and without the presence of pp65, alloreactivity resulted in <5% cell lysis. In conclusion, a cGMP scalable process for the generation of a large number of doses of CMV-specific cytotoxic T cells was successfully performed., Work in our laboratory was supported by the Spanish Cell Therapy Network (TerCel, file No. RD16/0011/0028), and carried out as part of AdvanceCat with the support of ACCIÓ (Catalonia Trade & Investment; Catalan government) under the Catalonian ERDF operational program (European Regional Development Fund) 2014-2020. Our laboratory was certified by the Catalan government as a Consolidated Research Group (ref. 2017SGR719).
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Machine-learning analysis identifies "elite" viral controllers with increased survival and homeostatic responses in critical COVID-19

  • García Mateo, Nadia
  • Álvaro Meca, Alejandro
  • Postigo, Tamara
  • Ortega, Alicia
  • Fuente, Amanda de La
  • Almansa, Raquel
  • Jorge, Noelia
  • González González, Laura
  • Sánchez Recio, Lara
  • Martínez, Isidoro
  • Martín Vicente, María Dolores
  • Muñoz Gómez, María José
  • Más, Vicente
  • Vázquez, Mónica
  • Cano, Olga
  • Vélez Serrano, Daniel
  • Tamayo, Luis
  • Berezo, José Ángel
  • Herrán Monge, Rubén
  • Blanco, Jesús
  • Enríquez, Pedro
  • Ryan Murúa, Pablo
  • Martínez de la Gándara, Amalia de la
  • Rodríguez, Covadonga
  • Andrade, Gloria
  • Bustamante Munguira, Elena
  • Renedo Sánchez Girón, Gloria
  • Cicuéndez Ávila, Ramón
  • Bustamante Munguira, Juan
  • Trapiello, Wysali
  • Gallego Curto, Elena
  • Úbeda Iglesias, Alejandro
  • Salgado Villén, María
  • Berruguilla Pérez, Enrique
  • Torre, María del Carmen de la
  • Güel, Estel
  • Casadiego, Fernando
  • Estella, Ángel
  • Recuerda Núñez, María
  • Sánchez Calvo, Juan Manuel
  • Campos Fernández, Sandra
  • Peñasco Martín, Yhivian
  • García Unzueta, María Teresa
  • Martínez Varela, Ignacio
  • Bouza Vieiro, María Teresa
  • Pérez García, Felipe|||0000-0002-4885-4334
  • Moreno Romero, Ana
  • Socias Crespí, Lorenzo
  • López Messa, Juan
  • Pérez Bastida, Leire
  • Vidal Cortés, Pablo
  • Río Carbajo, Lorena del
  • Nieto del Olmo, Jorge del
  • Prol Silva, Estefanía
  • Sagredo Meneses, Víctor
  • Albalá Martínez, Noelia
  • González Rivera, Milagros
  • Gómez, José Manuel
  • Carbonell, Nieves
  • Blasco, María Luisa
  • Gonzalo Calvo, David de
  • González, Jessica
  • Caballero, Jesús
  • Barberà, Carme
  • Martín Delgado, María Cruz
  • Valdivia, Luis Jorge
  • Martín López, Caridad
  • Nieto, María Teresa
  • Jorge García, Ruth Noemí
  • Maseda, Emilio
  • Loza Vázquez, Ana
  • Eiros, José María
  • Motos, Anna
  • Fernández Barat, Laia
  • Casenco Ribas, Joan
  • Ceccato, Adrián
  • Barbé, Ferran
  • Kelvin, David J.
  • Bermejo Martín, Jesús Francisco
  • Tedim, Ana P.
  • Resino, Salvador
  • Torres, Antoni
9 p., Instituto de Salud Carlos III, Canadian Institutes of Health Research, Fondo Europeo de Desarrollo Regional, European Social Fund, European Society of Clinical Microbiology and Infectious Diseases
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Evolution of the Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG) indication and mortality rates in Spain from 2010 to 2019

  • Gasulla Montardit, Óscar
  • Sarriá Santamera, Antonio
  • Mazaira Font, Ferrán Antonio
  • García Montero, Cielo|||0000-0001-6016-7855
  • Fraile Martínez, Óscar|||0000-0002-4494-6397
  • Cantalapiedra Vargas, Diego
  • Carrillo Rodríguez, Manuel Francisco|||0000-0002-0005-9235
  • Gómez Valcárcel, Belén
  • Ortega, Miguel A.
  • Álvarez de Mon Soto, Melchor|||0000-0003-1309-7510
  • Asúnsolo Del Barco, Ángel|||0000-0001-7898-4685
11 p., Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are the main interventional treatments for coronary artery disease (CAD) patients. Both procedures are constantly being perfected and developed. This study aims to analyze the evolution of intervention mortality rates of PCI and CABG in recent years in Spain. We use a database of all hospital discharges from CABG and PCI procedures in Spain during two periods, between the years 2010 to 2012 and 2016 to 2019. We elaborate two multivariate regression logistic models to test the differences in mortality between the two periods and the two procedures, adjusting the mortality rates by age, gender, and comorbidities. We find strong evidence that CABG significantly reduced mortality rates, especially in complex patients, while PCI remained almost constant. We also discuss how physicians incorporate the improvement in procedures? performance into the decision-making for the recommendation of these two procedures in CAD patient management., Comunidad de Madrid, Ministerio de Sanidad, Servicios Sociales e Igualdad, Fundación Starlite (ProACapital), Halekulani S.L., MJR
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Fluorescein labelled cationic carbosilane dendritic systems for biological studies

  • Fuentes Paniagua, María Elena
  • Serramía Lobera, María Jesús
  • Sánchez-Nieves Fernández, Javier|||0000-0003-0410-2285
  • Álvarez, Susana
  • Muñoz Fernández, María Ángeles
  • Gómez Ramírez, Rafael|||0000-0001-6448-2414
  • Mata de la Mata, Francisco Javier de la|||0000-0003-0418-3935
Cationic carbosilane dendrimers and dendrons labelled with one fluorescein unit have been synthesized. For dendrimers (generations 1–3), a random procedure was followed by successive addition of two types of thiol compounds to vinyl terminated derivatives, first one with –NH3Cl and second one with –NMe2HCl functions, subsequent reaction with FITC and finally quaternization with MeI. For dendrons, the use of compounds with a –NH2 group at the focal point and –NMe2 functions at the periphery allowed us to obtain the corresponding fluoresceinated cationic derivatives. The toxicity of these dendritic molecules was studied by MTT and their interaction with siRNA Nef by electrophoresis. Finally, second generation dendrimer and their dendriplexes with siRNA Nef were chosen as a model to analyse their in vivo biodistribution in a BALB/c mouse model. The highest levels for dendriplexes were found in spleen and liver, followed in lymph nodes, while lower levels were found in kidneys. This distribution is in accordance with long circulation times., Ministerio de Economía y Empresa, Comunidad de Madrid, Ministerio de Educación y Ciencia
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Dendronized Anionic Gold Nanoparticles: Synthesis, Characterization and Antiviral Activity

  • Peña González, Cornelia Emeritina|||0000-0002-9049-8804
  • García Broncado, Pilar
  • Ottaviani, Maria Francesca
  • Cangiotti, Michela
  • Fattori, Alberto
  • Hierro Oliva, Margarita
  • González Martín, M. Luisa
  • Pérez Serrano, Jorge|||0000-0002-4870-8978
  • Gómez Ramírez, Rafael|||0000-0001-6448-2414
  • Muñoz Fernández, María Ángeles
  • Sánchez-Nieves Fernández, Javier|||0000-0003-0410-2285
  • Mata de la Mata, Francisco Javier de la|||0000-0003-0418-3935
Anionic carbosilane dendrons decorated with sulfonate functions and with a thiol moiety at the focal point have been used to synthesize water soluble gold nanoparticles (AuNPs) by direct reaction of dendrons, gold precursor and reducing agent in water and also by place-exchange reaction. These nanoparticles have been characterized by nuclear magnetic resonance (NMR), transmission electron microscopy (TEM), thermogravimetric analysis (TGA), X-ray photoelectron spectroscopy (XPS), UV, elemental analysis, and Z potential. Also, the interacting ability of the anionic sulfonate functions was investigated by electron paramagnetic resonance (EPR) using copper(II) as a probe. It was found that the different structures and conformations of the AuNPs modulate the availability of sulfonate and thiol groups to be complexed by copper(II). Toxicity assays of AuNPs showed that those produced by direct reaction were less toxic than those obtained by ligand exchange. Inhibition of HIV-1 infection was higher for dendronized AuNPs than for dendrons., Ministerio de Economía y Empresa, Comunidad de Madrid, Universidad de Alcalá
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Transcriptomic profiling of thrombus-derived extracellular vesicles reveals PECAM-1 as a potential inflammatory marker for cardioembolic stroke patients

  • Machado, Florencio J.D.
  • Marta-Enguita, Juan
  • Herrera, María
  • Marta-Moreno, Javier
  • Páramo, José A.
  • Segura, Tomás
  • Serrano-Heras, Gemma
  • Hernández-Fernández, Francisco
  • Arias-Salazar, Lourdes
  • Yélamos-Sanz, Blanca
  • Zandio, Beatriz
  • Aymerich, Nuria
  • Muñoz, Roberto
  • Bermejo, Rebeca
  • Roncal Mancho, Carmen
  • Orbe, Josune
Accurate etiological diagnosis ensures appropriate secondary prevention of ischemic stroke (IS) patients. However, about 25–40% of IS cases remain of undetermined origin (referred to as ESUS if an unknown embolic source is suspected), highlighting the need to improve diagnostic precision. To identify potential biomarkers of IS etiologies, we analyzed the transcriptomic content of extracellular vesicles (EVs) from thrombi obtained after thrombectomy, including patients with cardioembolic (CE, n = 10), atherothrombotic (AT, n = 10) and ESUS (n = 10) IS (discovery cohort). mRNA levels of those differentially expressed genes in thrombus EVs were determined in microvascular brain endothelial cells after stimulation, revealing PECAM-1, as the most promising candidate. Next, PECAM-1 levels were determined in thrombi (n = 65) and serum samples (n = 95) of an independent validation cohort of IS patients, using immunohistochemistry and ELISA respectively. The transcriptome profiling and bioinformatics analysis revealed 1,514 gene transcripts in thrombus EVs, of which 114 were differentially expressed in AT vs CE etiologies. The genes upregulated in EVs from CE thrombi were enriched in pathways related to cell surface interactions at the vascular wall, leukocyte migration and neutrophil degranulation. Consistent with the increased PECAM-1 expression in thrombus EVs from CE vs AT etiologies, the endothelial expression of PECAM-1 increased after thrombin exposure and diminished upon atherogenic stimulation (oxLDL and TNFα). Moreover, thrombus expression of PECAM-1 was localized predominantly in platelet rich areas containing or surrounded by inflammatory cells and fibrin, and was higher in CE stroke thrombi. Serum levels of PECAM-1 were associated [OR (95%CI) 1.52 (1.14–2.03), p = 0.004] with the severity of stroke at Hospital admission. These findings collectively suggest that the transcriptional study of thrombus EVs may be useful to unravel the molecular pathways behind thrombus formation, and to explore local biological differences between IS etiologies. Specifically, PECAM-1, an adhesion molecule implicated in immuno-inflammatory processes, was increased in thrombi EVs and thrombi of patients with CE IS. Regarding the use of PECAM-1 as systemic biomarker, it did not discriminate IS etiologies, but was positively correlated with worse neurological outcome, suggesting a possible role of PECAM-1 in processes leading to brain injury post-IS., Red de Investigación Cooperativa Orientada a Resultados en Salud-Enfermedades Vasculares Cerebrales (RICORS-Ictus) RD21/0006/0008, RD24/0009/0028, and PI22/00436 financiado por el Instituto de Salud Carlos III, "Cofinanciado por la Unión Europea".
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Multimorbidity Patterns and Their Association with Social Determinants, Mental and Physical Health during the COVID-19 Pandemic

  • Carretero Bravo, Jesús Ángel
  • Ramos Fiol, Begoña
  • Ortega Martín, María Esther
  • Salazar Couso, Alejandro
  • O'Ferrall González, Cristina
  • Dueñas Rodríguez, María Ángeles
  • Peralta Sáez, Juan Luis
  • González Caballero, Juan Luis
  • Córdoba Doña, Juan Antonio
  • Lagares Franco, Carolina María
  • Martínez Nieto, José Manuel
  • Almenara Barrios, José
  • Álvarez Gálvez, Javier
  • Sanz Suarez-Lledo, Víctor José
Background: The challenge posed by multimorbidity makes it necessary to look at new forms of prevention, a fact that has become heightened in the context of the pandemic. We designed a questionnaire to detect multimorbidity patterns in people over 50 and to associate these patterns with mental and physical health, COVID-19, and possible social inequalities. Methods: This was an observational study conducted through a telephone interview. The sample size was 1592 individuals with multimorbidity. We use Latent Class Analysis to detect patterns and SF-12 scale to measure mental and physical quality-of-life health. We introduced the two dimensions of health and other social determinants in a multinomial regression model. Results: We obtained a model with five patterns (entropy = 0.727): ‘Relative Healthy’, ‘Cardiometabolic’, ‘Musculoskeletal’, ‘Musculoskeletal and Mental’, and ‘Complex Multimorbidity’. We found some differences in mental and physical health among patterns and COVID-19 diagnoses, and some social determinants were significant in the multinomial regression. Conclusions: We identified that prevention requires the location of certain inequalities associated with the multimorbidity patterns and how physical and mental health have been affected not only by the patterns but also by COVID-19. These findings may be critical in future interventions by health services and governments, 17 páginas
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

  • Bermejo Martin, Jesús F.
  • García Mateo, Nadia
  • Motos, Anna
  • Resino, Salvador
  • Tamayo, Luis
  • Ryan Murua, Pablo
  • Bustamante Munguira, Elena
  • Gallego Curto, Elena
  • Úbeda Iglesias, Alejandro
  • de la Torre, María del Carmen
  • Estella García, Ángel
  • Campos Fernández, Sandra
  • Martínez Varela, Ignacio
  • Pérez García, Felipe
  • Socias, Lorenzo
  • López Messa, Juan
  • Vidal Cortés, Pablo
  • Sagredo Meneses, Víctor
  • González Rivera, Milagros
  • Carbonell, Nieves
  • de Gonzalo Calvo, David
  • Martín Delgado, María Cruz
  • Valdivia, Luis Jorge
  • Martín López, Caridad
  • Jorge García, Ruth Noemí
  • Maseda, Emilio
  • Loza Vázquez, Ana
  • Kelvin, David J.
  • Barbé, Ferrán
  • Torres, Antoni
  • Ortega, Alicia
  • de la Fuente, Amanda
  • Almansa, Raquel
  • Postigo, Tamara
  • Jorge, Noelia
  • Tedim, Ana P.
  • González González, Laura
  • Sánchez Recio, Lara
  • Trapiello, Wysali
  • Berezo, José Ángel
  • Herrán Monge, Rubén
  • Blanco, Jesús
  • Enríquez, Pedro
  • Martínez, Isidoro
  • Martín Vicente, María
  • Muñoz Gómez, María José
  • Más, Vicente
  • Vázquez, Mónica
  • Cano, Olga
  • Martínez de la Gándara, Amalia
  • Rodríguez, Covadonga
  • Andrade, Gloria
  • Renedo, Gloria
  • Bustamante Munguira, Juan
  • Cicuendez Ávila, Ramón
  • Salgado Villén, María
  • Berruguilla Pérez, Enrique
  • Güell, Estel
  • Casadiego Monachello, Fernando Javier
  • Recuerda Núñez, María
  • Sánchez Calvo, Juan Manuel
  • Peñasco Martín, Yhivian
  • García Unzueta, María Teresa
  • Ceccato, Adrián
  • Fernández Barat, Laia
  • Bouza Vieiro, María Teresa
  • Moreno Romero, Ana
  • Pérez Bastida, Leire
  • del Río Carbajo, Lorena
  • Albalá Martínez, Noelia
  • Gómez, José Manuel
  • Blasco, María Luisa
  • Caballero, Jesús
  • Barberà, Carme
  • González, Jessica
  • Nieto, María Teresa
  • Nieto del Olmo, Jorge
  • Prol Silva, Estefanía
  • Canseco Ribas, Joan
  • Eiros, Jose María
Background: The contribution of the virus to the pathogenesis of severe COVID-19 is still unclear. We aimed to evaluate associations between viral RNA load in plasma and host response, complications, and deaths in critically ill patients with COVID-19. Methods: We did a prospective cohort study across 23 hospitals in Spain. We included patients aged 18 years or older with laboratory-confirmed SARS-CoV-2 infection who were admitted to an intensive care unit between March 16, 2020, and Feb 27, 2021. RNA of the SARS-CoV-2 nucleocapsid region 1 (N1) was quantified in plasma samples collected from patients in the first 48 h following admission, using digital PCR. Patients were grouped on the basis of N1 quantity: VIR-N1-Zero ([removed]2747 N1 copies per mL). The primary outcome was all-cause death within 90 days after admission. We evaluated odds ratios (ORs) for the primary outcome between groups using a logistic regression analysis. Findings: 1068 patients met the inclusion criteria, of whom 117 had insufficient plasma samples and 115 had key information missing. 836 patients were included in the analysis, of whom 403 (48%) were in the VIR-N1-Low group, 283 (34%) were in the VIR-N1-Storm group, and 150 (18%) were in the VIR-N1-Zero group. Overall, patients in the VIR-N1-Storm group had the most severe disease: 266 (94%) of 283 patients received invasive mechanical ventilation (IMV), 116 (41%) developed acute kidney injury, 180 (65%) had secondary infections, and 148 (52%) died within 90 days. Patients in the VIR-N1-Zero group had the least severe disease: 81 (54%) of 150 received IMV, 34 (23%) developed acute kidney injury, 47 (32%) had secondary infections, and 26 (17%) died within 90 days (OR for death 0·30, 95% CI 0·16–0·55; p<0·0001, compared with the VIR-N1-Storm group). 106 (26%) of 403 patients in the VIR-N1-Low group died within 90 days (OR for death 0·39, 95% CI 0·26–0·57; p[removed], 11 páginas